Experiences of living with Type I diabetes: psychological distress and clinical implications by Wilding, M. & Wilding, M.
Canterbury Christ Church University’s repository of research outputs
http://create.canterbury.ac.uk
Copyright © and Moral Rights for this thesis are retained by the author and/or other 
copyright owners. A copy can be downloaded for personal non-commercial 
research or study, without prior permission or charge. This thesis cannot be 
reproduced or quoted extensively from without first obtaining permission in writing 
from the copyright holder/s. The content must not be changed in any way or sold 
commercially in any format or medium without the formal permission of the 
copyright holders. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given e.g. Wilding, Michael G. 
(2015) Experiences of living with Type I diabetes: psychological distress and clinical 
implications. D.Clin.Psych. thesis, Canterbury Christ Church University. 
Contact: create.library@canterbury.ac.uk
   
 
 
MICHAEL G. WILDING BSc Hons  
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES: 
PSYCHOLOGICAL DISTRESS AND CLINICAL 
IMPLICATIONS 
 
 
Section A: Psychological distress and living with type 1 
diabetes: A review of the literature 
 
Word Count: 7960 (134) 
 
 
Section B: Exploring the lived experiences of adults with type 1 
diabetes: Psychological distress and implications for practice 
 
Word Count: 7932 (436) 
 
Overall Word Count: 15892 (570) 
 
A thesis submitted in partial fulfilment of the requirements of  
Canterbury Christ Church University for the degree of  
Doctor of Clinical Psychology 
 
 
APRIL 2015 
 
SALOMONS  
CANTERBURY CHRIST CHURCH UNIVERSITY  
 
 
2 
 
CANTERBURY CHRIST CHURCH UNIVERSITY 
Doctorate in Clinical Psychology (D.Clin.Psychol.) 
 
Assessment Cover Sheet for MRPs 
 
Please read the following candidate’s declaration, and tick the adjacent boxes to confirm that you 
have complied with each statement.  Then complete the cover sheet below in full.  Failing to do either 
will result in your assessment being delayed and/or returned to you for resubmission.  Please raise 
any queries regarding this form with your manager well in advance of submission. 
 
 
CANDIDATE’S DECLARATION 
This is my own work except where I have acknowledged the work of others.  I am 
aware that it is a breach of university regulations to copy the work of another without 
clear acknowledgement, and that attempting to do so will render me liable to 
disciplinary proceedings, both potentially through the University and my employer. 
 Tick to 
confirm 
 ✓ 
I confirm that, where appropriate and feasible, consent from research participants has 
been sought and obtained.  If consent has not been sought and/or obtained I confirm 
that the reasons for this have been addressed in the body of the report. 
 
Tick to 
confirm 
✓ 
I confirm that the word count cited below is exact, and within the limit allowed for this 
type of assessment.  The count includes all free text as well as words and numbers 
contained in quotations and footnotes (though not the title page, contents page, 
abstract, tables, figures, reference list or appendices).  I have presented the assessed 
work with line spacing, font size and page numbers as required in the relevant section 
of the assessment handbook. 
 Tick to 
confirm 
 ✓ 
I confirm that I have fully anonymised the context of this piece of work, such that no 
clients, personnel or services are identified  I am aware that should breaches of 
confidentiality be found, I may face both university and employer disciplinary 
procedures. 
 Tick to 
confirm 
 ✓ 
 
NAME Michael Wilding 
  
WORK TO BE ASSESSED 
(e.g. Clinical Portfolio Part 1, Child PPR, QIP) Major Research Project 
 
 
Tick if this is a resubmission of a Pass with Conditions ✓ 
  
SUBMISSION DATE 28/08/2015 
  
OVERALL WORD COUNT 15892 (570) 
 
 
 
4 
 
Acknowledgements 
 
Firstly I would like to extend my thanks to the people who gave up their time to 
meet with me and to share their experiences in the way that they did.  I feel honoured and 
deeply touched to have heard your stories and to have the opportunity to share your 
experiences as part of this research.  I also wish to thank the diabetes teams for your 
assistance with the project, the sharing of your ideas and your help with recruitment. 
To Dr Angela Busuttil; thank you for your support, the sharing of your vast 
experience and your enthusiasm about what this research could achieve.  Thank you to Prof 
Paul Camic for your guidance and thoughtful feedback throughout the research process.  A 
special thank you is also reserved for the Salomons library staff for their continued support 
and availability. 
Thank you as always to my Mum, Dad and sister Emma for your love and support, for 
always listening to my frustrations and offering me helpful advice.  
 Finally, thank you to my partner Juliet, for always believing in me, even when I 
found it hard to believe in myself. 
 
 
 
 
 
 
5 
 
Summary of the MRP portfolio 
 
Section A is a review of the literature concerning diabetes related psychological 
distress and the impact this has for both individuals living with type 1 diabetes and health 
professionals.  Studies investigating the relationship between diabetes related distress and 
various factors are examined, alongside studies evaluating the effectiveness of psychosocial 
interventions aimed at reducing diabetes related distress in practice.  Limitations of the 
literature and suggestions for further research are discussed alongside implications for 
clinical practice. 
 
Section B explores the experiences of adults living with type 1 diabetes using 
interpretative phenomenological analysis.  Eight participants completed a semi-structured 
interview and the master and sub themes that emerged from these discussions are 
considered with reference to prior research.  The implications of the findings for future 
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Abstract 
Background.  Previous research suggests that people living with diabetes are as 
much as two-three times more likely to experience mental health difficulties compared with 
the general population.  However, evidence is emerging that many of these difficulties may 
in fact be a direct result of feeling distressed about living with a complicated and stressful 
chronic health condition and not necessarily resultant from co-morbid psychiatric illness.  
These experiences are known by the term diabetes related distress.  Recent studies have 
demonstrated that high numbers of people living with diabetes across the world report 
experiences of diabetes related distress, but as yet there exists no systematic review of the 
literature on this subject for people living with type 1 diabetes. 
Aims. This review aimed to provide an overview of the recent literature concerning 
diabetes related psychological distress and consider the impact this has for both individuals 
living with type 1 diabetes and health professionals, within a biopsychosocial framework. 
Method. The databases PsycINFO, MEDLINE and Web of Science were searched 
usiŶg the folloǁiŶg teƌŵs: ͞Diaďetes͟ O‘ ͞TϭD͟ O‘ ͞IDDM͟ AND ͞psǇĐhologiĐal distƌess͟ O‘ 
͞eŵotioŶal distƌess͟.  Peer reviewed studies including; correlational studies exploring the 
associations between diabetes related distress and other factors, qualitative studies 
exploring peoples experiences of diabetes related distress and studies evaluating 
psychosocial interventions for diabetes related distress were identified and reviewed.  
References and citations were also checked for further relevant studies. 
Results.  Studies identified associations between diabetes related distress and poor 
management of the condition, alongside other factors such as: experiences of severe low 
blood sugar, level of satisfaction with healthcare support, and younger age.  Group 
psychosocial interventions such as mindfulness based cognitive therapy, facilitated peer 
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support, and psycho-education appeared particularly effective at reducing diabetes related 
distress.  Emerging evidence also suggests that individual psychological therapy within a 
mental health context may not be effective at reducing distress related to living with 
diabetes. 
Conclusion.  Diabetes related psychological distress is a complex phenomenon which 
potentially interrelates with various other psychological, biological and social factors across 
the lifespan.  Studies are beginning to consider this concept for people living with type 1 
diabetes alongside interventions which may be helpful.  Despite this, further research and 
awareness of diabetes related distress in practice is needed. 
 
Keywords: Type 1 Diabetes, Psychological Distress, Depression, Review 
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Introduction 
Type one diabetes (T1D) is a chronic autoimmune disease culminating in the 
destruction of insulin secreting beta (βͿ cells in the pancreas (Bluestone, Herold, & 
Eisenbarth, 2010; Todd, 2010).  Insulin is a hormone utilised in the metabolism of 
carbohydrates and lipids following digestion or release from storage, which results in 
elevated levels of glucose in the bloodstream (Randle, Garland, Hales, & Newsholme, 1963).  
Insulin operates by facilitating the uptake of glucose from the blood to the muscles for 
immediate use as energy, or fat and liver cells to become stored deposits (Peyrot, McMurry 
Jr, & Kruger, 1999).  In healthy individuals the regulation of blood glucose involving insulin is 
homeostatic, with insulin being released from the pancreas when blood glucose levels 
become elevated (Matthews et al., 1985).  In T1D the absence of insulin results in higher 
than optimum amounts of glucose in blood plasma known as hyperglaecemia (Giugliano, 
Ceriello, & Esposito, 2008). 
Biomedical effects of type 1 diabetes 
Hyperglaecemia can lead to acute physiological difficulties including fatigue, 
increased thirst and urination, headaches, dehydration and compromised immune 
functioning leading to increased risk of infection (Eastman, Johnson, Silverstein, Spillar, & 
McCallum, 1983; Montori, Bistrian, & McMahon, 2002).  High blood glucose levels can also 
affect mood and decrease cognitive performance (Cox et al., 2005; Sommerfield, Deary, & 
Frier, 2004).  Left untreated or when co-occurring with other acute illness, hyperglycaemia 
can quickly progress to dangerous states such as diabetic ketoacidosis (DKA), which are 
associated with multiple additional difficulties and a high risk of death (Kitabchi, Umpierrez, 
Miles, & Fisher, 2009). 
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Sustained hyperglaecemia over time can also lead to additional health complications.  
Long term blood glucose levels are monitored by testing glycosylated haemoglobin (HbA1c) 
as part of diabetes management.  Higher HbA1c values increase the risk of complications 
(Nathan, 2014).  However, only 26% of people with T1D in the UK have HbA1c values in the 
recommended range, and subsequently diabetes1 is the leading cause of blindness in 
working age adults and a direct contributor to cardiovascular disease, stroke, limb 
amputations, neuropathy and kidney failure (Diabetes UK, 2013).   
To achieve optimal glycaemic control, people living with T1D are required to 
regularly administer exogenous insulin via injection for the remainder of their lives 
(Atkinson, Eisenbarth, & Michels, 2014).  This forms part of ongoing blood glucose 
management as a component of a multifaceted behavioural and treatment regime 
(Shrivastava, Shrivastava, & Ramasamy, 2013).   
In healthy individuals when blood sugar levels decrease the endogenous release of 
insulin is halted and stored glucose is released in response (Quesada, Tudurí, Ripoll, & 
Nadal, 2008).  When treating T1D administering insulin can result in blood glucose levels 
decreasing even when below the optimum range (hypoglaecemia).  Common symptoms of 
hypoglaecemia include autonomic responses such as sweating, tremor and increased heart 
                                                          
1 Type two diabetes (T2D) and T1D are the two most common sub types of diabetes.  They are often 
ƌefeƌƌed to ĐolleĐtiǀelǇ ;aloŶgside less ĐoŵŵoŶ suď tǇpesͿ as ͚diaďetes͛ oƌ ͚diaďetes ŵellitus͛ ;Woƌld 
Health Organization, 2006).  Despite this the pathogenesis (and subsequent treatment) of T1D 
differs significantly from that of T2D.  The immune-associated destruction of pancreatic β cells 
present in T1D is not a feature in the development of T2D (Cnop et al., 2005).  T2D is thought to be 
caused by a combination of age, lifestyle and genetic factors (Lindström et al., 2006).  In T2D insulin 
is still produced by β cells but it is not utilised effectively due to the cells of the body becoming 
resistant to insulin activity (Alberti & Zimmet, 1998).  Without treatment, both T1 and T2 diabetes 
result in hyperglaecemia albeit due to differing aetiology. 
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rate, often accompanied by feelings of anxiety.  Furthermore, direct glucose deprivation to 
the brain causes neuroglycopenic symptoms including confusion, drowsiness and difficulties 
speaking or concentrating (Hepburn et al., 1991).  If hypoglycaemia is not treated by 
ingesting carbohydrates, it can progress to coma and then death (Cryer, 2007).  Attempting 
to control a metabolic process with a combination of medicine and behaviour is incredibly 
challenging.  Subsequently it is often difficult for people living with diabetes to achieve 
optimal glycaemic control (Ali et al., 2013; Diabetes UK, 2013).   
Psychosocial implications of living with type 1 diabetes 
The biopsychosocial model of health and illness theorises that understanding the full 
impact that living with an illness is impossible, unless it is considered it in terms of its 
biological, psychological and social dimensions (Engel, 1977).   Applying the biopsychosocial 
model to managing T1D expands the viewpoint further than simply adhering to a behaviour 
and treatment regime.  Peyrot et al., (1999) examined the interaction between biological 
and psychosocial determinants of diabetes control.  They found that whilst treatment 
regime compliance was an important mediating factor, glycaemic control in T1D is more 
responsive to psychosocial factors including; education, marital status, positive coping 
styles, and levels of emotional distress compared to T2D. 
Living with diabetes can introduce a number of social challenges.  A recent review of 
the literature by Schabert, Browne, Mosely, and Speight (2013) concluded that despite the 
fact the general public widely believe that diabetes is not a stigmatised condition, many 
people living with diabetes report feeling stigmatised, judged and monitored by others.  
Many people living with T1D describe experiences of discrimination in the workplace 
(Petrides et al., 1995) and many health professionals working in diabetes care report 
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perceived social discrimination against patients (Holt et al., 2013).  Family members of 
people living with diabetes often also experience a negative impact on their lives including: 
elevated distress, experiencing diabetes as a burden and feeling unable to help the family 
member concerned (Kovacs Burns et al., 2013).    
The complex and continuous nature of attempting to manage diabetes day to day is 
considered highly psychologically demanding (Cox & Gonder-Frederick, 1992), and related 
psychological sequalae are commonly reported.  Compared with the general population, 
people living with diabetes are up to 40% more likely to report elevated levels of anxiety, 
with rates of anxiety disorders 14% more common (Grigsby, Anderson, Freedland, Clouse, & 
Lustman, 2002).  Recent meta-analyses estimate that people living with diabetes are twice 
as likely to experience depression compared to people without (Anderson, Freedland, 
Clouse, & Lustman, 2001), with people living with T1D as much as three times more likely 
(Roy & Lloyd, 2012).  A meta-analytic review of the literature by Lustman et al., (2000) has 
also linked depression with hyperglaecemia for people living with both T1 and T2 diabetes. 
However, emerging research in diabetes suggests these figures must be interpreted 
with caution.  Fisher, Gonzalez, and Polonsky (2014) note that historic studies investigating 
the relationships between diabetes and depression (many included in the meta-analyses 
cited above) report inconsistent and contradictionary findings.  They suggest that taking a 
symptom based approach to quantifying emotional distress and depressive symptoms 
(often using traditional self-report measures without considering causes or content of 
symptoms), does not allow for the inclusion of the context of living with diabetes and its 
subsequent impact on these variables.  They conclude that this has resulted in a failure to 
consistently define and measure depression across previous research studies in relation to 
diabetes.   
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Diabetes related psychological distress 
Gonzalez, Fisher, and Polonsky (2011) argue that many emotional difficulties 
reported by people living with diabetes are labelled as co-morbid psychiatric disorders such 
as depression, when they may be better understood as reasonable feelings of distress about 
living with a health condition that is hard to manage, complicated and stressful.  These 
experiences have been termed diabetes related psychological distress2 and are defined by 
Strandberg, Graue, Wentzel-Larsen, Peyrot, and Rokne (2014) as:  
͞A range of emotional responses and reactions to life with diabetes, especially those 
related to the treatment regimen and self-care demands. It is part of a person's 
experience of managing diabetes and its treatment in the social context of family 
and health-care personnel͟ (p. 175).  
People across the world have reported experiencing diabetes related distress.  The 
recent diabetes attitudes wishes and needs (DAWN; Skovlund & Peyrot, 2005) and 
subsequent DAWN2 studies (Peyrot et al., 2013) involved nearly 15,000 people living with 
both T1 and T2 diabetes, a sample of their families and over 8,500 health professionals from 
17 countries.  The studies, reported across multiple papers, found that nearly 75% of people 
living with diabetes who were surveyed reported experiencing psychological distress related 
to one or more domains of their diabetes management (Skovlund & Peyrot, 2005).  In 
addition, 46% reported clinically significant levels of diabetes related distress, which is likely 
to seriously impact upon functioning and well-being (Nicolucci et al., 2013).  Diabetes 
                                                          
2 Also referred to as diabetes specific/related emotional distress, diabetes specific/related distress, 
diabetes distress or DD. 
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related distress is also described by healthcare professionals as having a negative impact on 
people͛s management of diabetes (Peyrot et al., 2005).   
Importance of understanding diabetes related distress 
van Bastelaar et al. (2010) investigated the relationship of diabetes related distress 
to both depression and HbA1c values for people living with both T1 and T2 diabetes.  They 
found that diabetes related distress was an important mediator variable between both of 
these factors.  This suggests not only that diabetes related distress may account for the 
presence of depressive symptoms using self-report measures, but also that it could 
potentially influence diabetes clinical outcomes such as glycaemic control.  Furthermore, 
research by Lloyd, Pambianco, and Orchard (2010) found strong correlations between 
diabetes related distress and depressive symptoms for people living with T1D independent 
of other potential covariates including gender, diabetes duration and the presence of 
additional complications.  Self-report measures for diabetes related distress have also been 
demonstrated to more accurately indicate the presence of sub-clinical depression, clinical 
depression and diabetes related distress when compared with measures of depression 
alone (Hermanns, Kulzer, Krichbaum, Kubiak, & Haak, 2006). 
These findings are consistent with the arguments of Fisher et al. (2014) that diabetes 
related distress may account for depressive symptoms on self-report instruments, leading to 
the over diagnosis of depression by diabetes healthcare professionals.  This lack of clarity 
has been described as promoting the use of interventions in clinical practice aimed at 
ƌeduĐiŶg depƌessiǀe sǇŵptoŵs that do Ŷot adeƋuatelǇ addƌess aŶ iŶdiǀidual͛s distƌess 
related to living with diabetes (Esbitt, Tanenbaum, & Gonzalez, 2013). 
Not providing appropriate support for diabetes related distress could have wide 
ranging implications.  There were an estimated 366 million people living with diabetes 
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worldwide in the year 2000; this is predicted to increase to 552 million by the year 2030 
(Whiting, Guariguata, Weil, & Shaw, 2011).  People living with T1D constitute approximately 
10% of this number (Diabetes UK, 2012), making them a significant minority within this 
group.  Treating T1D cost the UK NHS £1.9bn in 2010/11, with half of that figure spent 
treating potentially avoidable health complications resultant from sub-optimal glycaemic 
control.  Without action this figure is predicted to rise to £4.2bn (with £2.4bn spent on 
complications) by 2035/36 (Hex, Bartlett, Wright, Taylor, & Varley, 2012).  Additional health 
complications related to poorly managed diabetes have also been shown to have a 
sigŶifiĐaŶt Ŷegatiǀe iŵpaĐt oŶ aŶ iŶdiǀidual͛s perceived quality of life (QoL; Rubin & Peyrot, 
1999).  The associated costs (both economic and related to individual well-being) of poorly 
managed diabetes, mean that understanding ways to reduce its negative impact is 
considered a key ongoing public health issue (American Diabetes Association, 2013; Venkat 
Narayan, Gregg, Fagot-Campagna, Engelgau, & Vinicor, 2000).  Diabetes related distress has 
been shown to be a significant mediator variable in glycaemic control for people living with 
T1D (van Bastelaar et al., 2010), and could be a key piece of the puzzle in the management 
of this serious and often costly health condition. 
For people living with diabetes, optimal glycaemic control significantly reduces the 
risk of developing serious and costly health complications (Nathan, 2014) and is also 
associated with improved health related quality of life (Rubin & Peyrot, 1999).  Despite this, 
it is often difficult for people living with diabetes to achieve optimal glycaemic control (Ali et 
al., 2013; Diabetes UK, 2013) and diabetes related distress has been shown to be a negative 
influence on how people manage the condition (Lloyd et al., 2010; Peyrot et al., 1999; 
Peyrot et al., 2005; van Bastelaar et al., 2010).  Further understanding of this phenomenon 
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could be vitally important both for improving the lives people living with T1D and increasing 
knowledge of healthcare professionals who work with them. 
 
 
Methodology 
Aims of review 
The importance of further consolidating knowledge and understanding of diabetes 
ƌelated distƌess has ďeeŶ deŵoŶstƌated iŶ Egede aŶd Disŵuke͛s ;ϮϬϭϮͿ comprehensive 
review of the contemporary literature.  However, the review focused solely on T2D and the 
author is unaware of an existing review of this nature for T1D.  This review aims to provide a 
systematic overview of recent literature in order to answer the following questions: 
A) What is the impact of experiencing diabetes related psychological distress for 
people living with type 1 diabetes? 
B) What psychosocial interventions for diabetes related distress are available for 
healthcare professionals working with people living with type 1 diabetes? 
Review process 
The databases PsycINFO, MEDLINE and Web of Science were searched using the 
following terms:  
͞Diaďetes͟ O‘ ͞TϭD͟ O‘ ͞IDDM͟3 AND ͞psǇĐhologiĐal distƌess͟ O‘ ͞eŵotioŶal 
distƌess͟4. 
                                                          
3 IDDM = Insulin Dependent Diabetes Mellitus. 
4 The teƌŵ ͞distƌess͟ ǁas oƌigiŶallǇ used iŶ plaĐe of ͞psǇĐhologiĐal distƌess͟ O‘ ͞eŵotioŶal distƌess͟.  
However this combination of search terminology yielded too many results to be realistically included 
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Searches were restricted to peer reviewed journal articles published in English only.  
Searches were also limited to the years 2012-2015.  2012 was chosen as a start point as the 
first papers from the DAWN2 study began to emerge around this time (e.g. Holt et al., 2013; 
Kovacs Burns et al., 2013; Nicolucci et al., 2013; Peyrot et al., 2013) and was a definitive 
moment in establishing the prevalence of diabetes related distress across the world.  
Inclusion criteria 
Research studies were selected for inclusion when the sample consisted of 
participants living with T1D only, or people living with T1D in addition to other types of 
diabetes and when diabetes related distress was either a primary or secondary variable 
measured.  In addition, qualitative studies considering psychological distress for people 
living with T1D were also included. 
Article titles were screened for appropriateness before abstracts were read fully to 
identify papers to select for full text screening.  Identified articles were then read in full 
before deciding about inclusion in the review.   
Published reference lists all of full texts read were scanned for citations meeting the 
review inclusion criteria.  If identified, abstracts were retrieved and the process above 
repeated to assess eligibility and/or inclusion.  15 articles were selected to be included in 
the review.  Figure 1 outlines the selection process in further detail. 
                                                          
in a review of this nature.  In addition many of the results were inappropriate (e.g. investigating 
neuronal distress pathways). 
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Figure 1. Study selection process flow diagram 
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Evaluation criteria 
Articles included in the final review were critically evaluated with reference to 
appropriate criteria for good quality research.  Randomised controlled trials (RCTs) were 
reviewed with reference to the Consolidated Standards of Reporting Trials (CONSORT) 
criteria (Schulz, Altman, & Moher, 2010).  Other study designs were considered in light of 
the Critical Skills Appraisal Programme (CASP) criteria for good quality research relevant to 
the study design utilised (CASP, 2015).  Qualitative studies were critiqued with reference to 
Elliott, Fischer, and Rennie͛s (1999) guidelines for the publication of qualitative research. 
Many studies included in the review employed self-report instruments to measure a 
multitude of different variables.  It is beyond the scope of this paper to evaluate the quality 
of all of these in detail.  However the psychometric properties of self-report tools that were 
used to measure diabetes related psychological distress by 1 or more of the 15 review 
papers are presented in Appendix A. 
Findings 
Studies have been grouped together into four themes for reporting purposes, these 
are: ͚Relationship between diabetes related distress and glycaemic control͛, ͚relationship 
between diabetes related distress and other factors͛, ͚mindfulness based psychological 
interventions͛ and ͚other psychosocial interventions͛.  Table 1 provides an overview of 
studies included in the review. 
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Table 1. Articles reviewed 
 
Author(s)/ 
Year 
Sample Details Intervention 
(if applicable) 
Variables and Measures Used Study Design Key Reported Findings 
Relationship between diabetes related distress and glycaemic control 
Reddy, 
Wilhelm, & 
Campbell 
(2013) 
184 people 
living with 
diabetes (T1D 
n=51 & T2D n= 
133) 
 
Australia 
Battery of 
self-report 
measures 
and 
structured 
interview 
Diabetes related psychological 
distress (Problem Areas In 
Diabetes scale) 
General psychological distress 
(Kessler-10 item) 
Depressive Symptoms (Patient 
Health Questionnaire-9) 
Health Related QoL (Short-Form 
Health Survey) 
Past depressive history 
(Structured clinical interview with 
psychiatrist) 
Glycaemic control (HbA1c) 
Cross-sectional 
design 
Higher levels of diabetes related distress were 
significantly correlated with higher HbA1c 
values. 
Diabetes related psychological distress was 
strongly associated with current depression and 
general psychological distress. 
Experiences of diabetes related distress were 
more common for people with a previous 
history of depression even in the absence of 
current depressive symptoms. 
 
 
Scholes et 
al. 
(2013) 
14 young 
people (aged 
11-22) living 
with T1D 
 
USA 
N/A PaƌtiĐipaŶts plaĐed iŶto ͚high͛ oƌ 
͚loǁ͛ HďAϭĐ gƌoups ďased oŶ 
previous results prior to the 
study.  All participants completed 
the same open-ended interviews 
Qualitative design. 
Analysed using 
inductive thematic 
approach 
Many participants reported distress when 
dealing with health professionals who 
interacted in an authoritative way which was 
experienced as not understanding or helpful. 
Many friends or family members did not 
understand diabetes or were fearful of it, this 
was often experienced as increasing burden and 
distress about living with diabetes.  However 
many participants also reported that friends 
and family often showed concern and helped to 
reduce distress. 
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Diagnosis was described as a distressing time by 
many participants and this distress often 
continued if people did not feel they were given 
adequate support or guidance by parents or 
health professionals. 
People with a high HbA1c were more likely to 
report the experience of diagnosis as 
distressing, receiving less support from 
healthcare teams and families and were more 
likely to believe in the likelihood of a cure for 
diabetes in the future, than those with low 
HbA1c.  
Zoffmannn, 
Vistisen, & 
Due‐
Christensen 
(2014) 
710 young 
adults (aged 18-
35) living with 
T1D 
 
Denmark 
Battery of 
self-report 
measures 
Diabetes related distress 
(Problem Areas in Diabetes scale) 
Well-being (WHO-5 Well-being 
Index) 
Self-worth 
;‘oseŶďeƌg͛s “elf Esteeŵ “ĐaleͿ 
Support for autonomy from 
healthcare providers 
(Health Care Climate 
Questionnaire) 
Motivations for engaging in 
health behaviours (Treatment 
Self-Regulation Questionnaire) 
Perceived competence in 
managing diabetes 
(Perceived Competence in 
Diabetes Scale) 
Cross-sectional 
design 
Higher well-being and perceived competence 
were correlated with lower HbA1c values. 
Higher levels of motivation and lower diabetes 
related psychological distress were both 
correlated with lower HbA1c levels. 
Health care climate was not found to be 
significantly correlated with HbA1c. 
Clinically significant diabetes related distress 
was significantly more likely to be reported by 
participants with HbA1c values above 8%, but 
was also common amongst individuals with 
HbA1c values lower than 8%. 
Women were significantly more likely to report 
high levels of diabetes related psychological 
distress than men. 
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Glycaemic control (HbA1c & 
number of diabetes related 
complications) 
Strandberg 
et al. (2014) 
 
235 adults 
(aged 18-69) 
living with T1D 
 
Norway 
 
Battery of 
self-report 
measures 
Diabetes specific emotional 
distress (Diabetes Distress Scale & 
Problem Areas in Diabetes scale) 
Anxiety and Depression (Hospital 
Anxiety and Depression Scale) 
Well-being (WHO-5 Well-Being 
Index) 
Glycaemic control (HbA1c) 
Cross-sectional 
design 
Following regression analysis, significant 
associations between diabetes specific 
emotional distress and HbA1c values were 
reported. 
There were no significant associations between 
depression, anxiety or overall well-being with 
HbA1c levels. 
Relationship between diabetes related distress and other factors 
Balfe et al. 
(2013) 
35 young adults 
(aged 23-30) 
living with T1D 
 
Ireland 
N/A Semi-structured interviews Qualitative design. 
Analysed using 
thematic approach 
Diabetes related distress was commonly 
reported and was underpinned by many factors 
including; stigma/self-consciousness, difficulties 
managing diabetes day to day, fighting the 
health care system, restrictions and limitations, 
media representation of diabetes, worries 
about the future and concerns regarding 
pregnancy. 
Kibbey et al. 
(2013) 
86 young adults 
(aged 18-30) 
living with T1D 
from a region of 
social 
disadvantage 
 
Australia 
Battery of 
self-report 
measures 
Glycaemic control (Self-reported 
HbA1c) 
Diabetes related distress 
(Problem Areas in Diabetes scale) 
Depression/Anxiety  
(Hospital Anxiety and Depression 
Scale) 
Illness perceptions 
(Brief Illness Perceptions 
Questionnaire) 
Mixed-methods 
cross-sectional 
design 
Participants reported feeling significantly more 
satisfied with their diabetes care if they were 
treated in tertiary care, had contact with an 
endocrinologist or nurse specialist within the 
last 6 months and were aware of their latest 
HbA1c value.  
Those more satisfied with care experienced 
significantly lower levels of diabetes related 
distress, lower levels of anxiety and depression 
and lower HbA1c. 
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Enablers and barriers to accessing 
diabetes care (study-specific 
questionnaire) 
Optional free text responses 
Diabetes related distress was higher in this age 
group than compared with the general 
population in adults in Australia. 
Responses to free text questions indicated that 
many participants experienced feelings of 
disempowerment, lack of acknowledgment as 
an individual, and disillusionment with ongoing 
efforts to control and manage diabetes.   
Hendrieckx 
et al. (2014) 
422 adults 
(mean age 37.5 
years) living 
with T1D 
 
Australia 
Battery of 
self-report 
measures 
Assessments of hypoglaecemia: 
Self-reported severe 
hypoglaecemic episodes (derived 
from the Hypoglaecemia 
Awareness Questionnaire, 
HypoA-Q)  
Impaired awareness of 
hypoglaecemia (Gold score) 
Psychological measures: 
General emotional well-being 
(WHO-5 Well-being Index) 
Diabetes related distress 
(Problem Areas In Diabetes scale) 
Diabetes specific positive well-
being (Well-being Questionnaire-
28) 
Fear of hypoglycaemia  
(Hypoglaecemia Fear Survey) 
Cross-sectional 
design 
Participants who reported experiencing a 
severe hypoglaecemic episode in the previous 6 
months were significantly more likely to 
experience increased fear of hypoglaecemia, 
greater diabetes related psychological distress 
and poorer general emotional well-being than 
those who had not experienced a severe 
episode of hypoglaecemia. 
Stuckey et 
al. (2014) 
8,596 adults 
living with 
diabetes (T1D 
N/A Structured face to face, 
telephone and internet questions 
as part of larger survey. 
 
Qualitative design. 
Emergent coding 
used to identify 
commonalities in 
Negative psychosocial themes reported by 
participants included; feeling fearful and 
anxious, worry about hypos, concerns about the 
future complications, depression/negative 
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n=1,368 & T2D 
n=7,228) 
From 17 
countries; 
Algeria, Canada, 
China, 
Denmark, 
France, 
Germany, India, 
Italy, Japan, 
Mexico, 
Netherlands, 
Poland, Russia, 
Spain, Turkey, 
UK and USA. 
psychosocial 
experiences 
between countries. 
mood, discrimination at work, and public 
misunderstanding about diabetes. 
Helpful psychosocial themes were; receiving 
support from compassionate healthcare 
professionals, family, friends and other people 
living with diabetes. 
Mindfulness based psychological interventions 
van Son et 
al. (2013)  
139 people 
living with 
diabetes (T1D 
n=42 & T2D 
Ŷ=ϵϳͿ ǁith ͞loǁ 
emotional 
ǁellďeiŶg͟ 
(score > 13 on 
WHO-5 Well-
being Index) 
 
Netherlands 
Group 
mindfulness 
based 
cognitive 
therapy 
(MBCT) 
Perceived stress (Perceived Stress 
Scale) 
Anxiety and depressive symptoms 
(Hospital Anxiety and Depression 
Scale) 
Mood (Profiles of Mood States) 
Diabetes specific distress 
(Problem Areas in Diabetes scale) 
Health related QoL (12-Item 
Short-Form Health Survey) 
Glycaemic control (HbA1c) 
RCT cross-over 
design: MBCT 
intervention 
compared to 
treatment as usual 
(TAU) control group. 
Repeated measures 
(baseline, 4 and 8 
weeks follow up).  
MBCT intervention resulted in significant 
reductions in stress, depressive symptoms, and 
anxiety, alongside significant increases in QoL 
compared with TAU control group.  
No significant changes to either HbA1c levels or 
diabetes related distress were found following 
MBCT intervention or TAU. 
van Son et 
al. (2014) 
139 people 
living with 
Group 
mindfulness 
Perceived stress (Perceived Stress 
Scale) 
Follow up study for 
van Son et al. (2013). 
Significant reductions in stress and anxiety 
combined with significant increases in QoL 
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diabetes (T1D 
n=42 & T2D 
Ŷ=ϵϳͿ ǁith ͞loǁ 
emotional 
ǁellďeiŶg͟ 
(score > 13 on 
WHO-5 Well-
being Index) 
 
Netherlands 
based 
cognitive 
therapy 
(MBCT) 
Anxiety and depressive symptoms 
(Hospital Anxiety and Depression 
Scale) 
Mood (Profiles of Mood States) 
Diabetes specific distress 
(Problem Areas in Diabetes scale) 
Health related QoL (12-Item 
Short-Form Health Survey) 
Glycaemic control (HbA1c) 
RCT cross-over 
design: MBCT 
intervention 
compared to 
treatment as usual 
(TAU) control group. 
Repeated measures 
(original measures 
from 2013 study plus 
6 month follow up 
from current study). 
compared with TAU control group continued to 
be observed at 6 month follow up.  
The reported significant reduction in depressive 
symptoms found in the previous study was not 
maintained at 6 month follow up. 
No significant changes to either HbA1c levels or 
diabetes related distress were found in either 
group at 6 month follow up. 
Tovote et al. 
(2014) 
94 people living 
with diabetes 
(T1D n=37 & 
T2D n=57) and 
depressive 
symptoms 
;sĐoƌe ≥ ϭϰ oŶ 
BDI-II)   
 
Netherlands 
Individual 
mindfulness 
based 
cognitive 
therapy  
(MBCT) or 
cognitive 
behavioural 
therapy (CBT) 
Depressive symptoms (Beck 
Depression Inventory-II & 
Hamilton Depression Rating 
Scale) 
Anxiety (Generalized Anxiety 
Disorder 7) 
Well-being (Well-Being Index) 
Diabetes related distress 
(Problem Areas in Diabetes scale) 
Glycaemic control (HbA1c) 
RCT: MBCT 
intervention 
compared to CBT 
intervention or 
waiting list control 
group. 
Repeated measures 
(baseline and 3 
months post 
intervention) 
Significant reductions in depressive symptoms, 
anxiety and diabetes related distress alongside 
increases in well-being were reported for 
participants in MBCT and CBT groups compared 
with waiting list controls. 
No significant effect was reported on HbA1c 
values for participants in any group. 
Other psychosocial interventions 
Due‐
Christensen 
et al.  
(2012) 
 
54 people living 
with T1D (aged 
≥ Ϯϭ diagŶosed 
≥ ϭ Ǉeaƌ eaƌlieƌͿ  
 
Denmark 
Diabetes 
support 
group 
Diabetes related distress 
(Problem Areas In Diabetes scale)  
Psychological distress and 
depressive symptoms (Symptom 
Checklist 90-R and WHO-5 Well-
being Index)  
Glycaemic control (HbA1c) 
Mixed 
methodological: 
Quasi-experimental, 
two-group (equal 
numbers of sample 
with HbA1c above 
and below 8% split 
iŶto ͚pooƌ͛ aŶd 
Both diabetes related distress, general 
psychological distress and depressive symptoms 
reduced significantly following intervention and 
were sustained at 6 and 12 month follow ups 
foƌ people ǁith ďoth ͚good͛ aŶd ͚pooƌ͛ 
glycaemic control. 
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Qualitative data via focus group 
interviews 
͚good͛ groups) 
repeated measures 
design with pre and 
post intervention 
alongside 6 and 12 
month follow-ups.  
Additional focus 
groups completed at 
final follow up. 
No significant changes to HbA1c levels or 
improvement in general well-being were 
reported following group intervention. 
Participants reported major benefits of group 
participation as feeling less alone and being 
intuitively understood by peers. 
Significant diabetes related distress was 
ĐoŵŵoŶplaĐe ƌegaƌdless of ͚good͛ oƌ ͚pooƌ͛ 
glycaemic control, although this was higher on 
average for individuals with higher HbA1c levels. 
Hopkins et 
al. 
(2012) 
 
 
1,163 people 
living with T1D 
(mean age 41.5 
years)  
 
United Kingdom 
 
 
Structured 
group 
education 
programme 
in flexible 
insulin 
therapy 
Biomedical: Glycaemic control 
(HbA1c), weight, self-reported 
hypoglaecemia (hypo) awareness 
and severe hypo frequency. 
Psychological: Diabetes related 
distress (Problem Areas In 
Diabetes scale), mood (Hospital 
Anxiety and Depression Scale) 
and QoL (EuroQoL Group 5-
Dimension Self-Report 
Questionnaire). 
Repeated-measures 
design. Baseline and 
12 month follow up. 
Diabetes related distress, depressive symptoms 
and anxiety were all significantly reduced at 12 
month follow up compared to baseline. 
Mean rates of severe hypoglaecemia were 
significantly reduced and hypo recognition 
significantly improved at follow up. 
Significant reductions in HbA1c levels were 
found at 12 month follow up. 
No significant differences in QoL were observed 
at follow-up when compared with baseline. 
Snoek et al. 
(2012) 
1,567 people 
living with 
diabetes (T1D 
n= 691 & T2D 
n=876 ) age > 
18 
 
Multinational 
study involving: 
Computer 
assisted 
monitoring of 
individuals 
psychological 
status and 
glycaemic 
control by 
clinicians at 
Well-being (WHO-5 Well-being 
Index) 
Diabetes related distress 
(Problem Areas in Diabetes scale) 
Life Event Inventory (self-
developed scale based on Social 
Readjustment Rating Scale) 
Repeated-measures 
design.  Baseline and 
12 month follow up. 
Discussing the psychological aspects of living 
with diabetes at routine appointments resulted 
in significant reductions on baseline scores of 
diabetes related distress as well as increased 
well-being at 12 month follow up. 
HbA1c values were not significantly different 
from baseline at follow up. 
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Croatia, 
Denmark, 
Germany, 
Ireland, Israel, 
Netherlands, 
Poland & UK 
routine 
review 
appointment 
Patient Agenda Questionnaire 
(self-selection of topic areas to 
discuss during appointment) 
Glycaemic control (HbA1c) 
 
 
Forlani et al. 
(2013) 
60 people living 
with T1D 
(utilising 
intensive insulin 
treatment, all 
previously 
completed 
diabetes 
education 
programme) 
 
Italy 
Structured 
diabetes  
group 
psychological 
support 
programme 
Psychological distress 
(Psychological General Well-Being 
Index) 
Mood (Beck Depression Inventory 
& Self-Rating Anxiety Scale), 
Diabetes related quality of life 
(QoL) (Well-Being Enquiry for 
Diabetics) 
Health locus of control 
(Multidimensional Health Locus 
of Control) 
Glycaemic control (HbA1c) 
Quasi-experimental, 
two-group 
(intervention vs. 
delayed start 
control), repeated 
measures design 
(baseline, and 6 
months post-
intervention). 
Significant reductions in depressive mood, 
anxiety and psychological distress reported by 
intervention group at six month follow up. 
At follow up, significantly improved diabetes 
related QoL, alongside increased internal and 
reduced external locus of control reported by 
intervention group.  
Intervention group showed significant 
decreases in baseline HbA1c values at follow up. 
No significant changes were found in control 
group for any variables measured. 
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Relationship between diabetes related distress and glycaemic control 
Four studies considered the relationship between diabetes related psychological 
distress and glycaemic control as a primary outcome.  Regression analyses completed by 
Reddy, Wilhelm, and Campbell (2013), found strong positive correlations between diabetes 
related psychological distress and HbA1c values, consistent with previous research findings 
(e.g. Lloyd et al., 2010).  Furthermore, there were significant associations between diabetes 
related distress and both current and previous reported experiences of depression.  These 
findings support the ideas of Fisher et al., (2014) that diabetes related distress may account 
for high scores on self-report instruments for depression.  However, the study sample 
included individuals living with both T1D and T2D.   The results for people living with T1D 
were not reported independently therefore the possibility that findings may have been 
influenced by factors unique to living with T2D cannot be eliminated. 
Scholes et al., (2013) explored experiences of young people living with T1D using 
open-ended interviews.  Participants described a multitude of difficulties in the day to day 
management of diabetes and many believed that these were exacerbated by hormonal 
changes and/or diabetes related distress.  These findings are consistent those of Reddy et al. 
(2013) that diabetes related distress is correlated with glycaemic control. 
Participants with higher HbA1c values were more likely to report the experience of 
diagnosis as distressing, and described receiving less help and support from family 
members, friends and healthcare professionals than those with low HbA1c.  Many also felt 
that healthcare providers had a propensity to be authoritarian in their dealings with them 
and rarely offered emotional support, which they believed would be beneficial.  This 
suggests that the response of both healthcare professionals and the social system around an 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  34 
 
 
 
individual may be important in terms of both alleviating distress and improving glycaemic 
control.  
Some young people described relating to peers with diabetes as helpful and 
providing valuable learning, especially when interacting with others whom they perceived to 
have had good control over the condition.  This indicates that peer support may also help to 
reduce distress and/or glycaemic control.  FThe study used a sample of children and young 
adults only and suggests that young people may be more likely to experience diabetes 
related distress.  The results are particularly applicable when considering the transition to 
adulthood and from paediatric to adult diabetes services.  However it may be difficult to 
generalise the findings to adults living with T1D.   
Strandberg et al., (2014) also considered the relationship between diabetes related 
psychological distress, anxiety, depression, and general well-being with HbA1c.  A sample of 
adults living with T1D completed a number of self-report instruments to measure the above 
phenomena, whilst HbA1c was measured via blood test.  Two measures of diabetes related 
distress were used, the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress 
Scale (DDS).  Both were significantly associated with glycaemic control, with the regimen-
related subscale of the DDS having the strongest relationship.  In contrast, there were no 
significant associations between depression, anxiety or general well-being with HbA1c levels. 
The findings could suggest that diabetes related distress (particularly concerning 
diabetes self-care regimes) may influence an iŶdiǀidual͛s glǇĐaeŵiĐ ĐoŶtƌol more than many 
other psychosocial variables.  This is strengthened by the concurrent use of two well 
validated self-report measures of diabetes related distress.  The large sample size also 
increases the likelihood that results will be generalisable.   These results are consistent with 
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other studies (e.g. Lloyd et al., 2010), but are contrary to the findings of Reddy et al. (2013) 
that concurrent depression was significantly associated with diabetes related distress. 
Diabetes related psychological distress and its relationship to control of blood 
glucose levels was also investigated in a cross-sectional study by Zoffmann, Vistisen, and 
Due‐ChƌisteŶseŶ (2014).  Health records for a sample young adults living with T1D were 
screened for pre-existing data from standardised measures of psychosocial functioning and 
participants most recent HbA1c values. 
Results were adjusted for potentially confounding demographic variables and 
analysed using both linear and logistic regression models.  All psychosocial variables apart 
from perceived level of autonomy were strongly associated with HbA1c.  High prevalence 
rates of diabetes related psychological distress were reported across the sample.  Distress 
was significantly more likely to be reported by women rather than men and people with an 
HbA1c value above 8%.   
The results suggest that younger adults, particularly women and/or those with 
higher HbA1c values are more likely to report greater amounts of diabetes related distress.  
The reported associations between diabetes related distress and glycaemic control are also 
consistent with both Reddy et al., (2013) and Lloyd et al., (2010).  One strength of the study 
is the large sample size, which increases the generalisability of these findings, however 
these may be applicable to young adults only. 
The three quantative studies above all reported strong associations between 
diabetes related distress and glycaemic control.  Despite this it is not possible to infer 
causality from these correlations.  The cross-sectional nature of the research designs also 
makes it impossible to consider the direction of these relationships over time.   
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Relationship between diabetes related distress and other factors 
Four papers considered the relationship between diabetes related psychological 
distress and other specific factors.  Kibbey, Speight, Wong, Smith, and Teede (2013) 
surveyed a sample of Australian young adults using a study-specific questionnaire aimed at 
assessing enablers and barriers to care provision and the quality of current services.  The 
authors measured the relationship between levels of satisfaction with diabetes care and 
depression/anxiety, diabetes related distress, and HbA1c.  A large number of the sample 
(40%) reported severe diabetes related psychological distress, which was significantly higher 
than among other age groups of adults living with diabetes surveyed in Australia.  These 
results support the findings of Zoffmann et al., (2014) that young adults may be particularly 
susceptible to higher levels of diabetes related distress.   
Those feeling more satisfied with their diabetes care experienced significantly lower 
levels of diabetes related distress, anxiety and depression and HbA1c levels.  On free text 
questions some participants reported feelings of disempowerment and lack of 
acknowledgment as an individual e.g. ͞I kŶoǁ ŵǇself ďetteƌ thaŶ aŶǇoŶe. DoĐtoƌs ƌead out 
of a ďook aŶd eǆpeĐt that ǁhat theǇ ƌead is hoǁ it ǁoƌks. Well it͛s Ŷot, eǀeƌǇoŶe is 
diffeƌeŶt͟ ;pp. ϴϴϭͿ.  Others described disillusionment with ongoing efforts to manage 
diaďetes e.g. ͞MakiŶg aŶ effoƌt to iŵpƌoǀe HďA1c ďut usuallǇ eŶd up disappoiŶted͟ ;pp. 
881).  These findings suggest that experiences of good quality, person centered diabetes 
care can influence experiences of diabetes related distress and also glycaemic control and 
are consistent with the findings of Scholes et al., (2013).  Due to the study design it is not 
possible to infer causality or the direction of these relationships over time.  HbA1c values in 
this study were self-reported and not obtained from clinical records or from blood test 
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results.  This reduces the validity of this variable considerably given the potential of 
inaccurate reporting, especially given some participants qualitative accounts of feeling 
disappointed with their HbA1c results.   
Balfe et al., (2013) conducted semi-structured interviews with a sample of young 
adults in order to explore what was distressing about living with T1D.  Diabetes related 
distress was widely reported by the sample and appeared to be related to a number of 
factors.  These included: difficulties managing diabetes day to day, self-
stigma/consciousness, concerns about the future (including specific concerns about 
pƌegŶaŶĐǇͿ aŶd diffiĐulties ŶaǀigatiŶg aŶd ͚fightiŶg͛ the healthcare system.  Diabetes related 
distress appeared to be ameliorated when individuals had opportunities to discuss concerns 
with healthcare professionals and to attend peer support groups and education 
programmes.  These findings corroborate those of Scholes et al. (2013) that peer support 
was viewed as particularly helpful and that many young people wanted more emotional 
support from their diabetes team. 
The authors reported reaching data saturation during the interview process and 
provided examples of credibility checking with the participants, improving confidence in the 
validity of the findings.  The study findings support the notion that early adulthood is a 
particularly distressing time for people living with T1D (Zoffmann et al., 2014), and that 
helpful responses from healthcare providers could go some way to reducing this (Kibbey et 
al., 2013).  However the very specific age-range of the sample is also a significant limitation, 
reducing the generalisability of the results to the wider population of people living with T1D. 
Hendrieckx et al., (2014) looked at episodes of severe hypoglaecemia and its 
potential associations with diabetes related distress, other psychosocial factors and HbA1c 
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results for a sample of adults living with T1D.  Results showed strong positive associations 
between episodes of severe hypoglaecemia and levels of diabetes related distress, diabetes 
specific wellbeing, general well-being and fear of hypoglaecemia.  There were no 
associations between severe hypoglaecemia and HbA1c levels. 
The results indicate that experiencing severe hypoglaecemia may increase diabetes 
related distress.  The self-report measure used to record incidences of severe 
hypoglaecemia was not standardised (instead being created specifically for the study), and 
data provided was not confirmed (e.g. with blood glucose meter reading downloads).  
Therefore it is unclear how accurately participants were reporting these incidences, which 
presents the potential for over or under reporting of results.  The inclusion of diabetes 
related distress as a secondary outcome means that any potential associations with other 
variables were not reported. 
Stuckey et al., (2014) conducted large scale multinational qualitative research as part 
of the DAWN2 study.  The sample included adults living with diabetes from 17 countries.  
The authors used a structured interview schedule conducted via telephone, the internet or 
in-person depending on the region.  The interview focused on successes, challenges, and 
wishes for improvement in living with diabetes.  Emergent coding was used to identify 23 
categories related to psychosocial factors.  These categories were then grouped together 
into two positive and two negative psychosocial themes.   
The first negative theme was described as anxiety about hypoglaecemia and the 
possibility of developing diabetes related complications which is supported by findings from 
Hendrieckx et al., (2014) that experiences of severe hypoglaecemia can be distressing, and 
also corroborate previously reported associations between HbA1c and diabetes related 
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distress, given that high HbA1c values significantly increase the chance of developing 
complications (Nathan, 2014).  The second was discrimination at work and 
misunderstanding by the general public about diabetes which is consistent with other 
research (e.g. Petrides et al., 1995; Schabert et al., 2013).  One positive theme was described 
as maintaining a positive outlook and resilience, with the second being receiving 
psychosocial support from compassionate and caring friends, family, healthcare 
professionals, and others living with diabetes, which is consistent with many previously 
reported study findings (e.g. Balfe et al., 2013; Kibbey et al., 2013; Scholes et al., 2013).   
The large sample size and the multinational nature of the research make these 
results highly generalisable and suggests that there are shared positive and negative 
psychosocial experiences of people living with diabetes across many different cultures and 
societies.  However the large sample size has implications for the richness of the data with 
the stƌuĐtuƌed iŶteƌǀieǁ Ŷot ďeiŶg ĐoŶduĐiǀe to detailed eǆploƌatioŶ of people͛s 
experiences.  The sample size also resulted in a high volume of data, analysed by a large 
number of researchers.  The authors reported high inter-rater reliability in coding and data 
analysis, but it does not rule out potential inconsistencies in approaches between different 
countries during data collection.  This includes different translations of the interview 
schedule and how data may have been influenced by the use of multiple interview 
approaches (telephone, internet and face to face) in different regions.  The sample 
consisted of a mix of T1D and T2D, as only a small percentage of the sample were people 
living with T1D it would be hard to confidently generalise these to this population in 
practice.  Despite the limitations, the study nonetheless provides a convincing overview of 
peoples psychosocial experiences of living with diabetes. 
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Mindfulness based psychological interventions 
 
Three studies reported the use of mindfulness based psychological interventions and 
the effect they had on diabetes related psychological distress.  van Son et al., (2013) carried 
out an RCT with a sample of people living with diabetes and self-reported low emotional 
wellbeing.  The study compared a group mindfulness based cognitive therapy (MBCT) 
intervention with a treatment as usual (TAU) control group.   
Individuals in the MBCT group reported significant reductions in baseline levels of 
depressive symptoms, anxiety and perceived stress, as well as increased QoL compared with 
the TAU group at both four and eight week follow ups.  No significant differences were 
found in levels of diabetes related psychological distress, or HbA1c values between groups at 
any time point.  Individuals in the MBCT group did show overall reductions in diabetes 
related distress compared with the control group but this was not statistically significant. 
van Son et al., (2014) also reported the results of a six month follow up of the 
original (van Son et al., 2013) study.  The study reported sustained reductions demonstrated 
in the original study for levels of anxiety and perceived stress for the intervention group in 
comparison with controls.  However the previously reported significant reduction in 
depressive symptoms was not sustained at a six month follow up point, along with diabetes 
related distress and HbA1c as per the previous study.   
These results suggests that group MBCT may help alleviate anxiety, stress and QoL in 
long-term, but may not be as helpful for depression, diabetes related distress or glycaemic 
control.  The study protocol is well-reported increasing confidence in the rigour of the 
randomisation process.  One caveat is a large reported dropout rate from MBCT group 
(~26%) which may have exaggerated the treatment effect size.   
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Tovote et al. (2014) conducted an RCT comparing individual psychological 
interventions for people living with diabetes.  A sample of adults living with both T1D and 
T2D were randomised to receive an MBCT intervention, a cognitive behavioural therapy 
(CBT) intervention or to a waiting list control group.   
Statistically significant increases in reported well-being, alongside reductions in 
diabetes related distress, depressive symptoms and anxiety were reported by participants in 
the MBCT and CBT intervention groups post intervention unlike waiting list controls.  No 
significant differences in HbA1c values were found between groups.  The reduction in 
diabetes related distress was slightly higher for the MBCT condition than the CBT condition, 
although both were statistically significant. 
The results of Tovote et al., (2014) suggest that both individual CBT and MBCT may 
effectively reduce diabetes related distress.  This is inconsistent with the findings of van Son 
et al., (2013, 2014), indicating that the individual nature of the intervention may be an 
important factor.   This supports the findings of Kibbey et al., (2013) that receiving 
acknowledgement as an individual is an important component of good diabetes care.  The 
study sample was relatively small, resulting in statistical analyses not being fully powered 
according to a priori calculations of 42 participants per condition.  Furthermore, attrition 
rates were high for both intervention groups increasing the likelihood of overinflated effect 
sizes.   
Both RCTs (van Son et al., 2013, 2014; Tovote et al., 2014) recruited a sample of 
adults living with both T1D and T2D.  With the different subtypes of diabetes not being 
stratified separately in either study, it is difficult to confidently generalise these findings to 
the wider population of people living with T1D. 
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Other psychosocial interventions 
Four studies investigated the use of psychosocial interventions and the effect that 
these may have on diabetes related distress.  Due‐ChƌisteŶseŶ, Zoffmannn, Hommel, and 
Lau (2012) used a repeated measures design to investigate the effect of attending a 
diabetes support group over time for a sample of adults living with T1D.  The support group 
was aimed at reducing the burden of diabetes related psychosocial problems and facilitated 
by four diabetes healthcare staff.  Participants self-reported HbA1c values were used to 
diǀide eƋual Ŷuŵďeƌs of paƌtiĐipaŶts iŶto gƌoups ďased oŶ ͚good͛ oƌ ͚pooƌ͛ glǇĐaeŵiĐ ĐoŶtƌol 
(below or above 8% respectively). 
Clinically significant diabetes related psychological distress was commonplace for 
iŶdiǀiduals ďoth iŶ the ͚good͛ aŶd ͚pooƌ͛ glǇĐaeŵiĐ ĐoŶtƌol gƌoups, although this ǁas higheƌ 
oŶ aǀeƌage foƌ the ͚pooƌ͛ gƌoup.  The authoƌs ƌepoƌted sigŶifiĐaŶt ƌeductions in both 
diabetes related and general psychological distress, as well as depressive symptoms 
following completion of the group intervention.  These observed differences were sustained 
after both 6 and 12 months.  In addition, participants completed a focus group after the 
final follow up in order to gather qualitative data about whether or not the group had been 
helpful in meeting their needs.  Participants perceived the group to be beneficial in a 
number of ways.  Many felt less alone and intuitively understood by their peers regarding 
their concerns about living with diabetes.  Some desĐƌiďed Ŷot feeliŶg ͞fullǇ Đapaďle͟ ;pp. 
253) of managing diabetes alongside concerns that others were coping better.  When similar 
stories emerged through discussion, individuals described relief and surprise at hearing 
these shared experiences. This sharing and sense of togetherness in the support group was 
also described as encouraging more flexible attitudes to making beneficial changes to 
diabetes management routines.  
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The results suggest that people may experience high levels of diabetes related 
distress even if their glycaemic control is optimal, despite existing evidence of positive 
correlations between diabetes related distress and HbA1c (Reddy et al., 2013; Strandberg et 
al., 2014; Zoffmann et al., 2014).  HbA1c ǀalues used to diǀide iŶto ͚good͛ aŶd ͚pooƌ͛ gƌoups 
alongside measuring change in glycaemic control were self-reported and not validated 
against clinical records, which may have reduced the validity of these results.  The 
longitudinal data indicates that attending a diabetes support group may be of benefit across 
a large number of psychosocial indicators (including diabetes related distress) which can be 
sustained over significant time periods.  However, the lack of a control group for the study 
also means that any change observed over time cannot be definitely attributed to a specific 
characteristic of the intervention used.  Participants reported feeling better understood by 
peers and a sense of togetherness which may be important factors in the reduction of 
perceived distress.  The importance placed on support from peers in groups is also 
consistent with findings of Balfe et al., (2013) and Scholes et al., (2013). 
Hopkins et al., (2012) investigated the effect of attending the Dose Adjustment For 
Normal Eating (DAFNE; a structured education programme in flexible insulin dosage) on 
various biomedical and psychological outcomes.  DAFNE is a five day programme focusing 
on measuring carbohydrates consumed when eating and calculating a corresponding 
amount of insulin.  This insulin should then counteract the increase in blood glucose which 
occurs after digesting carbohydrates and aims to provide greater flexibility in what people 
can eat and when, in comparison with traditional insulin therapy (DAFNE study group, 
2002). 
A sample of adults living with T1D completed a battery of self-report measures at 
baseline and at a one year follow-up point.  High levels of diabetes related psychological 
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distress were reported at baseline.  Statistically significant improvements in HbA1c, 
awareness and severity of hypoglaecemia, diabetes related distress, anxiety and depression 
were reported at one year follow-up.  There were no significant differences in self-reported 
QoL observed at follow-up. 
The study employed a large sample, and presented strong evidence that completing 
the DAFNE programme could result in improvements in glycaemic control alongside many 
psychological factors (including diabetes related distress) which are sustained over time.   
This is consistent with previous studies that suggest peer support groups can reduce 
diabetes related distress (e.g. Balfe et al., 2013; Due‐ChƌisteŶseŶ et al., 2012; Scholes et al., 
2013). 
The reported reduction in both hypoglaecemic episodes and diabetes related 
distress also supports the findings of Hendrieckx et al., (2014) that severe hypoglaecemia is 
associated with diabetes related distress.  However, there is a risk of overestimating the 
effect of attending the DAFNE programme, as only 55% of participants completed follow up 
data.  This risk is further increased by the lack of of a control group.  
Snoek et al., (2012) measured the effect of introducing a computer assisted 
monitoring system to routine diabetes care.  Participants͛ ͚psǇĐhologiĐal status͛ was 
measured by completing self-report instruments in addition to latest HbA1c test results.  The 
scores were then included in a generated report, which was used by the individual and a 
clinician in order to guide discussion and agree outcomes during the routine diabetes 
outpatient appointments.  Data were recorded at baseline and at a 12 month follow up.  
High prevalence rates of psychological distress were reported, with 17.6% of the sample 
reporting clinically significant scores.  The authors found that discussing psychological 
aspects of living with diabetes prompted by the monitoring programme resulted in 
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significantly decreased levels of diabetes related distress and improved well-being at a 12 
month follow up.   There was no significant change observed in HbA1c values over time. 
The findings indicate that improvements in diabetes related distress and overall well-
being (but not glycaemic control) can be achieved with a relatively simple intervention in 
routine practice.  The study involved a large sample of 1,597 adults living with diabetes from 
many different countries͛ however only 891 were monitored at follow up.  Therefore it may 
be possible that the observed reduction in distress could be due in part to high attrition 
rates.  The sample also combined people living with T1D and T2D.  As with previous studies 
that used this sampling method, it is difficult to be sure if the results are 100% applicable to 
people living with T1D. 
Forlani et al., (2013) tested the effects of attending a structured psychological group 
support programme, for a sample of adults living with T1D.  The group intervention was 
facilitated by a psychologist and focused on managing daily living with diabetes, with 
participants being split between an intervention and delayed start control group.  Those 
participating in the psychological support group reported significant decreases in depressive 
symptoms, anxiety and HbA1c levels compared to the control group at the six month follow 
up point.  They also reported significant increases in both general and diabetes specific well-
being (including diabetes related distress), and an increased internal and decreased external 
health locus of control.  These results support other study findings (e.g. Balfe et al., 2013; 
Due‐ChƌisteŶseŶ et al., 2012) that attending support groups help with the psychosocial 
aspects of managing diabetes as well as adding additional evidence that glycaemic control 
may also be improved.  The study data suggests that self-efficacy (high internal locus of 
control) could also be an important component in promoting one or both of these 
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outcomes.  Allocation into control or intervention groups was not randomised, with the 
control participants electing to postpone group attendance.  This may have created a self-
selection bias, with more enthusiastic individuals or those more in a position to make life 
changes accessing the intervention first.  The studies high use of statistical testing also 
increases the likelihood of type 2 error. 
Discussion 
Implications for practice 
The papers included in the review are consistent with the DAWN study findings that 
high numbers of people living with T1D experience diabetes related psychological distress.  
Emerging evidence suggests that this distress may be more prevalent in younger adults and 
particularly young women (e.g. Zoffmann et al., 2014), with those experiencing frequent 
severe hypoglaecemic episodes also more likely to report experiences of diabetes related 
distress (Hendrieckx et al., 2014).   
Many studies reviewed reported strong positive correlations between diabetes 
related distress and glycaemic control.  This was also consistent with other findings 
suggesting that clinically significant levels of diabetes related distress were more commonly 
reported by people with high HbA1c values (e.g. Reddy et al., 2013).  However diabetes 
related distress was still highly prevalent amongst people with optimal glycaemic control 
(Due‐ChƌisteŶseŶ et al., 2012), which presents the potential for significant distress to exist 
as an unacknowledged difficulty for people who are achieving recommended HbA1c results.   
There is also evidence that diabetes distress may have greater influence on glycaemic 
control than depression (Strandberg et al., 2014), particularly if this distress is related to 
difficulties with diabetes treatment regimes.  This may be important to consider in practice 
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as the historic associations between living with diabetes and depression and its subsequent 
impact on glycaemic control have been the primary focus of much of the literature to date 
(Lustman et al., 2000; Anderson et al., 2001).  The high prevalence rates of distress reported 
across age groups and irrespective of glycaemic control demonstrates the importance of 
awareness and screening in routine practice for diabetes related distress, an idea which is 
already well supported in paediatric diabetes care (Cameron, Northam, Ambler, & 
Daneman, 2007; Schwartz, Axelrad, Cline, & Anderson, 2011). 
In terms of reducing diabetes related distress in practice, evidence suggests that 
simply disĐussiŶg aŶ iŶdiǀidual͛s psǇĐhosoĐial eǆpeƌieŶĐes of liǀiŶg ǁith diaďetes iŶ aŶd of 
itself may help to reduce levels of distress (Snoek et al., ϮϬϭϮͿ.  AŶ iŶdiǀidual͛s peƌĐeiǀed 
satisfaction with their quality of care has also been to found to be associated with both 
diabetes related distress and glycaemic control (Kibbey et al., 2013).  Qualitative data 
indicating the importance of response from healthcare staff further supports this.  
Responses considered positive and helpful included: consideration of the person as a valued 
individual, engaging in a non-authoritarian manner, having compassion and providing 
emotional support where possible (e.g. Balfe et al., 2013; Scholes et al., 2013; Stuckey et al., 
2014). 
Friends, family and particularly others living with T1D could also play an important 
role in reducing diabetes related distress.  Some studies reported that individuals living with 
T1D highly valued feeling intuitively understood by peers, and that peer interactions helped 
to promote positive changes in diabetes management, which may contribute to reduced 
diabetes related distress (e.g. Due‐ChƌisteŶseŶ et al., 2012; Scholes et al., 2013).  This is 
consistent with the growing popularity of seeking peer support amongst people living with 
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diabetes through social media platforms such as Facebook (Greene, Choudhry, Kilabuk, & 
Shrank, 2011).  Professionals may wish to consider recommending such online peer support 
networks and/or face to face facilitated support groups if available. 
Specific group interventions have also proved effective.  Attending a structured 
education programme in flexible insulin therapy was associated with sustained 
improvements in several biomedical and psychological outcomes including diabetes related 
distress and HbA1c (Hopkins et al., 2012).  Participation in a structured psychological group 
intervention also demonstrated similar improvements in glycaemic control, diabetes related 
distress, QoL and depressive symptoms (Forlani et al., 2013).  Young adults have also 
reported the value of attending such programmes (Balfe et al., 2013).  The importance of 
commissioning structured education programmes for T1D has been recognised by the 
National Institute for Health and Care Excellence (NICE), who advocate the inclusion of such 
groups in routine practice in the NHS wherever possible (NICE, 2011) and the results of this 
review further support those recommendations.  Furthermore, group MBCT was 
demonstrated to result in sustained improvements in stress, QoL, anxiety, but not diabetes 
related distress or HbA1c (van Son et al., 2013, 2014).  Depressive symptoms also improved 
post intervention, but were not observed after six months.  Whilst this intervention may 
offer some general benefits consistent with MBCT interventions in a psychiatric context 
(Hofmann, Sawyer, Witt, & Oh, 2010), the results of group MBCT do not compare favourably 
to other group interventions included in the review (e.g. Hopkins et al., 2012; Forlani et al., 
2013) and may require further adaptation in order to prove effective at reducing diabetes 
specific difficulties. 
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Early evidence suggests that individual CBT or MBCT may be effective at improving 
diabetes related distress alongside anxiety, depressive symptoms and perceived well-being 
(Tovote et al., 2014).  Whilst no changes were demonstrated for HbA1c levels, psychosocial 
improvements in diabetes are considered important outcomes in their own right (Rubin & 
Peyrot, 1999), suggesting that individual CBT or MBCT may be helpful for individuals 
experiencing clinically significant levels of diabetes related distress. 
Implications for future research 
Some studies reviewed reported strong correlations between diabetes related 
distress and glycaemic control for people living with T1D (e.g. Reddy et al., 2013; Strandberg 
et al., 2014; Zoffmann et al., 2014).  This is a potentially important relationship, but the 
cross-sectional nature of these studies mean that the direction of these relationships is yet 
to be determined and further longitudinal research investigating these associations is 
required.  It is also impossible to infer causal relationships from these results. van Bastelaar 
et al., (2010) has previously demonstrated diabetes related distress to be an important 
mediator variable for glycaemic control in a sample of people living with both T1 and T2 
diabetes.  Additional investigation of this relationship in a sample of people living with T1D 
alone would help to develop understanding further. 
Zoffmann et al., (2014) found that women were more likely to report diabetes 
related distress than men.  This gender difference may be related to fact that in general, 
women are more likely to utilise healthcare services than men (Green & Pope, 1999) and 
that experiences of mental distress are likely to increase healthcare use (Koopmans & 
Lamers, 2007).  Further exploration of gender differences amongst people living with T1D 
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may be required.  It may be that distress in males living with T1D is less common or it may 
simply be less expressed.  
Many studies measuring the effectiveness of interventions reported concurrent 
changes in both diabetes related distress and depressive symptoms (e.g Due‐ChƌisteŶseŶ et 
al., 2012; Forlani et al., 2013; Hopkins et al., 2012; Tovote et al., 2014).  This is consistent 
with diabetes related distress often appearing to account for depressive symptoms on self-
report instruments (Lloyd et al., 2010; Esbitt et al., 2013).  Fisher et al., (2014), propose that 
these tǁo ĐoŶstƌuĐts ŵaǇ shaƌe a diŵeŶsioŶ theǇ desĐƌiďe as ͞eŵotioŶal distƌess͟ ;pp. ϳϲϵͿ, 
which includes the context of diabetes alongside other life stressors and demands.  They call 
for further research iŶ oƌdeƌ to eŶd the ͞ĐoŶfusiŶg tale͟ ;pp. ϳϲϰͿ that ĐuƌƌeŶtlǇ eǆists iŶ the 
reporting of these experiences, which could lead to inappropriate interventions in clinical 
practice.  Many of the studies included in the review did not explicitly acknowledge this 
potential overlap, indicating that additional investigation and consideration of this area is 
needed in order to avoid these pitfalls.  
There is some indication that specific interventions can reduce diabetes related 
distress for people living with T1D.  However there still remains a dearth of robust large 
scale studies investigating the effect of various interventions on experiences of diabetes 
related distress as a primary outcome.  Of the two RCTs included in the review, one failed to 
achieve power and the other increased sample sizes by including a mixed sample of people 
living with both T1D and T2D.  Indeed 6 of the 15 papers reviewed used the same sampling 
method.  The lack of stratification or reporting of separate results for each subtype of 
diabetes makes extracting pertinent information from these studies difficult.  Future studies 
utilising a sample containing more than one subtype of diabetes should aim to report results 
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for differing subtypes independently, in order to minimise the risk of invalid findings being 
applied in practice.   
The review revealed a lack of recent well-evidenced psychosocial interventions for 
diabetes related distress for people living with T1D.  Of the studies that did report an 
intervention (Due-Christensen et al., 2012; Hopkins et al., 2012; Snoek et al., 2012; Forlani 
et al., 2013; van Son et al., 2013, 2014; Tovote et al., 2014) most provided relatively few 
details on how to deliver the intervention in practice.   A lack of detail in reporting how to 
deliver effective behavioural and psychosocial interventions for diabetes related distress in 
the extant literature has been previously noted (Peyrot & Rubin, 2007).  In addition, the lack 
of consensus when defining distress and depressive symptoms for people living with 
diabetes (Esbitt et al., 2013),  furthers concerns that ineffective interventions based on a 
limited evidence base are being offered to individuals who report symptoms of diabetes 
related distress in practice (Fisher et al., 2014).  Further research that aims to provide a 
more detailed understanding of diabetes related distress, in order to inform the research 
and development of additional, effective psychosocial interventions is required. 
Almost all of the studies employed the use of diabetes distress self-report measures 
to measure diabetes related distress.  These are useful in generating prevalence rates and 
associations between distress and other variables.  However they are less helpful at 
identifying in rich detail exactly what people find distressing about living with T1D, which 
might be useful in guiding future research and clinical interventions.  Some studies have 
begun to consider this question by using semi-structured or open-ended interviews to yield 
rich qualitative data that compliments existing quantitative studies in T1D.  However, to 
date theses have focused exclusively on children and/or young adults and do not cover the 
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experiences of working age or older adults living with T1D.  In a recent literature review 
Ritholz, Beverly and Weinger (2011), noted that qualitative research methods in diabetes 
are becoming increasingly utilised and suggest that their use can address important 
questions that quantitative research cannot.  Future qualitative research exploring the 
experiences of diabetes related distress for adults living with T1D could provide additional 
detail and understanding of this phenomenon, potentially complimenting data already 
provided by extant quantative studies.  This may in turn help to inform both the 
understanding of health professionals and further development of more effective 
psychosocial interventions for diabetes related distress for people living with T1D. 
Conclusion 
This review aimed to provide an overview of the recent literature concerning 
diabetes related psychological distress alongside potential implications for people living with 
T1D and health professionals.  Consideration of the papers reviewed suggests that diabetes 
related psychological distress is a complex phenomenon which potentially interrelates with 
various other psychological, biological and social factors across the lifespan.  Studies are 
beginning to consider this concept for people living with T1D alongside interventions which 
may be helpful.  Despite this, further research and awareness of both diabetes related 
distress and effective psychosocial interventions in practice is needed. 
 
 
 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  53 
 
 
 
References 
Alberti, K. G., & Zimmet, P. F. (1998). Definition, diagnosis and classification of 
diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes 
mellitus. Provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553. 
doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. 
(2013). Achievement of goals in US diabetes care, 1999–2010. New England Journal of 
Medicine, 368, 1613-1624. doi:10.1056/NEJMsa1213829 
American Diabetes Association. (2013). Economic costs of diabetes in the US in 2012. 
Diabetes Care, 36, 1033-1046. doi:10.2337/dc12-2625 
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). The 
prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 
24, 1069-1078. doi:10.2337/diacare.24.6.1069 
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The 
Lancet, 383, 69-82. doi:10.1016/S0140-6736(13)60591-7 
Balfe, M., Doyle, F., Smith, D., Sreenan, S., Brugha, R., Hevey, D., & Conroy, R. (2013). 
What͛s distƌessiŶg aďout haǀiŶg tǇpe ϭ diaďetes? A Ƌualitatiǀe studǇ of ǇouŶg adults͛ 
perspectives. BMC Endocrine Disorders, 13, 13-25. doi:10.1186/1472-6823-13-25 
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010). Genetics, pathogenesis and 
clinical interventions in type 1 diabetes. Nature, 464, 1293-1300. doi:10.1038/nature08933 
Cameron, F. J., Northam, E. A., Ambler, G. R., & Daneman, D. (2007). Routine 
psychological screening in youth with type 1 diabetes and their parents: A notion whose 
time has come?. Diabetes Care, 30, 2716-2724. doi:10.2337/dc07-0603 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  54 
 
 
 
Cnop, M., Welsh, N., Jonas, J. C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005). 
Mechanisms of paŶĐƌeatiĐ β-cell death in type 1 and type 2 diabetes many differences, few 
similarities. Diabetes, 54(Suppl.), 97-107. doi:10.2337/diabetes.54.suppl_2.S97 
Cox, D. J., & Gonder-Frederick, L. A. (1992). Major developments in behavioral 
diabetes research. Journal of Consulting and Clinical Psychology, 60, 628-638. 
doi:10.1037/0022-006X.60.4.628 
Cox, D. J., Kovatchev, B. P., Gonder-Frederick, L. A., Summers, K. H., McCall, A., 
Grimm, K. J., & Clarke, W. L. (2005). Relationships between hyperglycemia and cognitive 
performance among adults with type 1 and type 2 diabetes. Diabetes Care, 28(1), 71-77. 
doi:10.2337/diacare.27.10.2335 
Critical Appraisal Skills Programme (CASP). (2015, March). CASP checklists. Critical 
Skills Appraisal Programme. Retrieved from  
http://www.casp-uk.net/#!casp-tools-checklists/c18f8 
Cryer, P. E. (2007). Hypoglycemia, functional brain failure, and brain death. The 
Journal of Clinical Investigation, 117, 868-870. doi:10.1172/JCI31669. 
DAFNE Study Group. (2002). Training in flexible, intensive insulin management to 
enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating 
(DAFNE) randomised controlled trial. British Medical Journal, 325, 746-752. 
doi:10.1136/bmj.325.7367.746 
Diabetes UK. (2012). Diabetes in the UK 2011-12: Key statistics on diabetes. London: 
Author. 
Diabetes UK. (2013). State of the nation 2013: England. London: Author. 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  55 
 
 
 
Due‐Christensen, M., Zoffmann, V., Hommel, E., & Lau, M. (2012). Can sharing 
experiences in groups reduce the burden of living with diabetes, regardless of glycaemic 
control?. Diabetic Medicine, 29, 251-256. doi:10.1111/j.1464-5491.2011.03521 
Eastman, B. G., Johnson, S. B., Silverstein, J., Spillar, R. P., & McCallum, M. (1983). 
Understanding of hypo-and hyperglycemia by youngsters with diabetes and their parents. 
Journal of Pediatric Psychology, 8, 229-243. doi:10.1093/jpepsy/8.3.229 
Egede, L. E., & Dismuke, C. E. (2012). Serious psychological distress and diabetes: A 
review of the literature. Current Psychiatry Reports, 14, 15-22. doi:10.1007/s11920-011-
0240-0 
Elliott, R., Fischer, C. T., & Rennie, D. L. (1999). Evolving guidelines for publication of 
qualitative research studies in psychology and related fields. British Journal of Clinical 
Psychology, 38, 215-229. doi:10.1348/014466599162782 
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. 
Science, 196, 129-136. doi:10.1126/science.847460 
Esbitt, S. A., Tanenbaum, M. L., & Gonzalez, J. S. (2013). Disentangling clinical 
depression from diabetes-speĐifiĐ distƌess: MakiŶg seŶse of the ŵess ǁe͛ǀe ŵade. IŶ C. 
Lloyd, F. Pouwer & N. Hermanns (Eds.), Screening for depression and other psychological 
problems in diabetes (pp. 27-46). London: Springer. 
Fisher, L., Gonzalez, J. S., & Polonsky, W. H. (2014). The confusing tale of depression 
and distress in patients with diabetes: A call for greater clarity and precision. Diabetic 
Medicine, 31, 764-772. doi:10.1111/dme.12428 
Forlani, G., Nuccitelli, C., Caselli, C., Moscatiello, S., Mazzotti, A., Centis, E., & 
Marchesini, G. (2013). A psychological support program for individuals with type 1 diabetes. 
Acta Diabetologica, 50, 209-216. doi:10.1007/s00592-011-0269-x 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  56 
 
 
 
Giugliano, D., Ceriello, A., & Esposito, K. (2008). Glucose metabolism and 
hyperglycemia. The American Journal of Clinical Nutrition, 87(Suppl.), 217-222. 
Gonzalez, J. S., Fisher, L., & Polonsky, W. H. (2011). Depression in diabetes: Have we 
been missing something important?. Diabetes Care, 34, 236-239. doi:10.2337/dc10-1970 
Greene, J. A., Choudhry, N. K., Kilabuk, E., & Shrank, W. H. (2011). Online social 
networking by patients with diabetes: A qualitative evaluation of communication with 
Facebook. Journal of General Internal Medicine, 26, 287-292. doi:10.1007/s11606-010-1526-
3 
Green, C. A., & Pope, C. R. (1999). Gender, psychosocial factors and the use of 
medical services: A longitudinal analysis. Social Science & Medicine, 48, 1363-1372. 
doi:10.1016/S0277-9536(98)00440-7 
Grigsby, A. B., Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2002). 
Prevalence of anxiety in adults with diabetes: A systematic review. Journal of Psychosomatic 
Research, 53, 1053-1060. doi:10.1016/S0022-3999(02)00417-8 
Hendrieckx, C., Halliday, J. A., Bowden, J. P., Colman, P. G., Cohen, N., Jenkins, A., & 
Speight, J. (2014). Severe hypoglycaemia and its association with psychological well-being in 
Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Research 
and Clinical Practice, 103, 430-436. doi:10.1016/j.diabres.2013.12.005 
Hepburn, D. A., Deary, I. J., Frier, B. M., Patrick, A. W., Quinn, J. D., & Fisher, B. M. 
(1991). Symptoms of acute insulin-induced hypoglycemia in humans with and without 
IDDM: Factor-analysis approach. Diabetes Care, 14, 949-957. doi:10.2337/diacare.14.11.949 
Hex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012). Estimating the 
current and future costs of type 1 and type 2 diabetes in the UK, including direct health 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  57 
 
 
 
costs and indirect societal and productivity costs. Diabetic Medicine, 29, 855-862. 
doi:10.1111/j.1464-5491.2012.03698 
Hermanns, N., Kulzer, B., Krichbaum, M., Kubiak, T., & Haak, T. (2006). How to screen 
for depression and emotional problems in patients with diabetes: comparison of screening 
characteristics of depression questionnaires, measurement of diabetes-specific emotional 
problems and standard clinical assessment. Diabetologia, 49, 469-477. doi:10.1007/s00125-
005-0094 
Hofmann, S. G., Sawyer, A. T., Witt, A. A., & Oh, D. (2010). The effect of mindfulness-
based therapy on anxiety and depression: A meta-analytic review. Journal of Consulting and 
Clinical Psychology, 78, 169-183. doi:10.1037/a0018555 
Holt, R. I. G., Nicolucci, A., Kovacs Burns, K., Escalante, M., Forbes, A., Hermanns, N., 
… & PeǇƌot, M. ;ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: 
Cross‐national comparisons on barriers and resources for optimal care—healthcare 
professional perspective. Diabetic Medicine, 30, 789-798. doi:10.1111/dme.12242 
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & 
Heller, S. (2012). Improved biomedical and psychological outcomes 1 year after structured 
education in flexible insulin therapy for people with type 1 diabetes the UK DAFNE 
experience. Diabetes Care, 35, 1638-1642. doi:10.2337/dc11-1579 
Kibbey, K. J., Speight, J., Wong, J. L. A., Smith, L. A., & Teede, H. J. (2013). Diabetes 
care provision: Barriers, enablers and service needs of young adults with Type 1 diabetes 
from a region of social disadvantage. Diabetic Medicine, 30, 878-884. 
doi:10.1111/dme.12227 
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic 
crises in adult patients with diabetes. Diabetes Care, 32, 1335-1343. doi:10.2337/dc09-9032 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  58 
 
 
 
Koopmans, G. T., & Lamers, L. M. (2007). Gender and health care utilization: The role 
of mental distress and help-seeking propensity. Social Science & Medicine, 64, 1216-1230. 
doi:10.1016/j.socscimed.2006.11.018 
Kovacs Burns, K., Nicolucci, A., Holt, R. I. G., Willaing, I., HeƌŵaŶŶs, N., Kalƌa, “., … & 
PeǇƌot, M. ;ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: Cƌoss‐
national benchmarking indicators for family members living with people with diabetes. 
Diabetic Medicine, 30, 778-788. doi:10.1111/dme.12239. 
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., … 
& Tuomilehto, J. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle 
intervention: Follow-up of the Finnish diabetes prevention study. The Lancet, 368, 1673-
1679. doi:10.1016/S0140-6736(06)69701-8 
Lloyd, C. E., Pambianco, G., & Orchard, T. J. (2010). Does diabetes‐related distress 
explain the presence of depressive symptoms and/or poor self‐care in individuals with type 
1 diabetes?. Diabetic Medicine, 27, 234-237. doi:10.1111/j.1464-5491.2009.02896 
Lustman, P. J., Anderson, R. J., Freedland, K. E., De Groot, M., Carney, R. M., & 
Clouse, R. E. (2000). Depression and poor glycemic control: A meta-analytic review of the 
literature. Diabetes care, 23, 934-942. doi:10.2337/diacare.23.7.934 
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, 
R. C. (1985). Homeostasis model assessment: IŶsuliŶ ƌesistaŶĐe aŶd β-cell function from 
fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. doi: 
10.1007/BF00280883 
Montori, V. M., Bistrian, B. R., & McMahon, M. M. (2002). Hyperglycemia in acutely 
ill patients. Journal of the American Medical Association, 288, 2167-2169. 
doi:10.1001/jama.288.17.2167 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  59 
 
 
 
National Institute for Health and Care Excellence. (2011). NICE quality standard [QS6] 
diabetes in adults.  London: Author  
Nathan, D. M. (2014). The diabetes control and complications trial/epidemiology of 
diabetes interventions and complications study at 30 years: Overview. Diabetes Care, 37, 9-
16. doi:10.2337/dc13-2112 
 Nicolucci, A., Kovacs Burns, K., Holt, R. I. G., Comaschi, M., Hermanns, N., Ishii, H., … 
& Peyrot, M. (ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: Cƌoss‐
national benchmarking of diabetes‐related psychosocial outcomes for people with diabetes. 
Diabetic Medicine, 30, 767-777. doi:10.1111/dme.12245 
Petrides, P., Petermann, F., Henrichs, H. R., Petzoldt, R., Rölver, K. M., Schidlmeter, 
A., ... & Wendt, A. (1995). Coping with employment discrimination against diabetics: Trends 
in social medicine and social psychology. Patient Education and Counseling, 26, 203-208. 
doi:10.1016/0738-3991(95)00740-Q 
Peyrot, M., McMurry, J. F. Jr, & Kruger, D. F. (1999). A biopsychosocial model of 
glycemic control in diabetes: Stress, coping and regimen adherence. Journal of Health and 
Social Behavior, 40, 141-158. doi:10.2307/2676370 
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoek, F. J., Matthews, D. R., & Skovlund, S. E. 
(2005). Psychosocial problems and barriers to improved diabetes management: Results of 
the cross‐national diabetes attitudes, wishes and needs (DAWN) study. Diabetic Medicine, 
22, 1379-1385. doi:10.1111/j.1464-5491.2005.01644 
Peyrot, M., & Rubin, R. R. (2007). Behavioral and psychosocial interventions in 
diabetes: A conceptual review. Diabetes Care, 30, 2433-2440. doi: 10.2337/dc07-1222 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  60 
 
 
 
Peyrot, M., Burns, K. K., Davies, M., Forbes, A., Hermanns, N., Holt, R., ... & Skovlund, 
S. E. (2013). Diabetes attitudes wishes and needs 2 (DAWN2): A multinational, multi-
stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. 
Diabetes Research and Clinical Practice, 99, 174-184. doi:10.1016/j.diabres.2012.11.016 
Quesada, I., Tudurí, E., Ripoll, C., & Nadal, Á. (2008). Physiology of the pancreatic α-
cell and glucagon secretion: Role in glucose homeostasis and diabetes. Journal of 
Endocrinology, 199, 5-19. doi:10.1677/JOE-08-0290 
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963). The glucose 
fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes 
mellitus. The Lancet, 281, 785-789. doi:10.1016/S0140-6736(63)91500-9 
Reddy, J., Wilhelm, K., & Campbell, L. (2013). Putting PAID to diabetes-related 
distress: The potential utility of the problem areas in diabetes (PAID) scale in patients with 
diabetes. Psychosomatics, 54, 44-51. doi:10.1016/j.psym.2012.08.004 
Ritholz, M. D., Beverly, E. A., & Weinger, K. (2011). Digging deeper: The role of 
qualitative research in behavioral diabetes. Current Diabetes Reports, 11, 494-502. 
doi:10.1007/s11892-011-0226-7 
Roy, T., & Lloyd, C. E. (2012). Epidemiology of depression and diabetes: A systematic 
review. Journal of Affective Disorders, 142(Suppl.), 8-21. doi:10.1016/S0165-0327(12)70004-
6 
Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes/Metabolism 
Research and Reviews, 15, 205-218. doi:10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-
DMRR29>3.0.CO;2-O 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  61 
 
 
 
Schabert, J., Browne, J. L., Mosely, K., & Speight, J. (2013). Social stigma in diabetes: 
A framework to understand a growing problem for an increasing epidemic. The Patient-
Patient-Centered Outcomes Research, 6, 1-10. doi:10.1007/s40271-012-0001-0 
Scholes, C., Mandleco, B., Roper, S., Dearing, K., Dyches, T., & Freeborn, D. (2013). A 
qualitative study of young people's perspectives of living with type 1 diabetes: Do 
perceptions vary by levels of metabolic control?. Journal of Advanced Nursing, 69, 1235-
1247. doi:10.1111/j.1365-2648.2012.06111 
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated 
guidelines for reporting parallel group randomised trials. BMC Medicine, 8, 18. 
doi:10.1186/1741-7015-8-18 
Schwartz, D. D., Axelrad, M. E., Cline, V. D., & Anderson, B. J. (2011). A model 
psychosocial screening program for children and youth with newly diagnosed type 1 
diabetes: Implications for psychologists across contexts of care. Professional Psychology: 
Research and Practice, 42, 324-330. doi:10.1037/a0023836 
Shrivastava, S. R., Shrivastava, P. S., & Ramasamy, J. (2013). Role of self-care in 
management of diabetes mellitus. Journal of Diabetes and Metabolic Disorders, 12, 14-19. 
doi:10.1186/2251-6581-12-14 
Skovlund, S. E., & Peyrot, M. (2005). The diabetes attitudes, wishes, and needs 
(DAWN) program: A new approach to improving outcomes of diabetes care. Diabetes 
Spectrum, 18, 136-142. doi:10.2337/diaspect.18.3.136 
Snoek, F. J., Kersch, N. Y., Eldrup, E., Harman-Boehm, I., Hermanns, N., Kokoszka, A., 
… & Skovlund, S. E. (2012). Monitoring of individual needs in diabetes (MIND)-2: Follow-up 
data from the cross-national diabetes attitudes, wishes, and needs (DAWN) MIND study. 
Diabetes Care, 35, 2128-2132. doi:10.2337/dc11-1326 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  62 
 
 
 
Sommerfield, A. J., Deary, I. J., & Frier, B. M. (2004). Acute hyperglycemia alters 
mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes 
Care, 27, 2335-2340. doi:10.2337/diacare.27.10.2335 
Strandberg, R. B., Graue, M., Wentzel-Larsen, T., Peyrot, M., & Rokne, B. (2014). 
Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-
being with HbA1c in adult persons with type 1 diabetes. Journal of Psychosomatic Research, 
77, 174-179. doi:10.1016/j.jpsychores.2014.06.015 
Stuckey, H. L., Mullan-Jensen, C. B., Reach, G., Burns, K. K., Piana, N., Vallis, M., … & 
Peyrot, M. (2014). Personal accounts of the negative and adaptive psychosocial experiences 
of people with diabetes in the second diabetes attitudes, wishes and needs (DAWN2) study. 
Diabetes Care, 37, 2466-2474. doi:10.2337/dc13-2536 
Todd, J. A. (2010). Etiology of type 1 diabetes. Immunity, 32, 457-467. 
doi:10.1016/j.immuni.2010.04.001 
Tovote, K. A., Fleer, J., Snippe, E., Peeters, A. C., Emmelkamp, P. M., Sanderman, R., 
… & Schroevers, M. J. (2014). Individual mindfulness-based cognitive therapy and cognitive 
behavior therapy for treating depressive symptoms in patients with diabetes: Results of a 
randomized controlled trial. Diabetes Care, 37, 2427-2434. doi:10.2337/dc13-2918 
VaŶ Bastelaaƌ, K. M. P., Pouǁeƌ, F., Geelhoed‐DuijǀestijŶ, P. H. L. M., TaĐk, C. J., 
BazelŵaŶs, E., BeekŵaŶ, A. T., ... & “Ŷoek, F. J. ;ϮϬϭϬͿ. Diaďetes‐speĐifiĐ eŵotioŶal distƌess 
mediates the association between depressive symptoms and glycaemic control in type 1 and 
type 2 diabetes. Diabetic Medicine, 27, 798-803. doi:10.1111/j.1464-5491.2010.03025 
ǀaŶ “oŶ, J., NǇklíček, I., Pop, V. J., BloŶk, M. C., EƌdtsieĐk, ‘. J., “pooƌeŶ, P. F., … & 
Pouwer, F. (2013). The effects of a mindfulness-based intervention on emotional distress, 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  63 
 
 
 
quality of life, and HbA1c in outpatients with diabetes (DiaMind) a randomized controlled 
trial. Diabetes Care, 36, 823-830. doi:10.2337/dc12-1477 
ǀaŶ “oŶ, J., NǇklíček, I., Pop, V. J., Blonk, M. C., Erdtsieck, R. J., & Pouwer, F. (2014). 
Mindfulness-based cognitive therapy for people with diabetes and emotional problems: 
Long-term follow-up findings from the DiaMind randomized controlled trial. Journal of 
Psychosomatic Research, 77, 81-84. doi:10.1016/j.jpsychores.2014.03.013 
Venkat Narayan, K. M., Gregg, E. W., Fagot-Campagna, A., Engelgau, M. M., & 
Vinicor, F. (2000). Diabetes: A common, growing, serious, costly, and potentially preventable 
public health problem. Diabetes Research and Clinical Practice, 50(Suppl.), 77-84. 
doi:10.1016/S0168-8227(00)00183-2 
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011). IDF diabetes atlas: Global 
estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical 
Practice, 94, 311-321. doi:10.1016/j.diabres.2011.10.029 
World Health Organization. (2006). Definition and diagnosis of diabetes mellitus and 
intermediate hyperglycemia: Report of a WHO/IDF consultation. Geneva: Author. 
Zoffmann, V., Vistisen, D., & Due‐Christensen, M. (2014). A cross‐sectional study of 
glycaemic control, complications and psychosocial functioning among 18 to 35 year old 
adults with type 1 diabetes. Diabetic Medicine, 31, 493-499. doi:10.1111/dme.12363 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  64 
 
 
 
 
 
MICHAEL G. WILDING BSc Hons  
 
 
 
 
 
Section B: Exploring the experiences of adults living with type 1 
diabetes:  Psychological distress and implications for practice 
 
 
Word Count: 7932 (436) 
 
 
 
 
 
A thesis submitted in partial fulfilment of the requirements of  
Canterbury Christ Church University for the degree of  
Doctor of Clinical Psychology 
 
 
 
 
 
 
 
 
APRIL 2015 
 
 
SALOMONS  
CANTERBURY CHRIST CHURCH UNIVERSITY  
 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  65 
 
 
 
Abstract 
Background. Living with diabetes can present a number challenges for individuals.  
Managing diabetes day to day involves a complex medication and behavioural regime which 
interrelates with various important psychosocial factors.  Previous research suggests that 
people living with diabetes are as much as two-three times more likely to experience mental 
health difficulties compared with the general population.  However, evidence is emerging 
that many of these difficulties may in fact be a direct result of feeling distressed about living 
with a complicated and stressful chronic health condition and not necessarily resultant from 
co-morbid psychiatric illness.  These experiences are known by the term diabetes related 
distress.  To date psychosocial factors related to living with diabetes have mainly been 
explored quantitatively.  However, qualitative approaches have increased in popularity in 
diabetes research in recent years and can add valuable and rich information to existing data 
from quantitative research.  Extant qualitative research in diabetes has mainly focused on 
people living with type 2 diabetes or children with type 1 diabetes, leaving adults living with 
type 1 diabetes as a relatively under researched group. 
Aims. The study aimed to answer the following research questions: 
Primary: What are the lived experiences of adults with type 1 diabetes?  
Secondary: What aspects of living with type 1 diabetes are experienced as 
distressing? 
What are the potential implications for health services? 
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Method. Eight adults living with type 1 diabetes were interviewed about their 
experiences.  Interviews were transcribed and analysed using interpretative 
phenomenological analysis. 
Results. Six major themes emerged from participant͛s interviews.  These were: 
Experiences of diagnosis, physical impact of type 1 diabetes, psychological impact of type 1 
diabetes, social impact of type 1 diabetes, influence of healthcare teams and ways of 
coping.  Example subthemes are: Feeling frustrated and restricted by treatment regimes, 
psychological and emotional distress, constant awareness and worry, impact on 
development and sense of self, stigma and lack of understanding from others, support from 
diabetes team and experiences of a simplistic view of diabetes. 
Conclusion.  Participants reported a wide variety of experiences related to the 
biological, psychological and social components of type 1 diabetes.  Some of these were 
experienced as highly distressing whilst others were more easily managed.  This was often 
dependent on individual differences and was not necessarily static over time.  Further 
awareness of this in practice and a focus on diabetes and its treatment within the context of 
people͛s uŶiƋue psǇĐhosoĐial ĐiƌĐuŵstaŶĐes is highlǇ iŵpoƌtaŶt iŶ suppoƌtiŶg people to 
reduce diabetes related distress, which can improve glycaemic control, health related 
quality of life and wellbeing 
Keywords: Type 1 Diabetes, Psychological Distress, Depression, IPA, Qualitative 
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Introduction 
Diabetes mellitus (diabetes) describes a number of chronic metabolic illnesses that 
are a significant and costly worldwide public health issue (Hex, Bartlett, Wright, Taylor, & 
Varley, 2012; Whiting, Guariguata, Weil, & Shaw, 2011).  The most common subtypes of 
diabetes are type 2 (T2D) and type 1 (T1D; World Health Organization, 2006); current 
estimates suggest that approximately 36 million people live with T1D worldwide (Maahs et 
al., 2010).  T1D typically develops in childhood (Gale, 2005) and has a distinct aetiology and 
recommended treatment when compared to other diabetes subtypes (Bluestone, Herold, & 
Eisenbarth, 2010).   
Implications of living with type 1 diabetes 
In T1D pancreatic beta (βͿ cells responsible for generating insulin are destroyed due 
to an autoimmune response (Todd, 2010).  Insulin is a hormone involved in regulating blood 
glucose during metabolism of carbohydrates and fats (Randle, Garland, Hales, & 
Newsholme, 1963).  The absence of endogenous insulin in T1D necessitates a lifetime of 
insulin replacement via injection with the aim of avoiding dangerously elevated blood 
glucose levels (hyperglaecemia; Atkinson, Eisenbarth, & Michels, 2014).    
Hyperglaecemia causes excessive urination, headaches, severe dehydration, 
exhaustion and impaired immune response (Giugliano, Ceriello, & Esposito, 2008; Montori, 
Bistrian, & McMahon, 2002).  Untreated individuals experiencing hyperglaecemia can 
rapidly deteriorate to potentially life threatening conditions such as diabetic ketoacidosis 
(DKA; Kitabchi, Umpierrez, Miles, & Fisher, 2009).  Using insulin to achieve sustained 
glycaemic control also substantially reduces the risk of developing additional long-term 
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health complications (including neuropathy, retinopathy and nephropathy) that can result 
from prolonged periods of hyperglaecemia (Nathan, 2014).   
However insulin therapy alone is not a panacea and forms part of an ongoing and 
complex self-care regime (Coyle, Francis, & Chapman, 2013).  Injecting insulin can cause 
hypoglaecemia (low blood glucose levels), which results in various difficulties such as: 
shaking, sweating, confusion, drowsiness and disrupted cognitive functioning (Hepburn et 
al., 1991).  If hypoglaecemia is not treated by consuming sugars then individuals risk brain 
failure and death (Cryer, 2007).  In addition to medication use, many other factors can 
influence glycaemic control.   These include: frequency of blood glucose testing, diet, 
physical activity, coping styles and problem solving skills (Shrivastava, Shrivastava, & 
Ramasamy, 2013).    
Glycosylated haemoglobin (HbA1c), an indicator of long-term glycaemic control, is 
measured as a routine clinical outcome in diabetes.  National Institute for Health and Care 
Excellence (NICE; 2015) recommends an HbA1c value below 7.5% for adults living with T1D.  
However, the complicated nature of managing diabetes means that 74% of people living 
with T1D in the UK are unable to achieve this (Diabetes UK, 2013).  Consequently, diabetes 
is the primary cause of blindness in UK adults of working age and a significant contributory 
factor for serious health issues including limb amputations, kidney failure, cardiovascular 
disease and stroke. 
A biopsychosocial view of type 1 diabetes 
Applying the biopsychosocial model of illness (Engel, 1977) to T1D indicated that 
glycaemic control is heavily influenced by different psychosocial factors (Peyrot, McMurry 
Jr, & Kruger, 1999).  Kibbey, Speight, Wong, Smith, and Teede (2013) also found that 
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acknowledgement of an individual͛s psychosocial circumstances by healthcare staff is 
perceived as important by people living with diabetes.   
Living with T1D can impact on people͛s social networks.  Large numbers of people 
living with T1D report experiencing social stigma and discrimination (Schabert, Browne, 
Mosely, & Speight, 2013) and family members of people living with diabetes also report that 
diabetes has a negative impact on daily living (Kovacs Burns et al., 2013).     
There is also a well-documented link between living with diabetes and poorer 
psychological well-being.  Anxiety disorders are significantly more common for people living 
with diabetes (Grigsby, Anderson, Freedland, Clouse, & Lustman, 2002).  Depression is also 
estimated to be two to three times more prevalent for people living with T1D than the 
general population (Anderson, Freedland, Clouse, & Lustman, 2001; Roy & Lloyd, 2012) and 
is associated with poorer clinical outcomes (Lustman et al., 2000).  Poorer outcomes for 
people living with diabetes who are experiencing depressive symptoms can be further 
understood by applying the health belief model (Janz & Becker, 1984).  The model posits 
that the likelihood of engaging in health promoting behaviours (such as achieving optimal 
glycaemic control through self-management) is influenced by various factors including 
perceived self-efficacy and the perceived benefits to the individual.  However, negative 
ĐhaŶges iŶ aŶ iŶdiǀidual͛s psǇĐhosoĐial status ;suĐh as eǆpeƌieŶĐiŶg depƌessiǀe sǇŵptoŵsͿ 
has been shown to affect perceptions of health related behaviour, resulting in decreased 
likelihood of engaging in health promoting behaviours (Rosenstock, 1974). 
Depressive symptoms reported by people with T1D may be, however, more complex 
than first appears.  Gonzalez, Fisher, and Polonsky (2011) posit that psychological distress 
reported by people living with diabetes is often misdiagnosed as depression even when the 
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distress is directly related to living with and managing diabetes.  This diabetes related 
psychological distress has been demonstrated to account for the presence of depressive 
symptoms on self-report instruments (Lloyd, Pambianco, & Orchard, 2010).  This may be 
because many screening tools for psychological distress take a symptom based approach, 
without consideration of their content or causes (Fisher, Gonzalez, & Polonsky, 2014).   
The recent diabetes attitudes wishes and needs (DAWN and DAWN2) studies found 
that diabetes related distress is a reported by almost 50% of people living with diabetes in 
17 different countries (Nicolucci et al., 2013).  With reports of clinically significant distress 
also more likely in young people compared with the rest of the population (Kibbey et al., 
2013; Zoffmann, Vistisen, & Due‐ChƌisteŶseŶ, 2014).  This distress has also been found to 
have significant associations with glycaemic control (Strandberg, Graue, Wentzel-Larsen, 
Peyrot, & Rokne, 2014). 
Psychosocial interventions for diabetes 
The combination of physiological, psychological and social difficulties described 
above can have a significant impact on quality of life (QoL; Rubin & Peyrot, 1999) and 
research is beginning to consider psychosocial interventions that could help alleviate this.   
Attending structured psychoeducational group programmes in flexible insulin 
adjustment results in significant improvements in glycaemic control, reduced frequency of 
hypoglaecemia and reduction in diabetes related distress, depressive symptoms and anxiety 
(Hopkins et al., 2012).  Completion of a structured diabetes psychological support group 
programme also demonstrated comparable biomedical and psychological benefits, but 
without the same improvements in HbA1c (Forlani et al., 2013).  Facilitated peer support 
groups have also been evidenced to provide significant improvements in psychological 
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wellbeing over time (Due‐ChƌisteŶseŶ, Zoffmann, Hommel, & Lau, 2012).  In addition, those 
receiving individual cognitive behavioural therapy (CBT) or mindfulness based cognitive 
therapy (MBCT) also reported improvements in depressive symptoms and anxiety, but not 
diabetes related distress or glycaemic control (Tovote et al., 2014).   
Despite some evidence concerning potentially helpful psychological interventions, 
the DAWN2 study found that many diabetes healthcare professionals do not feel able to 
provide adequate support for psychosocial issues (Holt et al., 2013).  This is evident in UK, 
where approximately 85% of people living with diabetes do not have pre-determined access 
to psychological support (Trigwell et al., 2008).  Where this does exist the majority of this 
support takes the form of referral to generic mental health services, who lack specialist 
knowledge of diabetes.  This is confounded by the potential over diagnosis of depression 
amongst people living with diabetes resulting in these individuals potentially receiving 
inappropriate and/or harmful interventions in practice (Esbitt, Tanenbaum, & Gonzalez, 
2013; Fisher et al., 2014).   
Although there is a small number of research studies that outline potential 
psychosocial interventions for diabetes related distress for people living with T1D, there 
remains an overall paucity of evidence presenting effective psychosocial interventions in 
this area.  In addition, extant studies often fail to give a detailed overview of the 
intervention used (Peyrot & Rubin, 2007), making it difficult to accurately apply these 
interventions in practice.  When this is considered alongside inconsistencies in accurately 
defining and identifying diabetes related distress and depression for people living with T1D 
(Gonzalez et al., 2011), and the lack of confidence by health professionals that they can 
address these difficulties (Holt et al., 2013), this paints a concerning picture.   
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Qualitative research and diabetes 
Gaining a more detailed understanding of people͛s experiences of living with T1D 
(including diabetes related distress) could potentially inform the future research and 
development of effective psychosocial interventions in this area.  However, to date these 
phenomena have mostly been studied quantitatively (e.g. Nicolucci et al., 2013; Tovote et 
al., 2014).   
In a recent literature review, Ritholz, Beverly, and Weinger (2011) note that 
qualitative research is becoming increasingly valued in behavioural diabetes research and 
consequently has seen a steady increase in recent years.   The review highlighted that the 
majority of extant qualitative research in diabetes focuses on adults living with T2D, or 
children living with T1D.  This may be indicative of the fact that T1D typically develops in 
early life (Gale, 2005), and that the majority of adults living with diabetes have a diagnosis of 
T2D (Maahs, West, Lawrence, & Mayer-Davis, 2010).  However people living with T1D 
constitute 10% of people with a diagnosis of diabetes in the UK (Diabetes UK, 2012), making 
adults in this sub group a significant minority which is currently under researched.  
Qualitative studies have begun to investigate both experiences of living with T1D (Scholes et 
al., 2013) and experiences of distress for people living with T1D (Balfe et al., 2013) with 
samples of children and young people.  These have yielded rich and useful results which 
complement existing quantitative data.  However there remains a dearth of qualitative 
research exploring these same experiences in the population of adults living with T1D. 
In light of the above, this study will aim to answer the following research questions: 
Primary: What are the lived experiences of adults with T1D?  
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Secondary: What aspects of living with T1D are experienced as distressing? 
What are the potential implications for health services? 
Method 
Participants 
Eight people participated in the study.  All met the following inclusion criteria:  
 Aged 18 or older.  
 Living with T1D for at least 1 year or longer.   
 Receiving care from a diabetes team at one of three recruitment sites. 
Additional demographic information about the study sample can be found in Table 1. 
Table 1. Participant demographic data 
 Age 
(years) 
Gender Ethnicity Number of 
years living 
with T1D 
Presence of 
complications 
 
P1 23 Female White British 11 No 
P2 40 Female White British 37 Yes 
P3 25 Female White British 14 No 
P4 27 Male White British 12 No 
P5 34 Female White British 27 Yes 
P6 34 Male White British 31 No 
P7 25 Female White British 20 No 
P8 50 Male White British 41 Yes 
Mean 32 - - 24 - 
 
Recruitment 
Participants were recruited from three hospital sites across two separate NHS 
healthcare trusts.   An opportunity sampling method was used, with potential participants 
either responding to a recruitment poster (Appendix B), or contacting the author to opt in to 
the study after being provided with the participant information sheet (Appendix C) by a 
member of the diabetes team when they attended for routine outpatient appointments.  
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Potential participants were also offered the chance to win a £50 shopping voucher as an 
incentive for taking part in the study.   
Design 
The study employed a semi-structured interview design.  Participants were 
interviewed about their experiences of living with T1D and their responses were analysed 
using interpretative phenomenological analysis (IPA; Smith, Flowers, & Larkin, 2009). The 
aiŵ of IPA is to ͞ƌeǀeal soŵethiŶg of the eǆpeƌieŶĐe͟ (p.3) of individuals involved.  This is 
achieved by taking an idiographic approach to interpreting how an individual makes sense of 
personally significant phenomena within specific contexts.  IPA was selected in order to 
allow for exploration of the different connotations that people living with T1D attach to 
their experiences.  Other methodologies were considered, for example grounded theory 
(e.g. Glaser & Strauss, 2009) which would aim to generate a theory to explain the 
experience of diabetes related distress for adults living with T1D, and thematic analysis (e.g. 
Braun & Clarke, 2006), which aims to describe and categorise qualitative data into themes.  
However, as the phenomenon in question is currently under-researched in qualitative 
studies, a detailed and rich description and process of meaning making (such as would be 
provided by IPA) was considered to be a better fit for initially advancing knowledge in this 
area compared to other methods.   In addition, the author was diagnosed with T1D in 
childhood and the double-hermeneutic nature of IPA was also considered the best way to 
incorporate the authoƌ͛s peƌsoŶal kŶoǁledge and experience of T1D in a way that would be 
beneficial to the research. 
Ethical considerations 
The initial study proposal was approved by a university research review panel, a NHS 
research ethics committee review (Appendix D) and two local R&D departments (Appendix 
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E).  The main ethical issues discussed during the review process concerned identifying 
protocols to support participants who potentially became distressed following interview, 
alongside ensuring informed consent and confidentiality upon reporting. 
Procedure 
Once recruited participants met with the researcher, informed consent to participate 
was taken (Appendix F), followed by the completion of a semi-structured interview which 
was audio recorded and followed by a debriefing.  The interview schedule (Appendix G) was 
informed by a literature review and expert opinion provided by the author͛s two 
supervisors.  A pilot interview was also completed with one person living with diabetes prior 
to commencing and their views incorporated.  The interview schedule began by asking 
people to recall their experience of being diagnosed with T1D, in order to ascertain what 
meaning people attached it, given that diagnosis is often viewed as a significant and 
distressing experience (Skovlund & Peyrot, 2005).  The questioning then asked people to 
consider how this meaning had changed over time based on their experiences, both now 
and in the past, before considering how people felt about living with diabetes in the future.  
The schedule aimed to cover general areas of living with T1D, with the semi-structured 
nature also allowing individuals experiences of distress to emerge through discussion, given 
that this is an often expected reaction to living with T1D and its treatment (Gonzalez et al., 
2011).  The original interview questions did not change as the study progressed, but the 
interviewer made additional inquires about pertinent issues raised by participants, and 
would continue to discuss these in subsequent interviews.  Interviews lasted between 35-99 
minutes depending on the individual and their responses.  No participants reported 
significant distress after the interview or felt the need to discuss the interview with the 
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diabetes team.  All participants also wished to receive short summary report of results 
(Appendix H). 
Data analysis 
The recommendations of Smith et al., (2009) were used as an overview to guide the 
data analysis.  Following completion of the interview, transcripts were transcribed verbatim 
by the author.  Transcripts were then read through whilst listening to the audio recording in 
order to be immersed in the data.  Transcripts were then read a second time, whilst initial 
areas of interest or significance were marked and noted.  Finally texts were re-read and the 
authoƌ͛s iŶteƌpƌetatioŶs of marked parts of the transcript were recorded by hand, and were 
then assigned initial themes, aiming to encapsulate the meaning of paƌtiĐipaŶt͛s words (see 
Appendix I for an example annotated transcript).  Following this transcripts and themes 
were transferred to electronic format, and NVivo 10 computer software (QSR International, 
2014) was used to examine divergence and convergence between paƌtiĐipaŶts͛ experiences.  
This allowed for the grouping of initial emergent themes into sub themes and later into 
overarching master themes (see Appendix J for an overview of them development).    
Quality controls 
To ensure quality, Elliott, Fischer, and Rennie͛s (1999) guidelines for qualitative 
research was applied during the study process.  IŶ oƌdeƌ to assist ǁith ͞oǁŶiŶg oŶe͛s 
peƌspeĐtiǀe͟ (Elliott et al., 1999, p. 221), a colleague interviewed the author prior to data 
collection with the aim of increasing reflexivity by ͚ďƌaĐketiŶg͛ theiƌ assuŵptioŶs ;“ŵith et 
al., 2009), see Appendix L for an interview transcript.  The interview was based around 10 
key elements of reflexive bracketing outlined by Ahern (1999); an overview of these is 
provided in Appendix K.  These areas were also used to guide the process of continued self-
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  77 
 
 
 
reflection and the keeping of a research diary throughout (see Appendix M for diary 
extracts). 
In keeping with the recommendations of (Elliott et al., 1999) the analysis and results 
were also suďjeĐt to ǀaƌious ͞ĐƌediďilitǇ ĐheĐks͟ ;p. ϮϮϮͿ.  Firstly, initial theme development 
was discussed with two separate research supervisors, both with experience of direct work 
with people living with diabetes.  Interview transcripts were also read in full by one 
supervisor.  Ideas and discrepancies were discussed and were used to inform and amend 
the analysis as necessary.  In addition findings were further corroborated with feedback 
from participants who responded to the summary report (Appendix H).  For example 
participant three reported: ͚I thiŶk Ǉou'ǀe foĐused iŶ oŶ all the ŵassiǀe ďits͛ and participant 
four said: ͚I think it covers a lot aŶd has a lot of iŶsight. It͛s gƌeat!͛. 
Results 
Following data analysis, six master themes emerged.  These are presented along 
with their component sub themes in Table 2 below.  The themes are described below with 
example quotations so as to allow for ͞groundiŶg iŶ eǆaŵples͟ ;Elliot et al., 1999. p. 222) in 
the ǁoƌds of the paƌtiĐipaŶts͛ themselves (additional examples for each theme can be found 
in appendix N). 
Table 2. Overview of master and sub themes. 
 
Master Theme Sub Theme 
Experiences of diagnosis Process of diagnosis 
 
Reacting to diagnosis 
 
Adjustments and changes 
 
 
Physical impact of T1D Experiences of high blood glucose 
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Challenges managing blood glucose 
 
Experiences of hypoglaecemia 
 
Feeling frustrated and restricted by 
treatment regimes 
 
Additional health complications 
 
 
Psychological impact of T1D Psychological and emotional distress 
 
Constant awareness and worry 
 
Impact on behaviour 
 
Impact on development and sense of self 
 
 
Social impact of T1D Perceived impact on others 
 
Help and support from others 
 
Stigma and lack of understanding from 
others 
 
 
Influence of healthcare teams Support from diabetes team 
 
Difficulties with diabetes team 
 
Attending carbohydrate counting courses 
 
Simplistic view of diabetes 
 
 
Ways of coping Discussing diabetes 
 
Technology 
 
Not thinking about or engaging with 
diabetes 
 
Accepting and engaging with diabetes 
 
Hope and positivity 
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Experiences of diagnosis 
This ŵasteƌ theŵe Đoǀeƌs people͛s eǆpeƌieŶĐes of ďeing diagnosed with T1D and the 
immediate impact on individuals and their family networks. 
Process of diagnosis 
Most people described being unwell before receiving a diagnosis and being admitted 
to hospital ͚I ǁas dƌiŶkiŶg loads aŶd goiŶg to the toilet loads aŶd all the Ŷoƌŵal sǇŵptoŵs, 
um Mum and Dad took me to the hospital ŶeaƌďǇ aŶd, I got diagŶosed͛ (P2)5.  For the 
majority this felt like a sudden shift ͚I ǁas stƌaight iŶ the doĐtors and on insulin within like six 
houƌs͛ (P3) but others described the process taking longer due to symptoms being 
misdiagnosed.  Whilst in hospital, many people received limited information about T1D and 
felt unprepared upon being discharged ͚I wasn't really told, how to really manage it͛ (P1). 
Reacting to diagnosis 
For some diagnosis triggered feelings of disbelief and denial ͚I guess there was like, 
the classic sort of slight disbelief.͛ (P4), whilst others were scared and upset ͚It was a scary 
time.͛ (P5).  Those who had waited longer to receive a diagnosis experienced a sense of 
relief ͚WheŶ I ǁas fiƌst diagŶosed it ǁas ŵoƌe of a ƌelief to kŶoǁ soŵethiŶg ǁas ǁƌoŶg͛ 
(P7).  Whilst people diagnosed before they were old enough to remember felt less 
distressed by the experience ͚I haǀeŶ't kŶoǁŶ aŶǇ diffeƌeŶt ǁhiĐh I thiŶk is pƌoďaďlǇ easieƌ͛ 
(P2). 
Adjustments and changes   
Being diagnosed often resulted in significant changes for people that were difficult to 
manage ͚I started off on two injections, then rapidly went on to four. So. Quite a lot to deal 
                                                          
5 (Px) = participant number 
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with aged nine.͛ (P7).  Most people felt that diagnosis also had a significant impact on their 
parents ͚It ǁas ƌeallǇ ƌeallǇ sĐaƌǇ, sĐaƌǇ tiŵes foƌ ŵǇ, uh foƌ ŵǇ paƌeŶts aĐtuallǇ͛ (P8), as well 
as other family members ͚It would have been hard for my brothers and sisters͛ (P4).  
However those who felt that diagnosis didŶ͛t ƌesult iŶ dƌastiĐ changes (for example 
someone with a sibling living with T1D), felt that adjusting was easier ͚At hoŵe, the diet ǁas 
set aƌouŶd ŵǇ ďƌotheƌ aŶǇǁaǇ so, theƌe ǁasŶ't that ŵuĐh ĐhaŶge ;…Ϳ6 yeah, it was quite 
good because I just knew it, I knew what it was and it wasn't a scary thing͛ (P3). 
Physical impact of type 1 diabetes 
Living with T1D has on a sigŶifiĐaŶt iŵpaĐt oŶ people͛s physical wellbeing.  This 
master theme encapsulates paƌtiĐipaŶts͛ experiences in relation to this.   
Experiences of high blood glucose 
When people experienced hyperglaecemia, this resulted in feeling very unwell 
͚When I've got high glucose I do feel crap͛ (P4).  This common occurrence was often 
accompanied by intense frustration and confusion surrounding the potential cause ͚It ĐaŶ 
get fƌustƌatiŶg, ;…Ϳ espeĐiallǇ if Ǉou doŶ't kŶoǁ ǁhǇ it's Ƌuite so high, it's, Ǉou kŶoǁ Ƌuite a 
feǁ of theŵ I ĐaŶ't eǆplaiŶ.͛ (P2).  Keeping blood sugar levels in a slightly high range was also 
a coping strategy used by many.  This reduced uneasiness due to it minimising the risk of 
hypoglaecemia ͚Thinking about it I pƌoďaďlǇ just ƌuŶ high ŵost of the tiŵe ;…Ϳ it's pƌoďaďlǇ 
ŵoƌe the faĐt that I'll just ƌuŶ high just to stop that ƌisk of ďeiŶg loǁ͛ (P1). 
Challenges managing blood glucose 
Attempting to manage blood glucose levels day to day was experienced by almost all 
participants as complicated and draining ͚It's haƌd ǁoƌk soŵetiŵes, ƌeallǇ haƌd ǁoƌk͛ (P6).  
                                                          
6 Material deleted for confidentiality or clarity 
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Many felt out of control and that blood glucose levels were not fully manageable despite 
their best efforts ͚I'ǀe alǁaǇs goŶe up aŶd doǁŶ. EǀeŶ ǁheŶ I eat the saŵe thiŶg, oŶ the 
saŵe daǇ. MǇ sugaƌs go up aŶd doǁŶ.͛ (P7).  This was often exacerbated by a perceived lack 
of skills and knowledge in managing T1D ͚I ǁasŶ't sĐhooled iŶ aŶǇthiŶg ;…Ϳ There's no logic, 
it ǁas all just like, hit aŶd ŵiss.͛ (P4).  Practice over time and learning skills such as 
ĐaƌďohǇdƌate ĐouŶtiŶg appeaƌed to iŶĐƌease people͛s ĐoŶfideŶĐe that theǇ Đould Đope ͚AŶd I 
got all these skills about carbohydrate counting and then I starting getting, like feeling better 
aďout it I thiŶk͛ (P4).  Furthermore, experiencing a prolonged period of stable blood glucose 
or a reduced HbA1c value resulted in a strong sense of pride and achievement for many ͚It's 
brilliant being able to just go, you know, I've got this absolutely f**king nailed [Laughs] This 
diaďetes laƌk.͛ (P6).   
Experiences of hypoglaecemia 
Experiencing mild hypoglaecemia was unpleasant and confusing for the majority of 
people ͚BeĐause I'ǀe ďeeŶ hǇpo I theŶ feel ƌough foƌ the ƌest of the daǇ͛ (P2).  More severe 
hypoglaecemic episodes were experienced as very frightening 'I used to, um, be so scared of 
haǀiŶg a fit duƌiŶg the Ŷight͛ (P5).  Almost all participants described hypoglaecemia as 
having a noticeable impact on day to day life ͚It does get annoying if you're low and then you 
can't go somewhere or do something because it's low and you have to wait for it to come 
back up͛ (P2). 
Feeling frustrated and restricted by treatment regimes 
Feeling restricted by the requirements of diabetes treatment was an experience 
reported by many ͚Not haǀiŶg a lie-in, for, at least 10 years where ;…Ϳ you had to set your 
alaƌŵ foƌ ϴ o'ĐloĐk aŶd ǁake up aŶd iŶjeĐt aŶd theŶ go ďaĐk to sleep, aŶd thiŶgs like that͛ 
(P3).  People described a necessity for planning and effort to make it fit into everyday life 
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͚AŶd Ǉou haǀe to plaŶ, Ǉou ĐaŶ't just do soŵethiŶg, stƌaight off it just doesŶ't happeŶ these 
daǇs͛ (P8).  The need to plan and consider decisions meant that many felt they were often 
preoccupied with things such as diet and bodily sensations ͚I do haǀe to ďe Ƌuite Đaƌeful 
aďout ǁhat I'ŵ eatiŶg oƌ hoǁ I'ŵ feeliŶg͛ (P1).  Many described improvements in 
technology (such as insulin pumps) as helping alleviate restrictions, but there were still 
limits to what technology could do ͚It's ŵoƌe of a hassle ;…Ϳ ǁheŶ, the puŵp Ŷeeds to ďe 
ĐhaŶged eǀeƌǇ ϯ daǇs.͛ (P6). 
Additional health complications 
Some participants had developed diabetes related complications.  Experiencing 
complications led to being even further restricted by diabetes ͚I had a ŵassiǀe ďleed iŶ oŶe 
of ŵǇ eǇes. Uŵ. AŶd I ĐouldŶ't see out of that eǇe ;…Ϳ for those five months, I completely lost 
ŵǇ iŶdepeŶdeŶĐe͛ (P5).  Developing complications was also a frightening and distressing 
experience ͚It's sĐaƌǇ losing your sight, losing one of your senses. You miss so much, you just, 
I got depƌessed. Uŵ, just fouŶd life ƌeallǇ diffiĐult.͛  (P5).  For some developing complications 
triggered a change in focus such as a drive to improve control of diabetes ͚up uŶtil that point 
I'd not seen any of the long term effects. ;…Ϳ of actually having it. And at that point it was 
kiŶd of a tƌiggeƌ poiŶt͛ (P6), and for those with more severe complications it was difficult to 
focus on anything else ͚Diaďetes is all ĐoŶsuŵiŶg to ŵe Ŷoǁ.͛ (P8). 
Psychological impact of type 1 diabetes 
The psychological implications of living with T1D were widely discussed by 
participants and are explored within this master theme. 
Psychological and emotional distress 
Almost all of the participants reported experiencing distress related to living with 
diabetes at some point in their lives ͚BeĐause of eǀeƌǇthiŶg that ǁas goiŶg oŶ it ƌeallǇ 
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affeĐted ŵǇ ŵood ƌeallǇ ŶegatiǀelǇ͛ (P1).  Some felt that this was related to ongoing internal 
pressure ͚The haƌdest thing I think has just been, the, yeah, that kind of psychological 
pƌessuƌe that it's had oŶ ŵe.͛ (P4), whilst others believed diabetes contributed to feeling 
depressed ͚I kŶoǁ diaďetiĐs aƌe ŵoƌe pƌoŶe to gettiŶg depƌessioŶ aŶd I do go thƌough 
phases of it.͛ (P5).  During the interviews, discussing and acknowledging the emotional 
impact of diabetes was viewed as important ͚It's Ŷot aŶ easǇ thiŶg to liǀe ǁith. ;...Ϳ aŶd 
ďeiŶg aďle to get that ŵessage aĐƌoss ;…Ϳ Is iŵpoƌtaŶt, I thiŶk.͛ (P6), but was sometimes 
experienced as an upsetting thing to attempt to do ͚It ǁas diffiĐult to ǀeƌďalise ŵǇ thoughts 
aŶd feeliŶgs ;…Ϳ I kŶoǁ fƌoŵ past eǆpeƌieŶĐe talkiŶg aďout ŵǇ diaďetes iŶ aŶǇ depth ǁould 
ďƌiŶg ŵe to teaƌs oƌ ŵake ŵe ƌeallǇ upset͛ (P1).  The impact of psychological distress was 
also not static and shifted over time ͚The soƌt of Ŷegatiǀe stuff fƌoŵ the diaďetes has got 
better. ;…Ϳ it's Ŷot fiǆed͛ (P4). 
Constant awareness and worry 
The majority of people felt that the continuous nature of managing and thinking 
about diabetes, irrespective of whatever else was happening in their lives, was a significant 
psychological burden ͚You ĐaŶ't sǁitĐh off fƌoŵ ďeiŶg a diaďetiĐ, Ǉou ĐaŶ't foƌget aďout it͛ 
(P8).  Many felt they were constantly worrying about their blood sugars, to the extent that it 
was often hard to be present and engaged with other activities ͚I'm thinking about what's 
happening in my body and my brain, and ;…Ϳ it's like then I've removed myself from, you 
kŶoǁ, the, the eǀeŶt that I'ŵ iŶ ĐuƌƌeŶtlǇ.͛ (P4).  Most people also worried about what might 
happen in the future, such as developing complications ͚You͛ǀe alǁaǇs got the thought of 
thiŶgs Đould go ǁƌoŶg oƌ the ĐoŵpliĐatioŶs that Đould happeŶ.͛ (P2), or the potential impact 
on having children in the future ͚Kids.  AlǁaǇs oŶ the foƌefƌoŶt of ŵǇ ŵiŶd, ďeĐause, ;…Ϳ I 
just keep thinking if my diabetes isn't controlled, that can cause miscarriages, it can cause 
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ĐhildƌeŶ to haǀe disaďilities, Ǉou kŶoǁ heaƌt defeĐts, eǀeƌǇthiŶg͛ ;Pϯ).  Experiencing these 
regular concerns about diabetes led to a sense of failure and fears that people ǁeƌe ͚gettiŶg 
it ǁƌoŶg͛ ǁith theiƌ diaďetes Đaƌe ͚I got to a poiŶt ;…Ϳ ǁheƌe I ǁas like, it doesŶ't ŵatteƌ hoǁ 
hard I try, it's always going to be wrong, or there's always going to be something there that's 
goiŶg to get iŶ the ǁaǇ͛ (P1).  These prolonged periods of worry and stress appeared to 
accumulate over time resulting in a significant impact on wellbeing ͚It͛s this thiŶg of it just 
wearing you down over time like a, yeah. All these tiny little moments where you have all 
these, uh, like pƌoďleŵs ďeĐause of the diaďetes͛ (P4). 
Impact on behaviour 
Many people felt that physical symptoms influenced their mood and behaviour ͚I just 
get ŵoodǇ, I get iƌƌitaďle, uŵ gƌuŵpǇ I thiŶk. ;…Ϳ aŶd I do put that down to, just how you 
feel ǁith Ǉouƌ diaďetes, if Ǉou doŶ't feel gƌeat theŶ Ǉou feel gƌuŵpǇ͛ (P8).  This was usually 
eǆpeƌieŶĐed as outside of people͛s ĐoŶsĐious ĐoŶtƌol, ďut ǁas ofteŶ Ŷot iŶteƌpƌeted ďǇ 
others in this way, leading to feelings of guilt and blame ͚I was doing stuff that just wasn't, 
ǁasŶ't ǁho I ǁas, oƌ ǁho I aŵ. ;…Ϳ aŶd I got ƌeallǇ upset that I ǁas ďeiŶg ďlaŵed foƌ it as 
well, because it wasn't something that I could control.͛ ;Pϭ).  The need to think and plan 
when living with T1D meant that many people were often more careful about their 
behaviour as a result ͚IŶ a ǁaǇ I guess it's like, uh, it kiŶd of keeps ŵe, ŵoƌe iŶĐliŶed to ďe 
like ƌegulaƌ, Ŷot ďooziŶg aŶd stuff, like that.͛ (P4).  This also made it difficult to feel 
spontaneous and fun which was often overlooked or misinterpreted as being difficult by 
others ͚I ĐaŶ't ďe so kiŶd of "spoŶtaŶeous" uŵ, like the ƌest of the populatioŶ ĐaŶ͛ (P8). 
Impact on development and sense of self 
A large number of people felt upset and acutely aware of being different to others, 
particularly when growing up ͚The main thing was being different, and not wanting to be 
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different wanting to be the same as everybody else.  Um, the why me? Scenario.͛ (P2).  Many 
also eǆpeƌieŶĐed a peƌiod of ͚ƌeďellioŶ͛ during adolescence, which was fuelled by fighting 
against diabetes, more responsibility and expectation to manage independently ͚As I ǁeŶt 
thƌough ŵǇ teeŶage Ǉeaƌs, I ƌeďelled. ;…Ϳ I'd ďuǇ sǁeets oŶ the ǁaǇ hoŵe, ;…Ϳ Not do iŶsuliŶ 
for them. Um. Didn't test my blood sugars.  Just really rebelled.͛ ;Pϱ).  Most people felt that 
becoming more mature meant that they started to prioritise diabetes more highly ͚Growing 
up's helped. Hŵŵ, aŶd pƌioƌities ĐhaŶgiŶg. ;…Ϳ I thiŶk diaďetes has ŵade ŵe gƌoǁ up a lot 
fasteƌ͛ (P3), and that this helped to integrate diabetes into their sense of who they were as 
people ͚NoǁadaǇs I just aĐĐept it's paƌt of ŵe͛ (P2). 
Social impact of type 1 diabetes 
This master theme is comprised of sub themes related to people͛s eǆpeƌieŶĐes of 
living with T1D in the context of social situations and systems. 
Perceived impact on others 
All of the participants interviewed felt that diabetes often had a negative influence 
on relationships with others such as partners, family and colleagues ͚It does affect 
ƌelatioŶships͛ (P6).  This left some feeling like a burden and often endeavouring to minimise 
the perceived impact on other people ͚It's a lot to do with not putting other people out and 
thinking it's my condition and not anybody else's to deal with but, I know it does have a 
knock-on effect on other people͛ (P2).  Others experienced feelings of guilt ͚I think about it 
and I feel like, oh I was such a nightmare, I feel so guilty' (P4). 
Help and support from others 
Feeling supported by close family members (such as partners, siblings or parents) 
was experienced by most as extremely helpful ͚With ŵǇ Muŵ. ;…Ϳ she ǁas theƌe ǁheŶ I ǁas 
diagnosed. Um, and she's always supported me in everything. Really has, she's the only one 
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that understands what I've been through.͛ ;Pϱ).  Voicing and sharing worries and tasks 
involved in managing diabetes with others (such as house mates or work colleagues) also 
appeared to result in a feeling of normalisation and greater support ͚Like, everyone kind of 
knows, is aware of it and it sort of just, present, and vocalised.  That has made me, be more, 
I guess ŵoƌe aĐtiǀe ǁith it. ;…Ϳ ďeĐause it's, giǀes it like a soƌt of, Ŷoƌŵal, eƌƌ, like feel to it͛ 
(P4).  However, some reported a dilemma between asking for help and wanting to feel 
independent ͚Asking for help and accepting help is really difficult.  But at the same time I 
really want it, and now I'm really aware, I still want them to go, you know, are you alright? 
So, yeah, balancing those two is, difficult.͛ ;Pϭ).  Some also felt that the understanding of 
diabetes amongst the general public has improved over time, which was experienced as a 
helpful change to their wider social systems ͚I think people's knowledge has got a lot more.͛ 
(P3). 
Social stigma and lack of understanding from others 
Despite improvements in knowledge and awareness, many people often felt 
stigmatised by others, suĐh as diffiĐulties ǁheŶ tƌǇiŶg to do iŶjeĐtioŶs ͚I kind of felt like I was 
a drug addict, ;…Ϳ that's how they were treating me.͛ ;Pϳ).  The majority of people 
interviewed had a strong sense of often feeling alone with diabetes and that no one else 
truly understood ͚You always feel like you're on your own and nobody else quite 
uŶdeƌstaŶds͛ (P2).  These feelings were often exacerbated by the unseen nature of T1D and 
that people were not always aware of how difficult and serious it could be, even when 
people looked ͚normal͛ oŶ the outside ͚It's oŶe of those ;…Ϳ UŶseeŶ ĐoŶditioŶs, Ǉeah. It's oŶe 
of those things, where people just go ͞Oh, Ǉou look fiŶe͟. Yeah, I really don't feel fine 
[laughs]. Uŵ, Ǉou kŶoǁ, aŶd people doŶ't uŶdeƌstaŶd͛ (P6).  A large number of people also 
found it frustrating when people confused T1D with T2D, which appeared to happen 
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regularly ͚Oƌ I'ǀe had ͞oh, ďut Ǉou'ƌe Ŷot fat͟. Yeah I know! [Laughs] Cos I'm not type 2. 
There's no, understanding from, I think, members of the public and the hospital between the 
two diffeƌeŶĐes͚ (P7). 
Influence of healthcare teams 
Diabetes teams and the wider health service appeared to play a significant role in 
people͛s eǆpeƌieŶĐes of liǀiŶg ǁith TϭD.  “uď theŵes ƌelated to this aƌe eŶĐapsulated ǁithiŶ 
this master theme. 
Support from diabetes team 
A large number of people felt that on the whole the diabetes team was helpful and 
supportive ͚LoŶg story short. They're excellent͛ (P6).  In particular people felt supported 
when trying to think about managing blood glucose ͚TheǇ'ƌe Ŷot just haŶdiŶg it to Ǉou oŶ a 
plate, theǇ'ƌe ŵakiŶg ŵe kiŶd of thiŶk aŶd theǇ'ƌe suppoƌtiŶg ŵe doiŶg it͛ (P3).  Others felt 
reassured that regular health checks were carried out ͚The reassurance of the other tests 
that theǇ do like the Đholesteƌol͛ (P2), and also that the team were available to be contacted 
should they feel the need ͚I kŶoǁ the suppoƌt is theƌe if I ǁaŶt it͛ (P5).  Many felt that they 
had developed good relationships with their diabetes nurse over time and this was 
experienced as comforting and supportive ͚MǇ diaďetes Ŷuƌse is ŵǇ ƌoĐk͛ (P3).  This was 
particularly evident when people felt that they had taken time to try and understand them 
as an individual ͚I felt like she ǁas ƌeallǇ lookiŶg to uŶdeƌstaŶd, ŵe, aŶd hoǁ she Đould help 
ŵe ŵaŶage the diaďetes ďetteƌ͛ (P4).  Acknowledgement from the diabetes team that living 
with T1D was difficult and hard work was also experienced as being particularly valuable 
͚TheǇ ǁeƌe ǀeƌǇ kiŶd of, ǁe kŶoǁ. We kŶoǁ that people didŶ't look afteƌ aŶd doŶ't look afteƌ 
theŵselǀes at poiŶts iŶ theiƌ life, ǁe kŶoǁ that it's haƌd ǁoƌk͛ (P6). 
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Difficulties with diabetes team 
However not all encounters with the diabetes team over time had been experienced 
as positive by participants.  Some described not feeling supported or held in mind by the 
team ͚Theƌe͛s Ŷot a lot of suppoƌt theƌe I guess ;…Ϳ I'ŵ suƌe theǇ do lots of stuff ďut I just 
don't, I'm not in contact so I don't know it, or know them at all.͛ ;Pϭ).  Others described 
feeliŶg ͚told off͛ oƌ ďlaŵed foƌ high ďlood gluĐose eǀeŶ ǁheŶ theǇ felt theǇ had ďeeŶ 
working hard, which was upsetting ͚EǀeƌǇ tiŵe I ǁeŶt to the hospital foƌ ĐheĐk-ups I got told 
off for the high blood sugars͛ (P5).  Difficulties managing the health system, such as in regard 
to appointments was also a common experience ͚TheǇ eitheƌ get ĐaŶĐelled oƌ, Ǉou're waiting 
foƌ houƌs͛ (P5).  One person spoke about experiencing significant distress when she was 
referred for what she felt was an inappropriate course of psychotherapy after being 
admitted to hospital with DKA ͚Hospitalisation with DKA. ;…Ϳ that ǁas Ƌuite a diffiĐult tiŵe.  
Just the whole, getting my head around that, aŶd Ǉou kŶoǁ afteƌǁaƌds ;…Ϳ theǇ just said, ǁe 
thiŶk it ǁould ďe ďeŶefiĐial foƌ Ǉou to go to this shƌiŶk, heƌe's aŶ appoiŶtŵeŶt. ;…Ϳ I ǁeŶt to 
shrink and ;…Ϳ I was in floods of tears, for like 20 minutes, and he didn't mention my diabetes 
oŶĐe ;…Ϳ So I stopped going, because I was like I'm not going to talk to you about unrelated 
matters which to me don't mean anything when actually, you don't have a clue about 
diabetes, which is why I'm here in the first place.͛ ;Pϯ). 
Attending carbohydrate counting courses 
Being referred to a carbohydrate counting course was described as a unanimously 
positive experience by all participants.  ͚AŶd theŶ I did the ;…Ϳ Đouƌse, ǁhiĐh ǁas gƌeat. That 
was, to be honest, I think that was the best thing I've ever done, positively, for turning the 
diaďetes aƌouŶd.͛ (P4).  This appeared to be due to the increase in perceived control that 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  89 
 
 
 
new skills and knowledge provided alongside a noticeable impact on quality of life ͚AŶd theŶ 
I learn to carb count. So it could be, anything with carbohydrate that I eat, I know to have 
iŶsuliŶ ǁith it. “o I ĐaŶ eat, aŶǇthiŶg I ǁaŶt. As loŶg as I ĐouŶteƌaĐt it ǁith iŶsuliŶ.͛ (P7).  
Another benefit of attending was the opportunity to meet and share experiences with peers 
who truly understood diabetes ͚OŶe of the ďiggest thiŶgs ;…Ϳ afteƌ doiŶg the ;…Ϳ Đouƌse ǁas 
that there is actually other people out there who go through the same crap.  Um, who deal 
with the same thing day in day out. Um, who, have been through the same thing you've 
ďeeŶ thƌough͛ (P6). 
Simplistic view of diabetes 
Many participants felt that diabetes and its management was viewed as overly 
simple by members of the diabetes team, which often led to feelings of frustration and a 
perceived lack of empathy ͚“o, it's alŵost like the teaŵs have always felt that, diabetes is 
black and white. But it's not. And like, obviously you get the text books about diabetes. And 
they seem to follow that. And they don't seem to look at you as an individual as to why you 
might, ďe up aŶd doǁŶ͛ (P7).  This feeling often resulted from a perceived over emphasis on 
HbA1C ǀalues, ǁhiĐh ŵaŶǇ felt didŶ͛t fullǇ eŶĐapsulate theiƌ eǆpeƌieŶĐes of ŵaŶagiŶg 
diabetes day to day ͚Most of the tiŵe I'ŵ, ďetǁeeŶ ϭϮ aŶd ϭϳ aŶd if ŵǇ HďA1c is still coming 
back good that's not, there's something not matching up there and that is what they look 
at,͛ ;Pϭ).  Some people also described feeling that recognition and support regarding the 
emotional impact of living with T1D was not considered important compared to managing 
blood glucose ͚I feel like, I'ǀe Ŷeǀeƌ had aŶǇ, ƌeal help ǁith ;…Ϳ the health sǇsteŵ aƌouŶd 
diabetes at least for um, the emotional side of this disease. Which I think is like, you know, 
eƋual to gettiŶg the ďlood sugaƌs soƌted out, it's just as iŵpoƌtaŶt.͛ (P4). 
Ways of coping  
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The final master theme encapsulates peoples reported ways of coping with T1D. 
Discussing diabetes 
Many people found it helpful to discuss T1D with others ͚I do alǁaǇs like talkiŶg 
aďout it. Cos it's like a ŶiĐe soƌt of, offload͛ (P4) and in particular talking to other people 
living with diabetes and/or attending diabetes peer support groups ͚I thiŶk aĐtuallǇ talkiŶg 
to other diabetics is quite a good thing, because you always feel like you're on your own and 
nobody else quite understands but, there is a lot of people that do͛ (P2).  Others also found 
discussing T1D during psychological therapy as a helpful was of coping ͚MǇ oǁŶ theƌapǇ has 
alloǁed ŵe to leaƌŶ ĐopiŶg ŵeĐhaŶisŵs͛ (P1). 
Technology 
Advances in technology were widely recognised as improving people͛s experiences 
of living with diabetes.  This was due to additional opportunities to connect with others 
online ͚ThiŶgs like FaĐeďook ŵake that easier. Join groups. That helps.͛ (P6), as well as 
improvements in medical technology helping to reduce the burden of treatment ͚The Ŷeǁ 
equipment, the technology has got so much better over the years͛ (P2). 
Not thinking about or engaging with diabetes 
Some individuals talked about trying not to think about diabetes or not engaging 
with it too much as a helpful way to cope ͚I guess a lot of ŵǇ life I haǀeŶ't ƌeallǇ thought too 
much about the diabetes.  I just tried to live [pause] as, I tried to live as everybody else has 
liǀed͛ (P8).  Some described trying not to place too much emphasis on diabetes so that they 
Đould feel ͚Ŷoƌŵal͛.  However this also had downsides when needing additional support ͚The 
main thing has been not making a big deal out of it, I think for me so that I still feel normal 
;…Ϳ the flipside of me trying to be normal is that sometimes, I could potentially be in a 
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dangerous situation because people didn't realise the gravity of a hypo, or even know that I 
ǁas diaďetiĐ͛ (P1). 
Accepting and engaging with diabetes 
Many people talked about how accepting diabetes was a pivotal step.  When people 
stopped fighting against the fact that they were living with diabetes they experienced a 
reduction in its negative impact on their lives ͚What's the point of ignoring the diabetes 
when it's there for the rest of my life?  I might as well work with it, to kind of, get the most 
out of ŵǇ life aŶd, ǁhat I ǁaŶt.͛ (P7).  Others felt that deciding to take things day by day 
also helped to reduce pressure and worry about what might happen in the future ͚You 
know, I might end up in a wheel chair. Or I might end up having a heart attack, pfff, don't 
kŶoǁ, doŶ't thiŶk aďout it. Uŵ, I just take eaĐh daǇ as it Đoŵes ƌeallǇ.͛ (P8). 
Hope and positivity 
Some individuals described a sense of hope that things would be better in the future 
due to improvements and research ͚A lot of things have changed over the years already 
there's still time to make a lot of improvements.͛ (P2).  Others described a sense of trying to 
search for positives wherever possible as being helpful ͚I doŶ't kŶoǁ if theƌe is aŶǇthiŶg 
actually positive from being diabetic, but I think there's a lot of positives you can make, 
ǁhilst ďeiŶg diaďetiĐ͛ (P3).  Adopting a proactive and positive attitude towards life with 
diabetes also helped when trying to live life to the full ͚I haǀeŶ't, let it, stop ŵe fƌoŵ doing 
anything. I haven't gone I can't do that because I'm diabetic. I've gone oh, let me think about 
how I can do that with the diabetes͛ (P7).  Some people also described a sense of strength 
and positive growth as a result of their experiences, even if these were initially difficult ͚I'ǀe 
been through a lot with the diabetes which I think has made me stronger as a person. I think 
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I've learnt from it and I think I want to help others. I think that's a positive. And I think that 
I've coped with a lot.͛ ;Pϱ). 
 
Discussion 
A wide variety of experiences were reported by participants.  The master themes 
that emerged from discussion were: experiences of diagnosis, physical impact of T1D, 
psychological impact of T1D, social impact of T1D, influence of healthcare teams and ways 
of coping.  Some experiences were described as highly distressing whilst others were more 
easily managed.  This was not fixed over time, and was often affected by individual 
differences and other life events separate to diabetes. 
Implications for practice 
The study findings are consistent with those of the DAWN studies (e.g. Nicolucci et 
al., 2013) that diabetes related psychological distress is a commonly experienced 
phenomenon.  Distress could not be directly attributed to one specific cause but rather was 
related to how diabetes interfaced with a combination of different biological, psychological 
and social factors at any one time.  Experiences of distress were regularly discussed, despite 
there being no direct questions about it in the interview schedule, suggesting that it is 
understood by participants as an intrinsic part of the experience of living with diabetes and 
not necessarily as an additional mental health issue.  The findings also indicate that applying 
existing diagnostic criteria for depressive symptoms to experiences of diabetes related 
distress in practice may not fully capture the context of living with diabetes or be consistent 
with aŶ iŶdiǀidual͛s oǁŶ ǀieǁ of these experiences.  For example, being referred to generic 
mental health services lacking in diabetes specific skills and knowledge was experienced as 
extremely unhelpful and upsetting by one participant.  These findings are consistent with 
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existing ideas surrounding diabetes related distress as accounting for the presence of 
depressive symptoms but being distinct from psychiatric illness (e.g. Fisher et al., 2014; 
Gonzalez et al., 2011).  Awareness of this in practice is important in order to avoid the use of 
potentially inappropriate and unhelpful interventions for people experiencing significant 
diabetes related distress (Esbitt et al., 2013; Trigwell et al., 2008). 
Response from healthcare staff appeared to play a significant role in people͛s 
experiences of living with diabetes.  Whilst the majority felt that support with managing 
blood glucose from the diabetes team was extremely helpful, some participants felt that 
diabetes management was sometimes viewed as overly simple by staff teams.  For example, 
focusing on HbA1c results and glycaemic control without acknowledging people͛s individual 
differences and/or the psychosocial context within which this occurred.  Focusing on 
glycaemic control to the detriment of other relevant psychosocial factors was experienced 
by many as a lack of perceived empathy from staff and minimised opportunities to consider 
how diabetes treatment interfaced with the rest of their lives, something which many felt 
was equally as important to discuss during appointments as control of blood glucose.   
Attempts from staff to understand diabetes management in the context of people͛s 
individual circumstances was highly valued by participants, and this is consistent with the 
findings of Kibbey et al., (2013) that satisfaction with diabetes care and acknowledgement 
as an individual can play an important role in reducing diabetes related distress.  In addition 
to routine clinical outcomes such as HbA1c, health related quality of life in diabetes is also 
considered an important outcome in its own right (Rubin & Peyrot, 1999).  Therefore it is 
important to adopt a truly biopsychosocial approach to diabetes care in practice by 
considering the impact that any steps toward improving glycaemic control may have on an 
iŶdiǀidual͛s psychosocial wellbeing and vice versa.  
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Many people described a sense of feeling alone and not being fully understood by 
others with regards to their experiences of living with diabetes.  This is often exacerbated by 
stigma and lack of understanding from others, consistent with the findings of Schabert et al., 
(2013) that large numbers of people living with diabetes experience social stigma from 
others.  Conversely, discussing experiences with other people living with the condition 
either online or in person was described as helpful and normalising, supporting previous 
findings of Due‐Chƌistensen et al., (2012) and Forlani et al., (2013) that feeling intuitively 
understood by peers is helpful.  Consideration of this and facilitating the implementation 
and attendance of diabetes peer support groups may be a helpful step toward reducing 
distress in practice. 
Acceptance of diabetes appeared to result in both improved psychological and 
physical wellbeing.  Participants described this process as being driven by numerous factors 
such as: attending carbohydrate counting courses, developing complications, maturity and 
changing life priorities.  It is important to remain aware of this process in practice and also 
how it was also not a one off task, appearing markedly different for each individual and with 
distinct challenges to overcome in order to helpfully integrate diabetes into their sense of 
self at different life stages.  A frequently discussed time where people experienced 
difficulties with this was adolescence and early adulthood, supporting previous research 
findings that this can be a particularly distressing time for people living with T1D (Balfe et 
al., 2013; Scholes et al., 2013; Kibbey et al., 2013; Zoffmann et al., 2014).  After accepting 
diabetes, individuals described a sense of strength and positive growth, consistent with 
reported experiences of post traumatic growth by those experiencing other serious medical 
conditions (Barskova & Oesterreich, 2009).  Supporting people to fit diabetes management 
into their lives in a way that is least restrictive and distressing in the context of their life 
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stage, unique personal challenges and psychosocial circumstances may help to facilitate the 
process of accepting diabetes and improve health and wellbeing. 
 
Limitations and implications for future research 
The present study has a number of limitations.  The sampling method utilised may 
have created a self-selection bias, with more enthusiastic individuals and/or those more 
comfortable discussing living with diabetes more likely to elect to participate in the study 
than others.  This may have resulted in the study sample not being fully representative of all 
adults living with T1D, potentially reducing the generalisability of the findings.  In addition, 
nothing is known about the distress or mental health histories of the study sample.  This 
could have ďeeŶ aŶ iŵpoƌtaŶt faĐtoƌ iŶ iŶflueŶĐiŶg people͛s deĐisioŶs to paƌtiĐipate and is 
something that could be considered further in future mixed methods studies. 
Whilst the present study had a significant higher mean age (32) than previous 
qualitative studies of T1D involving children and young adults (e.g. Balfe et al., 2013;  
Scholes et al., 2013), the study did not recruit anyone older than 50.   This means that the 
experiences of older adults living with T1D were potentially not represented in the collected 
data.  The entirety of the sample were also White-British individuals, which may mean that 
the results are not fully generalisable to those with different ethnic backgrounds.  Further 
research exploring the experiences of individuals who are older and/or from minority ethnic 
backgrounds living with T1D would help to expand knowledge concerning any specific 
challenges that these groups may face that have not been covered in the present study. 
Some of the sample had also gone on to develop complications whilst others had 
not.  This appeared to be a significant influence people͛s experiences of living with T1D.  
Complications were not explicitly focused on in depth during the present study and further 
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consideration of the experiences of a sample of people who have developed additional 
diabetes related complications could potentially further knowledge in this area.   
Many people reported experiencing a lack of empathy from healthcare staff.  This 
raises the question of why this may be occurring in practice.  Are professionals not 
demonstrating this effectively or are people living with diabetes not hearing or receiving 
well intended approaches from staff?  The DAWN2 study found that many healthcare 
professionals reported feeling unable to provide adequate support for psychosocial issues 
(Holt et al., 2013), and professionals in the UK have previously reported feeling de-skilled in 
dealing with psychosocial elements of diabetes management (Trigwell et al., 2008).  This 
may be underpinning a reluctance to discuss psychosocial issues with patients due to fears 
about how to manage this in practice, which is sometimes experienced as staff not fully 
attending to their individual needs.  Further research investigating the experiences of 
diabetes healthcare professionals when supporting people living with diabetes may help to 
answer these questions. 
Conclusion 
Adults living with type 1 diabetes report a wide variety of experiences related to the 
biological psychological and social components of the illness.  Some of these are 
experienced as highly distressing whilst others are more easily managed.  This is often 
dependent on individual differences and is not necessarily static over time.  Further 
awareness of this in practice and a focus on diabetes and its treatment within the context of 
people͛s unique psychosocial circumstances is highly important in supporting people to 
reduce diabetes related distress, which can improve glycaemic control, health related 
quality of life and wellbeing. 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  97 
 
 
 
 
 
References 
Ahern, K. J. (1999). Ten tips for reflexive bracketing. Qualitative Health Research, 9, 
407-411. doi:10.1177/104973239900900309 
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). The 
prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 
24, 1069-1078. doi:10.2337/diacare.24.6.1069 
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The 
Lancet, 383, 69-82. doi:10.1016/S0140-6736(13)60591-7 
Balfe, M., Doyle, F., Smith, D., Sreenan, S., Brugha, R., Hevey, D., & Conroy, R. (2013). 
What͛s distƌessiŶg aďout haǀiŶg tǇpe ϭ diaďetes? A Ƌualitatiǀe studǇ of ǇouŶg adults͛ 
perspectives. BMC Endocrine Disorders, 13, 13-25. doi:10.1186/1472-6823-13-25 
Barskova, T., & Oesterreich, R. (2009). Post-traumatic growth in people living with a 
serious medical condition and its relations to physical and mental health: A systematic 
review. Disability & Rehabilitation, 31, 1709-1733. doi: doi:10.1080/09638280902738441 
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010). Genetics, pathogenesis and 
clinical interventions in type 1 diabetes. Nature, 464, 1293-1300. doi:10.1038/nature08933 
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative 
Research in Psychology, 3, 77-101. doi:10.1191/1478088706qp063oa 
Coyle, M. E., Francis, K., & Chapman, Y. (2013). Self-management activities in 
diabetes care: A systematic review. Australian Health Review, 37, 513-522. 
doi:10.1071/AH13060 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  98 
 
 
 
Cryer, P. E. (2007). Hypoglycemia, functional brain failure, and brain death. The 
Journal of Clinical Investigation, 117, 868-870. doi:10.1172/JCI31669. 
Diabetes UK. (2012). Diabetes in the UK 2011-12: Key statistics on diabetes. London: 
Author. 
Diabetes UK. (2013). State of the nation 2013: England. London: Author. 
Due‐Christensen, M., Zoffmann, V., Hommel, E., & Lau, M. (2012). Can sharing 
experiences in groups reduce the burden of living with diabetes, regardless of glycaemic 
control?. Diabetic Medicine, 29, 251-256. doi:10.1111/j.1464-5491.2011.03521 
Elliott, R., Fischer, C. T., & Rennie, D. L. (1999). Evolving guidelines for publication of 
qualitative research studies in psychology and related fields. British Journal of Clinical 
Psychology, 38, 215-229. doi:10.1348/014466599162782 
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. 
Science, 196, 129-136. doi:10.1126/science.847460 
Esbitt, S. A., Tanenbaum, M. L., & Gonzalez, J. S. (2013). Disentangling clinical 
depression from diabetes-speĐifiĐ distƌess: MakiŶg seŶse of the ŵess ǁe͛ǀe ŵade. In C. 
Lloyd, F. Pouwer & N. Hermanns (Eds.), Screening for depression and other psychological 
problems in diabetes (pp. 27-46). London: Springer. 
Fisher, L., Gonzalez, J. S., & Polonsky, W. H. (2014). The confusing tale of depression 
and distress in patients with diabetes: A call for greater clarity and precision. Diabetic 
Medicine, 31, 764-772. doi:10.1111/dme.12428 
Forlani, G., Nuccitelli, C., Caselli, C., Moscatiello, S., Mazzotti, A., Centis, E., & 
Marchesini, G. (2013). A psychological support program for individuals with type 1 diabetes. 
Acta Diabetologica, 50, 209-216. doi:10.1007/s00592-011-0269-x 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  99 
 
 
 
Gale, E. A. M. (2005). Type 1 diabetes in the young: The harvest of sorrow goes on. 
Diabetologia, 48, 1435-1438. doi:10.1007/s00125-005-1833-0 
Giugliano, D., Ceriello, A., & Esposito, K. (2008). Glucose metabolism and 
hyperglycemia. The American Journal of Clinical Nutrition, 87(Suppl.), 217-222. 
Glaser, B. G., & Strauss, A. L. (2009). The discovery of grounded theory: Strategies for 
qualitative research. New Jersey: Transaction Publishers. 
Gonzalez, J. S., Fisher, L., & Polonsky, W. H. (2011). Depression in diabetes: Have we 
been missing something important?. Diabetes Care, 34, 236-239. doi:10.2337/dc10-1970 
Grigsby, A. B., Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2002). 
Prevalence of anxiety in adults with diabetes: A systematic review. Journal of Psychosomatic 
Research, 53, 1053-1060. doi:10.1016/S0022-3999(02)00417-8 
Hepburn, D. A., Deary, I. J., Frier, B. M., Patrick, A. W., Quinn, J. D., & Fisher, B. M. 
(1991). Symptoms of acute insulin-induced hypoglycemia in humans with and without 
IDDM: Factor-analysis approach. Diabetes Care, 14, 949-957. doi:10.2337/diacare.14.11.949 
Hex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012). Estimating the 
current and future costs of type 1 and type 2 diabetes in the UK, including direct health 
costs and indirect societal and productivity costs. Diabetic Medicine, 29, 855-862. 
doi:10.1111/j.1464-5491.2012.03698 
Holt, R. I. G., Nicolucci, A., Kovacs Burns, K., Escalante, M., Forbes, A., Hermanns, N., 
… & PeǇƌot, M. ;ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: 
Cross‐national comparisons on barriers and resources for optimal care: Healthcare 
professional perspective. Diabetic Medicine, 30, 789-798. doi:10.1111/dme.12242 
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & 
Heller, S. (2012). Improved biomedical and psychological outcomes 1 year after structured 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  100 
 
 
 
education in flexible insulin therapy for people with type 1 diabetes the UK DAFNE 
experience. Diabetes Care, 35, 1638-1642. doi:10.2337/dc11-1579 
Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health 
Education & Behavior, 11, 1-47. doi:10.1177/109019818401100101 
Kibbey, K. J., Speight, J., Wong, J. L. A., Smith, L. A., & Teede, H. J. (2013). Diabetes 
care provision: Barriers, enablers and service needs of young adults with Type 1 diabetes 
from a region of social disadvantage. Diabetic Medicine, 30, 878-884. 
doi:10.1111/dme.12227 
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic 
crises in adult patients with diabetes. Diabetes Care, 32, 1335-1343. doi:10.2337/dc09-9032 
Kovacs Burns, K., Nicolucci, A., Holt, R. I. G., WillaiŶg, I., HeƌŵaŶŶs, N., Kalƌa, “., … & 
PeǇƌot, M. ;ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: Cƌoss‐
national benchmarking indicators for family members living with people with diabetes. 
Diabetic Medicine, 30, 778-788. doi:10.1111/dme.12239. 
Lloyd, C. E., Pambianco, G., & Orchard, T. J. (2010). Does diabetes‐related distress 
explain the presence of depressive symptoms and/or poor self‐care in individuals with type 
1 diabetes?. Diabetic Medicine, 27, 234-237. doi:10.1111/j.1464-5491.2009.02896 
Lustman, P. J., Anderson, R. J., Freedland, K. E., De Groot, M., Carney, R. M., & 
Clouse, R. E. (2000). Depression and poor glycemic control: A meta-analytic review of the 
literature. Diabetes care, 23, 934-942. doi:10.2337/diacare.23.7.934 
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010). Epidemiology 
of type 1 diabetes. Endocrinology and Metabolism Clinics of North America, 39, 481-497. 
doi:10.1016/j.ecl.2010.05.011 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  101 
 
 
 
Montori, V. M., Bistrian, B. R., & McMahon, M. M. (2002). Hyperglycemia in acutely 
ill patients. Journal of the American Medical Association, 288, 2167-2169. 
doi:10.1001/jama.288.17.2167 
National Institute for Health and Care Excellence. (2015). Diabetes pathway: 
Managing type 1 diabetes in adults.  London: Author.  
Nathan, D. M. (2014). The diabetes control and complications trial/epidemiology of 
diabetes interventions and complications study at 30 years: Overview. Diabetes Care, 37, 9-
16. doi:10.2337/dc13-2112 
Nicolucci, A., Kovacs Burns, K., Holt, R. I. G., CoŵasĐhi, M., HeƌŵaŶŶs, N., Ishii, H., … 
& PeǇƌot, M. ;ϮϬϭϯͿ. Diaďetes attitudes, ǁishes aŶd Ŷeeds seĐoŶd studǇ ;DAWNϮ™Ϳ: Cƌoss‐
national benchmarking of diabetes‐related psychosocial outcomes for people with diabetes. 
Diabetic Medicine, 30, 767-777. doi:10.1111/dme.12245 
Peyrot, M., McMurry, J. F. Jr, & Kruger, D. F. (1999). A biopsychosocial model of 
glycemic control in diabetes: Stress, coping and regimen adherence. Journal of Health and 
Social Behavior, 40, 141-158. doi:10.2307/2676370 
Peyrot, M., & Rubin, R. R. (2007). Behavioral and psychosocial interventions in 
diabetes: A conceptual review. Diabetes Care, 30, 2433-2440. doi: 10.2337/dc07-1222 
QSR International. (2014). NVivo 10 [computer software].  Melbourne: Author. 
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963). The glucose 
fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes 
mellitus. The Lancet, 281, 785-789. doi:10.1016/S0140-6736(63)91500-9 
Ritholz, M. D., Beverly, E. A., & Weinger, K. (2011). Digging deeper: The role of 
qualitative research in behavioral diabetes. Current Diabetes Reports, 11, 494-502. 
doi:10.1007/s11892-011-0226-7 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  102 
 
 
 
Rosenstock, I. M. (1974). Historical origins of the health belief model. Health 
Education & Behavior, 2, 328-335. doi:10.1177/109019817400200403 
Roy, T., & Lloyd, C. E. (2012). Epidemiology of depression and diabetes: A systematic 
review. Journal of Affective Disorders, 142(Suppl.), 8-21. doi:10.1016/S0165-0327(12)70004-
6 
Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes/Metabolism 
Research and Reviews, 15, 205-218. doi:10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-
DMRR29>3.0.CO;2-O 
Schabert, J., Browne, J. L., Mosely, K., & Speight, J. (2013). Social stigma in diabetes: 
A framework to understand a growing problem for an increasing epidemic. The Patient-
Patient-Centered Outcomes Research, 6, 1-10. doi:10.1007/s40271-012-0001-0 
Scholes, C., Mandleco, B., Roper, S., Dearing, K., Dyches, T., & Freeborn, D. (2013). A 
qualitative study of young people's perspectives of living with type 1 diabetes: Do 
perceptions vary by levels of metabolic control?. Journal of Advanced Nursing, 69, 1235-
1247. doi:10.1111/j.1365-2648.2012.06111 
Shrivastava, S. R., Shrivastava, P. S., & Ramasamy, J. (2013). Role of self-care in 
management of diabetes mellitus. Journal of Diabetes and Metabolic Disorders, 12, 14-19. 
doi:10.1186/2251-6581-12-14 
Skovlund, S. E., & Peyrot, M. (2005). The diabetes attitudes, wishes, and needs 
(DAWN) program: A new approach to improving outcomes of diabetes care. Diabetes 
Spectrum, 18, 136-142. doi:10.2337/diaspect.18.3.136 
Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological 
analysis: Theory, method and research. London: Sage. 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  103 
 
 
 
Strandberg, R. B., Graue, M., Wentzel-Larsen, T., Peyrot, M., & Rokne, B. (2014). 
Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-
being with HbA1c in adult persons with type 1 diabetes. Journal of Psychosomatic Research, 
77, 174-179. doi:10.1016/j.jpsychores.2014.06.015 
Todd, J. A. (2010). Etiology of type 1 diabetes. Immunity, 32, 457-467. 
doi:10.1016/j.immuni.2010.04.001 
Tovote, K. A., Fleer, J., Snippe, E., Peeters, A. C., Emmelkamp, P. M., Sanderman, R., 
… & “Đhƌoeǀeƌs, M. J. ;ϮϬϭ4). Individual mindfulness-based cognitive therapy and cognitive 
behavior therapy for treating depressive symptoms in patients with diabetes: Results of a 
randomized controlled trial. Diabetes Care, 37, 2427-2434. doi:10.2337/dc13-2918 
Trigwell, P., Taylor, J.P., Ismail, K., Nicholson, T., Alibhai, M., Gosden, C., Proud, P., & 
Turner, B. (2008). Minding the gap: The provision of psychological support and care for 
people with diabetes in the UK: A report for Diabetes UK. London: Diabetes UK. 
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011). IDF diabetes atlas: Global 
estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical 
practice, 94, 311-321. doi:10.1016/j.diabres.2011.10.029 
World Health Organization. (2006). Definition and diagnosis of diabetes mellitus and 
intermediate hyperglycemia: Report of a WHO/IDF consultation. Geneva: Author. 
Zoffmann, V., Vistisen, D., & Due‐Christensen, M. (2014). A cross‐sectional study of 
glycaemic control, complications and psychosocial functioning among 18 to 35 year old 
adults with type 1 diabetes. Diabetic Medicine, 31, 493-499. doi:10.1111/dme.12363 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  104 
 
 
 
 
 
MICHAEL G. WILDING  BSc Hons  
 
 
 
 
 
Section C: Appendices and supporting material 
 
 
 
 
 
 
 
A thesis submitted in partial fulfilment of the requirements of  
Canterbury Christ Church University for the degree of  
Doctor of Clinical Psychology 
 
 
 
 
 
 
 
 
 
 
 
APRIL 2015 
 
 
SALOMONS  
CANTERBURY CHRIST CHURCH UNIVERSITY  
 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  105 
 
 
 
Appendix A: Psychometric properties of self-report instruments used to measure diabetes 
related distress by studies included in the review 
Of the 15 studies reviewed, 11 utilised the Problems Area in Diabetes (PAID) questionnaire 
(Polonsky et al., 1995) to measure diabetes related psychological distress.  The PAID is a 20 
item self-report tool designed to measure whether or not feelings related to diabetes 
and/or the process of diabetes management are perceived as a problem for the individual 
concerned.  The PAID uses a 5-point Likert scale and generates a score of between 0-100 
(higher scores indicate greater levels of distress), with an accepted cut-off point of 40 to 
indicate clinically significant diabetes related distress.   
The PAID is considered overall to have good psychometric properties (Welch, Weinger, 
Anderson, & Polonsky, 2003).  The PAID has demonstrated consistently high internal 
reliability, good item-to-total correlations, robust two-month test–retest reliability, and also 
correlates strongly with expected associated constructs, including: depression, emotional 
distress, fear of hypoglycaemia, disordered eating, HbA1c, self-care behaviours, and the 
presence of diabetes related complications (Polonsky et al., 1995; Weinger & Jacobson, 
2001).  Furthermore, the PAID has shown high levels of cross-cultural validity in translated 
versions (e.g. Snoek, Pouwer, Welch, & Polonsky, 2000).   
 
 
There is a strong overlap between constructs measured by the PAID and also measures used 
to screen for major depressive disorder (MDD; Fisher, Gonzalez & Polonsky, 2014).  
However, the fact that diabetes (or other health conditions) could be a contextual factor in 
experiences of depression are disregarded in measures typically used to measure MDD.  
This ofteŶ ƌesults iŶ sĐoƌes of ͞suď-ĐliŶiĐal͟ depression that still have a significant impact on 
the health and well-being of the person living with diabetes (Esbitt, Tanenbaum, & 
Gonzalez, 2013).  The PAID has been demonstrated to more accurately indicate the 
presence of sub-clinical depression, clinical depression and diabetes related distress when 
compared with other measures of depression alone, including: Self-report measures for 
depression, structured clinical interviews and non-structured clinical interviews including 
psychiatric history when used with people living with diabetes (Hermanns, Kulzer, 
Krichbaum, Kubiak, & Haak, 2006).  However, living with diabetes and experiencing 
depression are not mutually exclusive: Higher scores on some questions in the PAID related 
to feeling burnt out from managing diabetes and feeling depressed about living with 
diabetes were more strongly related to measures of clinical depression, suggesting a clinical 
need to also consider screening for MDD alongside diabetes related distress in some cases.  
Despite reported good psychometric properties and sensitivity, the PAID has received 
criticism for being overly long and for not sufficiently capturing levels of distress related to 
aŶ iŶdiǀidual͛s healthĐaƌe pƌoǀideƌs ;PoloŶskǇ et al., ϮϬϬϱͿ.   
 
One study also utilised the Diabetes Distress Scale (DDS; Polonsky et al. 2005) alongside the 
PAID as two measures of diabetes related distress.  The DDS was developed by Polonsky et 
al., (2005) in response to criticisms of the PAID, and consists of 17 items which are 
subdivided across 4 subscales.  These are Emotional Burden (EB), diabetes-related 
Interpersonal Distress (ID), Physician-related Distress (PD), and Regimen-related Distress 
(RD).  The DDS is a 17-item test and utilises a 6 point Likert scale to generate an overall 
distress score and 4 subscale scores. A mean score of two or higher on any domain indicates 
moderate distress and three or higher denotes the presence of serious distress.  The DDS 
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has also been demonstrated to have good psychometric properties.  Fisher, Hessler, 
Polonsky, and Mullan (2012) found increases in diabetes distress as measured by the DDS to 
be associated with other expected constructs such as: higher HbA1c levels, lower self-
efficacy, less physical activity, and poorer diet.  The DDS has been shown to have a 
generalisable factor structure as well as acceptable validity and internal reliability across the 
four subscales (Polonksy et al., 2005).  Whilst both the PAID and the DDS have been shown 
to have acceptable psychometric properties, Graue et al., (2012) found the DDS to be 
preferable to the PAID for clinical and research purposes due the ability to identify different 
sub-domains of distress.  Even with the DDS being potentially more sensitive to diabetes 
related distress than PAID, it still recommended that the assessor review responses with 
individuals (regardless of their score) in keeping with comprehensive assessment of diabetes 
related distress and/or depression (Polonsky et al., 2005). 
 
The Well-being Enquiry for Diabetics (WED; Mannucci, Ricca, Bardini, & Rotella, 1996), is a 
50 item Italian-language self-report instrument of diabetes related QoL, with good reported 
reliability and sensitivity (Forlani et al., 2014).  One of its four subscales (the Discomfort 
scale) aims to measure diabetes related worries and emotional status, and was used by one 
of the studies included in the review to measure diabetes related psychological distress.  
There is a dearth of studies about the psychometric properties of this measure that are 
written in English which makes a detailed examination of its robustness difficult. 
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Appendix B: Participant recruitment poster 
 
         
Do you have type 1 diabetes (controlled by insulin)? 
 
Have you had diabetes for 1 year or more? 
 
Would you like the chance to win £50 worth of vouchers 
to spend at Amazon.co.uk? 
 
My name is Michael Wilding, I am conducting a research 
project as part of my Doctorate in Clinical Psychology at 
Canterbury Christ Church University. I am interested in 
interviewing a sample of people about their experiences 
of living with type 1 diabetes. 
 
If you might be interested in taking part or would like 
more information, please speak to a member of the 
diabetes team who can provide you with an information 
pack.  Alternatively you can contact me directly at 
mw366@canterbury.ac.uk, or give me a call on 07804 
554 569.  I will be happy to tell you more about the 
research and answer any questions you may have.  I look 
forward to hearing from you. 
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Appendix C: Participant information sheet 
    
 
PARTICIPANT INFORMATION SHEET 
 
 
Exploring the experiences of people living with type 1 diabetes 
 
Hello. My name is Mike Wilding and I am a Trainee Clinical Psychologist at Canterbury Christ Church 
University. I would like to invite you to take part in a research study.  Before you decide whether or 
not you would like to take part it is important that you understand why the research is being done and 
what it would involve for you.  Please talk to others about the study if you wish.  
 
Part 1 tells you more information about the purpose of the study and what will happen to you if you 
take part.   
Part 2 give you more detailed information about the conduct of the study. 
 
PART 1 
 
What is the purpose of the study?  
I am interested in talking to people living with type 1 diabetes.  I would like to hear from people about 
their experiences of living with diabetes, and to think with them about how it may influence their 
health and well-being.  It is hoped that the information gained from interviewing people will provide 
useful knowledge for professionals working with people living with diabetes, including those who 
might offer emotional and/or psychological support. 
  
Why have I been invited?  
A selection of adults living with type 1 diabetes have been invited to take part in the study.  It is hoped 
that up to 15 people living with diabetes will take part. 
 
Do I have to take part?  
No, taking part in the study is entirely voluntary. Whether or not you decide to take part will not affect 
your care at the diabetes clinic in any way. None of the staff team will know whether or not you have 
taken part in the research. 
 
What will happen to me if I take part?  
If you would like take part, you will be invited to attend an interview. You will be asked to confirm that 
you have a copy of this information sheet and have read and understood it. You will then be asked to 
sign a consent form before beginning the interview with the researcher.  You are free to withdraw at 
any time during the interview, without giving a reason.  
 
You will be contacted by the researcher to arrange a time to meet for an interview.  This can be either 
at your diabetes department, or the researcher can travel to conduct the interview at your home 
should you prefer. 
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On the day of the interview: 
 
- first you will be asked to confirm that you have a copy of this information sheet and have read 
and understood it,  
- You will then be given consent form to sign.  
- You will then be asked to complete some details about yourself. 
- After this the interview will begin, there will be a discussion about certain points related to 
some of the topics highlighted above, the interview will be audio recorded. 
- Afterwards there will then be an opportunity to discuss the interview and ask any more 
questions. 
 
The interviews are planned to last approximately one hour, but may be shorter or longer depending 
on how quickly the interview is completed.  Your involvement should last no more than 2 hours.  
 
Expenses and payments   
- You will be given the option to enter an online draw to win £50 of Amazon vouchers as a thank 
you for your time. You can leave your email address on the consent form should you wish to 
do this.  Please note that this will not be stored with the answers you give to the questionnaire 
in order to preserve anonymity. 
 
- You will also be reimbursed (up to a maximum of £10) for travel expenses if the interview is 
conducted at the diabetes centre. 
 
What are the possible disadvantages and risks of taking part? 
It may be that some of the things discussed in the interview will be difficult and/or distressing for 
people to talk about, every effort will be taken to discuss things in a sensitive manner, however there 
is still a small risk that some of the things discussed might be upsetting.  The researcher will be on 
hand to discuss any issues, you also have the option to take a break whenever you like, or to withdraw 
from the study at any time, without giving a reason. 
 
What are the possible benefits of taking part?   
No direct benefits are planned, although some people may benefit directly from the chance to talk 
and think about some of their experiences of living with diabetes with someone. 
 
It is hoped that people may benefit indirectly, as the information gained from participants in this 
research may influence how diabetes services are developed in the future and that they take into 
account what people living with diabetes have talked about. 
 
This completes part 1.  
If the information in Part 1 has interested you and you are considering participation, please read the 
additional information in Part 2 before making any decision.  
 
PART 2 
 
What will happen to the results of the research study?  
The study will aim for publication in a peer review journal and may lead to further research in the 
future.  Any identifiable information will be removed so that participants cannot be identified in any 
report/publication.  Anonymised quotes from interviews may be included in published reports. 
Will my taking part in the study be kept confidential? 
Yes.  Your information will not be shared with anybody outside of the research team consisting of 
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myself and two research supervisors.  The only exception to this would be in the unlikely event that 
something was discussed which led the researcher to believe that there was a significant risk posed 
to either yourself or others. 
 
The recordings of the interviews will be transcribed by the researcher, only the researcher and his two 
supervisors will have access to the original recordings. 
 
The data collected will form part of the present study. Data will be stored in anonymous form on 
encrypted CD which will be kept in a locked cabinet at Canterbury Christ Church University. The data 
will be kept for 10 years following the completion of the project, as is university policy. After this time 
the data will be destroyed.   
 
Who is organising and funding the research?  
The research is being funded by Canterbury Christ Church University. 
 
Who has reviewed the study?  
The research has been reviewed by an independent research panel at Canterbury Christ Church 
University.  The study has also been reviewed by a local NHS ethics review panel on 11/07/2014 and 
was given a favourable opinion on both occasions. 
 
What ǁill happeŶ if I doŶ’t ǁaŶt to Đarry oŶ ǁith the study?  
During the interview let the researcher know, and the interview will be stopped.  You do not need to 
give a reason why. 
 
What if there is a problem?  
If you have any concerns with any aspect of the study, then in the first instance, please speak to me.  
I can be contacted on mw366@canterbury.ac.uk or on 07804 554 569. 
 
If you remain unsatisfied with my response and wish to complain formally, you can do this through 
Professor Margie Callanan at margie.callanan@canterbury.ac.uk director of the Salomons Centre for 
Applied Psychology at Canterbury Christ Church University.  
 
If participating in the study results in you experiencing personal distress, please contact your GP or 
contact NHS 111 by dialling 111 from any phone.   The researcher will also be available directly after 
the interview to discuss any concerns and options for additional support from the Clinical Health 
Psychology service should you feel the need. 
 
Further information and contact details: 
 
If you are interested in participating in the research, or you have any questions 
you would like to discuss with me, please either e-mail me at 
mw366@canterbury.ac.uk or give me a call/leave a message on 07804 554 
569.  Please state your name and leave a contact number or e-mail address so 
that I can get back to you. 
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Appendix D: Letter of favourable opinion from NRES ethics board 
 
This has been removed from the electronic copy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  113 
 
 
 
Appendix E:  Letter(s) of R&D approval 
 
This has been removed from the electronic copy 
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Appendix F: Participant consent form 
CONSENT FORM – RESEARCHER COPY 
 
Exploring the experiences of people living with type 1 diabetes 
 
Researcher: 
Michael Wilding 
Trainee Clinical Psychologist 
 
Canterbury Christ Church University 
Salomons Centre for Applied Psychology 
Broomhill Road 
Tunbridge Wells 
TN3 0TF 
Please initial boxes below: 
 
1. I confirm that I have read and understood the information 
sheet, and have had an opportunity to ask questions. 
 
2. I understand that my participation is voluntary and I am free to 
withdraw at any time, without giving a reason. 
 
3. I agree to take part in the above study 
 
 
4. I agree to the interview being recorded. 
 
 
5. I agree to the use of anonymised quotes in publications. 
 
 
 
 
Name of Participant____________________________________ Date________________  
 
Signature____________________________________________ 
 
 
Name of Researcher_____________________________________Date_______________  
 
Signature_____________________________________________ 
 
 
PLEASE TURN OVER & COMPLETE THE SECOND COPY OF THE CONSENT FORM 
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CONSENT FORM – PARTICIPANT COPY 
 
Exploring the experiences of people living with type 1 diabetes 
 
Researcher: 
Michael Wilding 
Trainee Clinical Psychologist 
 
Canterbury Christ Church University 
Salomons Centre for Applied Psychology 
Broomhill Road 
Tunbridge Wells 
TN3 0TF 
 
Please initial boxes below: 
 
1. I confirm that I have read and understood the information 
sheet, and have had an opportunity to ask questions. 
 
2. I understand that my participation is voluntary and I am free to 
withdraw at any time, without giving a reason. 
 
3. I agree to take part in the above study 
 
 
4. I agree to the interview being recorded. 
 
 
5. I agree to the use of anonymised quotes in publications. 
 
 
 
 
Name of Participant____________________________________ Date________________  
 
 
Signature____________________________________________ 
 
 
Name of Researcher_____________________________________Date_______________  
 
 
Signature_____________________________________________ 
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REQUEST FORM 
 
 
Please tick the appropriate box below: 
 
 YES NO 
I would like to be entered into a prize draw to win £50 of Amazon 
vouchers 
 
  
I would like to be e-mailed a summary of the research findings 
 
 
  
 
If Ǉou haǀe aŶsǁeƌed ͞YE“͟ to eitheƌ ƋuestioŶ, please pƌoǀide Ǉouƌ e-mail address below so you can 
be notified of a win or the study findings (your e-mail address will be stored separately from your 
study data in order to preserve anonymity): 
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Appendix G: Semi-structured interview schedule 
INTERVIEW SCHEDULE 
  Explain procedure.  Check information sheet has been read and understood and consent form signed.  Ask the participant if they have any further questions before starting. 
 
 
1) I wondered if you could start by telling me about when you were first diagnosed with 
diabetes?   
 
Prompts:  How long ago was this? 
 
  *How old were you at the time? 
 
Can you recall what that meant to you at the time? 
 
 
2)  Has the way you have felt about living with diabetes changed over time? 
 
Prompts: In what ways? 
 
  *could you say more about X experience and how it affected this view? 
   
  *why do you think that was the case? 
 
What sort of things have made it easier to live with?   
 
What sort of things make it harder? 
  
 
3) Can you describe how diabetes effects your relationships with other people? 
 
Prompts: e.g. partner/ family members/ friends/ colleagues? 
 
 
4) What role does the diabetes team have in your life at the moment? 
 
Prompts: What sort of things do the diabetes team do that is helpful? 
 
  What in your opinion would be a positive change to the care you receive? 
 
 
5) Hoǁ do you thiŶk life ŵight ďe differeŶt if you didŶ’t haǀe diaďetes? 
 
Prompts: Could you describe some difficult times you have experienced in relation to living 
with diabetes? 
 
Can you tell me about some of the more positive aspects about living with 
diabetes?   
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Has living with diabetes changed the way you think and feel about yourself? 
 
6) *Looking to the future, what comes to mind when you think about living with diabetes? 
 
 
7) * What has it been like to talk about living with diabetes in the way you have done with 
me today? 
 
8) Is there anything else that you think I should have asked or that you would like to tell me? 
 
 
General Prompt Questions: 
 
What do you mean by that?  
 
Can you tell me a bit more about that?   
 
And how did you feel?   
 
Why was that?   
 
Tell me what you were thinking? 
 
 
DEBRIEF: 
  That was all of the questions.    Did you want to ask anything about what we have discussed?  How are you feeling?  Do you feel I need to talk to anyone about how you are feeling?  Provide details of self-referral to                                                                                if necessary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Questions marked with an asterisk were added to the interview schedule as the study progressed 
in response to discussions with previous participants 
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Appendix H: Summary report for participants 
 
Salomons Centre for Applied Psychology  
Canterbury Christ Church University, Runcie Court  
Broomhill Road, Tunbridge Wells  
TN3 0TF  
 
20th April 2015 
Dear X, 
Firstly I would like to take this opportunity to say thank you once again for taking the time to 
participate in this research study.  I interviewed 8 people living with type 1 diabetes and the 
study has now been completed. 
I am contacting you as you indicated that you would like to receive a short summary of the 
study results.  This can be found in the attached short summary report.  If you would like 
any further information or to receive a copy of the study once it is published, please contact 
me before the end of September 2015 by e-mail or telephone on: 
 
 
Kind Regards, 
 
Mike Wilding 
Clinical Psychologist in Training 
Salomons Centre for Applied Psychology 
Canterbury Christ Church University 
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Summary of findings: Exploring the experiences of people living with type 1 diabetes 
Background 
UŶdeƌstaŶdiŶg people͛s eǆpeƌieŶĐes of liǀiŶg ǁith diaďetes is iŵpoƌtaŶt ďeĐause it can help 
health professionals provide the best care and support possible.  ‘eseaƌĐh iŶto people͛s 
experiences of living with diabetes has been ongoing for many years but has often not 
iŶǀestigated people͛s lived experiences in rich detail.  Previous research that has done this 
has tended to focus on adults living with type 2 diabetes and/or children and young people 
living with type 1 diabetes, meaning that adults living with type 1 diabetes are currently an 
under researched group of people.  Because of this gap in knowledge, this study aimed to 
find out more about the experiences of a sample of adults living with type 1 diabetes. 
Study overview 
I interviewed 8 adults with type 1 diabetes and explored their experiences of living with the 
condition.  Interviews were transcribed and analysed using a process called interpretative 
phenomenological analysis (IPA) in order to group these experiences into themes. 
Study findings 
Six key themes were identified from your combined experiences, these were: 
Experiences of diagnosis 
Many of you described feeling unwell and then being diagnosed as a scary and stressful time 
for both yourselves and your families, often resulting in a lot of changes to your lives.  
However some of you that were not old enough to remember being diagnosed felt that this 
meant that it was easier for you to come to terms with things, as you had not known any 
differently.  Some of you also talked about feeling that you left hospital after being 
diagnosed without a great deal of information about how to manage diabetes well.   
Physical impact of diabetes 
Almost all of you talked about feeling frustrated and confused when trying to manage your 
diabetes day to day, especially when it not clear why your blood sugars appear to go up and 
doǁŶ oƌ ͚Ǉo-Ǉo͛.  However, you also talked about a sense of pride and achievement when 
you are able to manage your diabetes well for periods of time.  Many talked about how 
trying to fit diabetes management into your lives required a great deal of planning and 
effort, and sometimes this could make it more difficult to do things you would like to do.  
Some of you also talked about developing additional diabetes related complications.   This 
often left people feeling scared and out of control, for some this also led to a change of 
focus with regards to diabetes. 
Psychological impact of diabetes 
Many of you described feeling distressed about living with diabetes at one time or another.  
Feeling upset or worried is not fixed and often changes in response to other things that are 
happening in your lives.  Some of you felt that changes to your blood sugar levels affected 
your mood, whilst other people felt ground down by a sense of constantly being aware of 
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how you felt, what you were eating and/or worrying about your blood sugars.  Many of you 
talked about how diabetes influenced your development and sense of identity, especially 
duƌiŶg adolesĐeŶĐe ǁheƌe lots of Ǉou desĐƌiďed a peƌiod of ͚ƌeďellioŶ͛ against diabetes.  
However, many of you felt becoming more mature as you grew older helped you to 
prioritise diabetes more highly and try to improve your control. 
Social impact of diabetes 
A lot of you worried that diabetes had a knock-on effect on other people around you, such 
as partners, family, friends and colleagues.  Some of you described sometimes being grumpy 
with those close to them if their blood sugars were high or low.  Many of you felt guilty 
about this, but also felt it was important to emphasise that often you did not feel 100% in 
control of your behaviour when this happened.  Some felt that needing to plan ahead also 
ŵade it diffiĐult to ďe as ͚spoŶtaŶeous͛ as otheƌs which often impacted on social events.  
Many of you talked about experiencing stigma and a lack of understanding from others.  
Such as being asked to do injections in toilets and first aids rooms, people confusing type 1 
and type 2 diabetes, and experiences of people not really understanding some of the 
diffiĐulties Ǉou faĐe ďeĐause Ǉou looked ͚fiŶe͛ aŶd ͚Ŷoƌŵal͛ oŶ the outside.  Despite soŵe of 
these difficulties, most of you talked about receiving help and support from those around 
you as comforting and helpful. 
Influence of healthcare teams 
Diabetes teams appeared to be an important factor in how many of you experienced living 
with diabetes.  Most of you described the team as helpful in supporting you to manage your 
blood glucose, and some of you described regular visits with the diabetes nurse as 
particularly helpful, particularly if you had a chance to build a strong relationship over time.  
Despite this many of you felt that sometimes the team placed too much emphasis on blood 
sugars and HbA1c results, often takiŶg a ͚teǆtďook͛ appƌoaĐh to ŵaŶagiŶg diaďetes oǀeƌ 
acknowledging you as individuals and thinking about how diabetes management fitted into 
the rest of your lives.  Many of you also talked about feeling as if there was a lack of 
emotional support from the diabetes team.  Almost all of you felt that being referred to carb 
counting courses by the diabetes team, such as DAFNE and SADIE, were very helpful 
experiences.  People described a feeling of increased control over their diabetes, and many 
of you also valued the chance to meet others living with diabetes and share and learn from 
eaĐh otheƌ͛s eǆpeƌieŶĐes.  
Ways of coping 
You described a number of different way of coping with diabetes.  Some people described 
not thinking about it and trying to feel as ͚normal͛ as possiďle as a helpful ǁaǇ to Đope.  
Otheƌs talked aďout ͚accepting͛ diabetes as part of you and trying to work with it rather 
than against it in order to get the most out of your lives.  Others talked about using new 
technology such as insulin pumps, as helpful.  Many of you felt discuss diabetes with other 
people living with the condition was helpful, such as online discussion boards or attending 
peer support groups.  Many of you also talked about trying to maintain a sense of hope and 
positivity for the future.  Many of you talked about how much things have improved in the 
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time since your diagnosis and that there is no reason why this should not continue.  Some of 
you also talked about experiencing a sense of strength and positive growth as a result of 
some of your experiences. 
Summary and conclusions 
All of you reported a wide variety of experiences related to living with type 1 diabetes.  
Some of these were experienced as distressing and upsetting whilst others were more easily 
managed.  This was not fixed over time, and was often affected by differences in you as 
individuals and other things that were happening in your lives outside of diabetes.  I am 
recommending further awareness of this by diabetes healthcare staff and a focus on 
diaďetes aŶd its tƌeatŵeŶt ǁithiŶ the ĐoŶteǆt of people͛s uŶiƋue circumstances as highly 
important in supporting people to reduce diabetes related distress. 
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Appendix I: Example of coded Interview transcript for participant 4 (27 y/o male living with T1D for 12 years). All names are pseudonyms. 
This has been removed from the electronic copy 
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Appendix J:  Overview of theme development 
 
Master Theme Sub Theme Emergent Theme(s) Related to Sub Theme 
 
Experiences of diagnosis 
 
Process of diagnosis 
 
 
 
 
Reacting to diagnosis 
 
 
 
 
Adjustments and changes 
 
 
 
 
 
 
 
Feeling unwell 
Hospital admission 
Receiving diagnosis 
Lack of information 
 
Disbelief and denial 
Not knowing any different 
Scared and upset 
Relief 
 
Changes were sudden 
Difficult for parents to accept 
Hard for siblings 
Theƌe ǁasŶ͛t ŵuĐh ĐhaŶge 
Things just happened – Just got on with it 
Physical impact of T1D Experiences of high blood glucose 
 
 
 
 
Experiences of managing blood glucose 
 
 
Feeling awful 
Diabetes is confusing and hard to predict 
Running blood sugars high as a way of 
coping 
 
Feeling out of control – Up and down blood 
glucose 
Finding logic and a pattern is hard work 
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Experiences of hypoglaecemia 
 
 
 
Feeling frustrated and restricted by 
treatment regimes 
 
 
 
 
 
Additional health complications 
 
 
 
 
 
Lack of knowledge 
Gaining skills 
Sense of pride and achievement 
 
Feeling ill when hypo 
Hypoglaecemia is frightening 
Hypos affect day to day life 
 
Day to day life restricted by treatment 
Diet and eating influenced by insulin 
Extra planning and effort 
Extra awareness of body and diet 
Limits of technology 
Negative impact on body and body image 
 
Developing complications is scary 
Complications lead to change of focus 
Complications restrict life further 
Experiences of DKA 
 
Psychological impact of T1D Psychological and emotional distress 
 
 
 
 
 
 
Constant awareness and worry 
 
Depression, distress and sadness 
Fear and anxiety 
Frustrating and annoying 
Emotional impact is important but hard to 
talk about 
Negative impact is not fixed 
 
Diabetes is there 24/7 – No time off 
Worrying about blood glucose levels 
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Behavioural impact of T1D 
 
 
 
 
Impact on development and sense of self 
 
 
 
 
 
Worrying about developing complications 
Worries about children 
Constant awareness of T1D – Difficult to be 
present 
Feeling like a failure – Getting it wrong 
 
Physical symptoms affect mood and 
behaviour 
Awareness of impact of behaviour on T1D 
Difficult to be spontaneous 
 
Impact on self-development 
Feeling different – Why me? 
Rebelling 
Maturity and changing priorities 
Diabetes is a part of me 
 
 
Social impact of T1D Perceived impact on others 
 
 
 
 
 
Help and support from others 
 
 
 
 
 
Feeling a burden to others 
Impact on family members 
Impact on partners 
Impact on work 
Feeling guilty about the impact on others 
 
Support from partners, family members 
and friends 
Support from work colleagues 
General public have more knowledge 
Awareness from others and sharing 
experiences is normalising 
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Stigma and lack of understanding from 
others 
 
 
 
 
 
Balancing independence and need for 
support 
 
Feeling alone – people doŶ͛t uŶdeƌstaŶd 
Difficult for others to understand hypos 
Experiences of social stigma 
Confusion between T1D and T2D 
Looking fine and normal but not feeling fine 
 
 
Influence of healthcare teams Support from diabetes team 
 
 
 
 
 
 
 
 
 
 
Difficulties with diabetes team 
 
 
 
 
 
 
 
 
Support with managing blood glucose 
Regular support from the diabetes nurse 
Reassurance of additional health checks 
Helping you think 
Support with insulin pumps and other 
technology 
Recognition of hard work 
Acknowledgement and treatment as an 
individual is important 
Help is there if I need it 
 
Diabetes team not very involved 
Feeling told off or blamed by the diabetes 
team 
Poor communication 
Inappropriate referrals to mental health 
services 
Difficulties navigating the health system 
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Attending carbohydrate counting courses 
 
 
 
 
 
 
Simplistic view of diabetes 
 
Gaining new knowledge 
Attending course improved quality of life 
Attending the course helped improved 
control of blood glucose 
Meeting and learning with other people 
living with T1D 
 
Lack of acknowledgement and treatment as 
an individual 
Too much emphasis on HbA1c  
Lack of recognition and support for 
emotional and psychological difficulties 
Simplistic view of diabetes management 
 
 
Ways of coping Discussing diabetes 
 
 
 
 
Technology 
 
 
Not thinking about or engaging with 
diabetes 
 
 
 
 
 
Attending Diabetes support groups 
Discussing diabetes is helpful 
Psychological therapy has helped 
Sharing experiences – I͛ŵ Ŷot aloŶe 
 
Access to information 
Improvements in technology 
 
Not thinking about diabetes – Just get on 
with it 
Not engaging with diabetes care 
Trying to feel normal – Not making a big 
deal out it 
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Accepting and engaging with diabetes 
 
 
 
Hope and positivity 
Accepting and engaging with diabetes 
Taking it day by day 
Working with it rather than against it 
 
Hope for the future 
Small rewards 
Staying positive 
Strength and growth 
Trying not to be held back by diabetes 
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Appendix K:  Overview of Ahern’s (1999) criteria for good quality reflexive bracketing 
 
1. Identify interests that as a researcher, you might take for granted in undertaking this 
research.  
2. Clarify your personal value systems and acknowledge areas in which you know you are 
subjective.  
3. Describe possible areas of potential role conflict.  
4. IdeŶtifǇ gatekeepeƌs͛ iŶteƌests aŶd ĐoŶsideƌ the eǆteŶt to ǁhiĐh theǇ aƌe disposed 
favourably toward the project. 
5. Recognise feelings that could indicate a lack of neutrality. These include avoiding 
situations in which you might experience negative feelings, seeking out situations in which 
you will experience positive feelings (such as friendly and articulate respondents), feeling 
guilty about some of your feelings, blaming others for your feelings, and feeling disengaged 
or aloof. 
6. Is anything new or surprising in your data collection or analysis? If not, is this cause for 
concern.  Consult colleagues before you assume that you have reached saturation in your 
data analysis. You might be bored, blocked, or desensitized. 
7. When blocks occur in the research process, reframe them. Instead of getting frustrated 
ǁheŶ thiŶgs do Ŷot go as plaŶŶed, ask Ǉouƌself, ͞Aƌe theƌe aŶǇ methodical problems that 
ĐaŶ ďe tƌaŶsfoƌŵed iŶto oppoƌtuŶities?͟  
8. Even when you have completed your analysis, reflect on how you write up your account. 
Are you quoting more from one respondent than another? If you are, ask yourself why. Do 
Ǉou agƌee ǁith oŶe peƌsoŶ͛s seŶtiŵeŶt oƌ tuƌŶ of phƌase ŵoƌe thaŶ those of another? If so, 
go back to your analysis and check that an articulate respondent has not biased your 
analysis by virtue of making your analytic task easier. Did you choose to write up the 
account in the first or third person? Why? 
9. Consider whether the supporting evidence in the literature really is supporting your 
analysis or if it is just expressing the same cultural background as yourself. 
10. A significant aspect of resolving bias is the acknowledgment of its outcomes.   It is also 
worth remembering that even if preconceptions and biases are acknowledged, they are not 
always easily abandoned.  An indication of resistance to abandoning bias includes 
consistently overlooking data concerning a different analytical conclusion than the one you 
have drawn.  Discussion with a co-coder should counteract this analytic blindness. 
 
 
 
Criteria extracted from Ahern (1999, pp. 401-410) 
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Appendix L: Transcript of bracketing interview 
This has been removed from the electronic copy 
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Appendix M: Abridged research diary 
The following has been extracted from a reflective journal regarding the research process. 
2012 
November Potential MRPs presented today at research fair.  Currently interested in project 
looking at people with a learning disability who have diabetes.  There is still 
possibility to create MRP not on the list based on own ideas, not ruled out as option 
just yet. 
October Met with one potential supervisor for LD and diabetes project.  Also in discussion 
with another potential supervisor regarding another idea concerning psychological 
support for diabetes in the general population.  
December Supervisor selection form is due in soon.  Need to decide on which idea to pursue, 
both potential supervisors are interested in working with me. 
Decided to go for my own idea conducting a survey based design investigating the 
psychological support for people living with diabetes and how people living with 
diabetes would potentially like this delivered in practice (if at all).  Have identified 
internal supervisor with space.  Now need to find external supervisor willing to 
supervise. 
2013 
January E-mailed some potential supervisors in the area who may be willing to supervise 
project idea.  Meeting with 2 potential supervisors soon to discuss ideas. 
Identified external supervisor who is interested in project, appeared very interested 
in the area following meeting. 
February Supervisor selection form handed in. 
March Began preparation of research proposal.  Interesting completing further literature 
search to expand on my previous knowledge. 
May Discussed draft research proposal with service user consultants with interest in 
research.  They feel the research would have value and that people living with 
diabetes might benefit from further psychological support. 
Research proposal due soon, having difficulty finalising proposal and narrowing the 
research down into a specific enough question. 
Research proposal submitted. 
June Research proposal review panel today.  Experienced process as difficult (suspect I 
took some of the feedback too personally).  Panel have suggested that I have tried 
to take oŶ too ŵuĐh, iŶ aŶ aƌea that ŵaǇ ďe a little ͚too Đlose to hoŵe͛.  I am 
required to revise and re-submit proposal for August. 
I have been considering feedback from panel and discussed with supervisors 
following a bit of a breather.  One comment is particularly standing out for me, that 
panel felt that I have made a number of assumptions which have formed the basis 
of my initial proposal, namely that psychological support for people living with 
diabetes would be helpful and that most people would want it.  The panel suggest 
that it may be helpful to explore what people living with diabetes think about their 
experiences and to consider how psychological support may or may not fit within 
this as a more appropriate course of action. 
July Visit to Diabetes UK (charity) head office in London today.  Discussed the beginnings 
of revised research proposal with head of research.  He appeared interested in the 
project and suggested that linking in with research about to be published 
concerning diabetes related distress as part of the DAWN studies in their 
practitioner journal would increase its relevance and publishability. 
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Discussed meeting with Diabetes UK with external supervisor, who suggested 
thinking about qualitative methodologies as well as possibly focusing on one type of 
diabetes (i.e. just type 1) in order to narrow down the research questions.  I too feel 
these are good suggestions for the revised proposal.  Now need to decide which 
methodology would be most applicable - possibly grounded theory or IPA. 
After research about different philosophical and theoretical positions decided on 
IPA for methodology due to the double hermeneutic allowing for me to draw upon 
my own personal experience of living with diabetes.  Both supervisors also feel IPA 
is best fit for the research questions and that the explicit interpretative nature of 
this method will help to include my personal knowledge in the study in a way that 
adds extra depth to the research. 
August Revised proposal submitted. 
September Revised research proposal has been approved – feelings of significant relief and 
validation that research idea is now being viewed as valid and useful by multiple 
sources (e.g. Review panel, supervisors, and Diabetes UK).  Minor changes to 
consider following second review - now onto NHS ethics approval. 
October Begin IRAS process – very long form!  Lots to consider and identify on form. 
November Struggling to begin getting stuck in to IRAS process.  Internal supervisor has just 
started two month sabbatical and very limited time to discuss research and provide 
support with this.  Noticing feelings of particular anxiety that project will not be 
viewed as worthwhile by ethical review panel – possibly linked in with my 
experiences as a patient and/or resonating with first research review panel? 
2014 
January IRAS application moving slowly after Christmas break.  Booked meeting with 
supervisors to discuss this. 
February Helpful meeting with external supervisor to focus process – very validating 
experience and helped to narrow down what value research will potentially bring 
once completed – this is something I had lost sight of in last few months.  Beginning 
to get back on track. 
March Beginning to make contact with local diabetes teams in order to discuss project, 
potential recruitment and identify support and local collaborators – very nervous 
about taking this step, and I am surprised at some positivity of feedback and 
interest, even from busy consultants that I felt may have not been overly 
interested. 
April IRAS form is coming together – still lots add to form and may be tight for time with 
data collection after waiting for review panel date.  May have to consider deferred 
submission. 
June NHS ethics application submitted – good news is research qualifies for a 
proportionate review.  This means review will happen in 1 or 2 weeks instead of 
many months - should speed up process and regain some lost time. 
July Ethical review panel today, received a phone call from principal reviewer.  Feedback 
was positive (again was surprised/particularly anxious about this) have received 
letter of conditional ethical approval - now a few minor conditions to change for 
favourable opinion. 
August Local R&D approval request submitted to one NHS trust that is willing to support 
the research. 
Conditions of full ethical approval have been met and acknowledgement received – 
now to continue with local R&D approval for the 2 trusts that are interested in the 
research. 
R&D approval for first trust received, now to begin recruitment whilst continuing 
with R&D approval for second trust. 
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Delays with receiving authorisation of local collaborator with second trust for R&D 
approval – frustrating.  
Undertook bracketing interview today with colleague.  Many useful reflections and 
things to consider further: 
Interesting to consider some of my assumptions and motivations for completing 
this research.  Given my lived experiences of type 1 diabetes and experiences 
accessing services in relation to this it is important to be aware of these. 
Some of the discussion revolved around where might my personal interest in 
diabetes related distress have come from.  Ahern (1999) recommends clarifying 
ones personal value systems and areas where you are subjective. related to this, I 
recounted some of my personal experiences of occasionally feeling a lack of 
acknowledgement from others that diabetes is serious, and that my own distress 
about living with diabetes at times has not been validated.  I wonder if I am also 
wanting to give others an opportunity for these experiences to be heard and 
acknowledged?  I also became more aware of my own motivations to see more 
specialist psychological support for people living with diabetes in practice, as I 
currently feel this is often overlooked.  I recognised this was an important driver 
behind my first unsuccessful project proposal and must be careful to hold this in 
mind throughout the remainder of the study progress. 
We also explored situations that so far have felt particularly anxiety provoking for 
me.  This was discussed with the aim of identifying feelings that may indicate a lack 
of neutrality for me in parts of the research process, as recommended by Ahern 
(1999).  I talked in particular about contacting diabetes teams and applying for 
ethics as periods of particular anxiety for me. At these moments I felt that I would 
have a fight on my hands to convince others of the value of my research.  I have 
experienced surprise that in general people are interested in project, and that many 
of these are not people living with diabetes themselves.  This feels strange given 
own experience of often feeling that the psychological impact of living with 
diabetes was not always acknowledged or thought about by others and/or diabetes 
teams.  This may be fuelling anxiety around meetings with otheƌ pƌofessioŶal͛s and 
receiving feedback about the project.   I suspect this also might have been partially 
behind my roadblock with getting started with the IRAS form.  It will be important 
for me to be aware of this when I conduct my interviews as a number of my 
questions involve discussions about how people experience their relationship with 
their diabetes team, and my own views about this have the potential to influence 
my questioning. 
September “till pƌoďleŵs ǁith seĐoŶd tƌust͛s ‘&D depaƌtŵeŶt – in continued dialogue with 
R&D department about this who are helping to push this forward on my behalf.  
Beginning to arrange interviews with some potential participants from trust number 
one. 
Now I have ethical approval – arranged meeting with both supervisors, to discuss 
ideas for section A - exciting meeting and injected enthusiasm.  I will try to pull 
some of this thinking together and begin the section A write-up whilst also 
collecting data for section B concurrently. 
Additionally, following the recent bracketing interview I have been reflecting on 
areas of possible role conflict as per Ahern's (1999) criteria.  A major consideration 
to emerge from the bracketing interview is whether or not I disclose my own 
diabetes prior to completing the interview or not.  This is a potential conflict 
between my role as someone living with diabetes and also as a researcher.  I 
discussed this with my supervisors and decided not to disclose this at the beginning 
because it may influence how people decide to describe components of their 
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experience if they presume me to have prior knowledge or experience myself.  
Instead I shall disclose this at the end of the interview as part of the debrief. 
Finally managed to arrange a meeting with the diabetes team from the second trust 
with support of my external supervisor, team interested and keen to support the 
research, hopefully should speed up R&D approval process now. 
Beginning to meet first participants and conduct interviews. 
October First two interviews completed. Very interested to get started.  Both respondents 
report quite different experiences and appear to be in different stages with life with 
diabetes, both in terms of age and how they view and respond to it – this appears 
to have different impacts for them on an individual level and how they view the 
diabetes team.  It will be important to try to give equal credence to these 
differences in the report write up and not attend to one more than the other based 
on my own experiences.  I was surprised to hear that one participant had described 
her relationship with the diabetes team as highly positive and supportive for the 
most part.  Ahern (1999) recommends giving extra attention to areas of the data 
collection and analysis that is particularly surprising for you.  I am thinking about my 
reaction to this, on some level I feel jealous that this individual is describing a 
positive relationship to the support network that I do not feel I have always had 
myself.  Additionally I notice myself being drawn to discount this from my thinking 
and future questioning because it is not consistent with my experience.  I must try 
to keep this in mind and to give it equal credence to more negative reports in the 
study write up. 
It is difficult to find time between completing interviews, transcribing, arranging 
others, working on section A, and noting initial themes.  Meeting with internal 
supervisor soon to discuss initial theme development that may help to focus this. 
Useful meeting with supervisor to discuss initial reflections and theme 
development.  Provided some useful additional insights and things to consider.  On 
the whole they felt I was interrogating the data well. 
November R&D approval for second trust finally received after long delay.  Beginning to recruit 
participants from this trust ASAP. 
December Three more interviews completed – interviews are now taking slightly longer, 
perhaps as I relax into the process and/or introduce lines of questioning informed 
by previous interviews.   Also beginning to notice some convergence and divergence 
iŶ people͛s stoƌies.  Experiences of distress are coming up regularly.  This is despite 
me not explicitly asking people about psychological or emotional issues.  Also this 
distress appears to be interwoven into the day to day experiences of living with the 
condition and not necessarily contingent on one or more specific events. 
2015 
January Two more interviews completed.  Met with supervisor to discuss theme 
development.  Discussed that although I haǀe desĐƌiďed people͛s eǆpeƌieŶĐes ǁell 
and generally remained faithful to the data, I am maybe struggling to take the 
heƌŵeŶeutiĐ leap aŶd add fuƌtheƌ iŶteƌpƌetatioŶ to people͛s eǆpeƌieŶĐes.   
Upon reflection, this part of the analysis (i.e. taking a hermeneutic leap) feels like a 
'block' in the research process described by Ahern (1999).  I discussed this with my 
supervisor with a view to reframing this block in order to transform it into an 
opportunity as Ahern suggests.  I talked about feeling a strong sense of 
ƌespoŶsiďilitǇ to tell peoples stoƌies aŶd to get it ͚ƌight͛.  My supervisor discussed 
the importance of trying not to feel constrained by this as long as I can feel 
confident in what I am doing and why – the aim is not to try to remove bias 
completely (that is impossible) but to try to acknowledge it and be aware of it 
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throughout theme development.  Will re-visit themes and attempt to take more of 
an interpretative stance following the meeting. 
February Final interview completed, adding transcripts to NVivo computer software which is 
extra work but is helping me to organise peoples words and organise theme 
development.  Section A also progressing well, first draft should be ready for 
feedback soon. 
All transcripts have also been sent through to external supervisor who wishes to 
read them all in full, this will be helpful when evaluating my theme development 
later down the line. 
March Section A draft complete some positive feedback and minor changes to make but 
shouldŶ͛t take loŶg to get iŶto good shape. 
Analysis is now more or less finished and I can begin to write up section B results 
In line with Ahern's (1999) recommendations.  I am taking some time to reflect on 
how I have chosen to write up the study findings.  I am noticing that I am being 
drawn to include example quotes from 2-3 participants in particular.  This is 
because they tended to speak in a succint way and it is making my task of writing 
the study up easier.  However on another scan through there are other example 
quotes from other participants that I can/would like to use, but I may need to cut 
words from other areas to include them.  I will re-visit the results section to try to 
include quotes from all participants roughly equally where possible. 
April Draft of section B sent to supervisors – might be tight to get feedback incorporated 
before the deadline. 
I do not feel I will have things quite to the stage I would like in time for the initial 
hand in, I have discussed with supervisors and my manager the possibility of a 2 
week extension.  
Extension agreed which should give me time to complete the work to the required 
standard. 
Summary report of results has been sent to participants.  Have received some initial 
feedback – largely positive and participants feel that I have captured their 
eǆpeƌieŶĐes ǁell.  MaŶǇ aƌe eǆĐited to see soŵethiŶg tǇped up aŶd ͚ƌeal͛ aŶd that 
their experiences could possibly help others in the future. 
Writing ethics and R&D end of study report and tying up loose ends preparation for 
submission 
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Appendix N: List of example interview quotations supporting each sub theme 
Experiences of diagnosis 
Process of diagnosis 
͚I ǁas just dƌiŶkiŶg galloŶs of ǁateƌ, I ǁas ƌeallǇ thiƌstǇ, ƌeallǇ tiƌed͛ ;PϭͿ 
͚I ǁas oŶ holidaǇ ;…Ϳ aŶd, I ǁas dƌiŶkiŶg loads aŶd goiŶg to the toilet loads and all the 
Ŷoƌŵal sǇŵptoŵs͛ ;PϮͿ 
͚I staƌted ǁettiŶg the ďed, up to ϯ, Ϯ to ϯ tiŵes a Ŷight. Uŵ, eǆĐessiǀe thiƌst. Uŵ, eǆtƌeŵelǇ 
skinny. Complaining of achiness. FeeliŶg ill peƌŵaŶeŶtlǇ.͛ ;PϳͿ 
͚I ǁas thiƌstǇ, uh, aŶd I had lost, I ǁas Ƌuite a chubby kid, um, and I'd lost, I'd lost ǁeight,͛ 
(P8) 
͚MǇ ŵuŵ Đaught the sǇŵptoŵs ǁithiŶ the fiƌst daǇ, aŶd I ǁas stƌaight iŶ the doĐtoƌs aŶd oŶ 
iŶsuliŶ ǁithiŶ like ϲ houƌs͛ (P3) 
͚Muŵ aŶd Dad took ŵe to the hospital ŶeaƌďǇ aŶd, I got diagŶosed͛ (P2) 
͚MǇ ŵuŵ told ŵe ;…Ϳ that theǇ had a phoŶe Đall fƌoŵ the hospital, Ǉou kŶoǁ, the ŵiddle of 
the Ŷight aĐtuallǇ ;…Ϳ saǇiŶg, theǇ didŶ't eǆpeĐt ŵe to ŵake it.  TheǇ thought it ǁas like 
pneumonia, something else, I can't remember. And there's only, at you know, a later stage 
they did, they did a test that they discovered, um, you know, diabetes and started giving 
ŵe, giǀiŶg ŵe iŶsuliŶ.͛ (P8) 
͚You͛ƌe iŶ hospital, theǇ, keep Ǉou oŶ ŵoŶitoƌ, aŶd keep Ǉou iŶ theƌe foƌ like ϯ daǇs aŶd, 
give you like, really, not very comprehensive instructions on how to manage the disease and 
theŶ seŶd Ǉou hoŵe. AŶd, leaǀe Ǉou to soƌt of get oŶ ǁith it I guess.͛ (P4)  
͚I ǁasŶ't ƌeallǇ told, hoǁ to ƌeallǇ ŵaŶage it, ǁe ǁeƌe just said ah Ǉou kŶoǁ, giǀe a set 
dosage at breakfast, lunch aŶd diŶŶeƌ, eƌŵ aŶd that ǁas aďout it ƌeallǇ.͛ (P1) 
Reacting to diagnosis 
͚I guess theƌe ǁas like, the ĐlassiĐ soƌt of slight disďelief. I ƌeŵeŵďeƌ, eaƌlǇ, eaƌlǇ oŶ, 
probably for the first like week or so. Basically just being like yeah, no, you know, it's fine, 
I'ŵ Ŷot aĐtuallǇ diaďetiĐ, Ǉou kŶoǁ, it doesŶ't ŵeaŶ aŶǇthiŶg.͛ (P4) 
͚WheŶ I ǁas fiƌst diagŶosed it ǁas ŵoƌe of a ƌelief to kŶoǁ soŵethiŶg ǁas ǁƌoŶg. AŶd that 
it wasn't just people thinking I was just being attention seeking. [Laughs] I was like, 'I 
aĐtuallǇ aŵ ill.͛ (P7) 
͚It ǁas a sĐaƌǇ tiŵe.͛ (P5) 
͚I doŶ't ƌeallǇ ƌeŵeŵďeƌ too ŵuĐh aďout the, uŵ, aďout the aĐtual diagŶosis ŵǇself. 
BeĐause I ǁas just too ǇouŶg ƌeallǇ.͛ (P6) 
͚I haǀeŶ't kŶoǁŶ aŶǇ diffeƌeŶt ǁhiĐh I thiŶk is pƌoďaďlǇ easieƌ͛ (P2) 
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Adjustment to changes 
͚“o. I'ǀe staƌted off oŶ Ϯ iŶjeĐtioŶs, theŶ ƌapidlǇ ǁeŶt oŶ to ϰ. “o. Quite a lot to deal ǁith at 
ϵ.͛ (P7) 
͚It ǁould haǀe ďeeŶ haƌd foƌ ŵǇ ďƌotheƌs aŶd sisteƌs iŶ the house ďeĐause, uŵ [pause], I 
would, I was like suddenly this like ill child aŶd theǇ pƌoďaďlǇ ǁould haǀe felt, ;…Ϳ ǀeƌǇ like 
ĐoŶĐeƌŶed aďout ŵe͛ (P4) 
͚I thiŶk ŵǇ oldest ďƌotheƌ stƌuggled Ƌuite a lot ďeĐause ;…Ϳ he alǁaǇs saǇs like "Ohh, I ǁas 
dƌagged to this hospital appoiŶtŵeŶt, dƌagged to that hospital appoiŶtŵeŶt"͛ (P3) 
͚WheŶ I ǁas a Đhild, ŵǇ ďƌotheƌ used to ǁatĐh out foƌ ŵe all of the tiŵe͛ (P2) 
͚I ŵeaŶ it ǁas, ƌeallǇ haƌd foƌ ŵǇ ŵuŵ aŶd dad to haǀe to, aĐĐept that I got the disease, as it 
ǁas foƌ ŵe.͛ (P4) 
͚TheǇ hated the idea of haǀiŶg to giǀe ŵe iŶjeĐtioŶs, ďut theǇ, said that, when I was first 
diagnosed they couldn't bear me sitting across the other side of the room while they 
watched a nurse giving me an injection. So they wanted to get involved, they wanted to do 
it͛ (P6) 
 ͚It ǁas ƌeallǇ ƌeallǇ sĐaƌǇ, sĐaƌǇ tiŵes foƌ ŵǇ, uh foƌ ŵǇ paƌeŶts aĐtuallǇ͛ (P8) 
͚I had food alleƌgies as a Đhild so I ǁas oŶ a sugaƌ fƌee diet aŶǇǁaǇ ;…Ϳ aŶd ďeĐause I'd ďeeŶ 
oŶ a stƌiĐt diet aŶǇǁaǇ, losiŶg out oŶ ĐeƌtaiŶ foods ǁasŶ't that ďig a deal to ŵe.͛ (P7) 
͚At home, the diet was set around my brother anyway so, there wasn't that much change 
aŶd I kŶeǁ eǀeƌǇthiŶg that ǁas goiŶg oŶ ;…Ϳ Ǉeah, it ǁas Ƌuite good ďeĐause I just kŶeǁ it, I 
kŶeǁ ǁhat it ǁas aŶd it ǁasŶ't a sĐaƌǇ thiŶg.͛ (P3) 
͚I guess I just, just like aŶǇ, just like ĐhildƌeŶ I just soƌt of got oŶ ǁith it,͛ (P4) 
͚I kiŶd of dealt ǁith it Ƌuite ƋuiĐklǇ, aŶd just got oŶ ǁith it.͛ (P7) 
͚Uŵŵ, aŶd I thiŶk, ďeiŶg ϭϭ it just kiŶd of, it just happeŶed͛ (P3) 
 
Physical impact of T1D 
Experiences of high blood glucose 
͚I just feel aǁful, I haǀe headaĐhes a lot of the tiŵe aŶǇǁaǇ so theǇ get ǁoƌse͛ (P2) 
͚WheŶ I'ǀe got high gluĐose I do feel Đƌap, headaĐhes, aŶd it, all the ĐlassiĐ stuff aŶd, I get 
kiŶd of, gƌuŵpǇ,͛ (P4) 
͚The fƌustƌatioŶs of ǁhǇ's ŵǇ ďlood sugaƌ high ǁheŶ I haǀe doŶe the ƌight aŵouŶt of 
insulin? (P5) 
͚It ĐaŶ get fƌustƌatiŶg, ;…Ϳ espeĐiallǇ if Ǉou doŶ't kŶoǁ ǁhǇ it's Ƌuite so high, it's, Ǉou kŶoǁ 
Ƌuite a feǁ of theŵ I ĐaŶ't eǆplaiŶ.͛ (P2) 
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 ͚ThiŶkiŶg aďout it I pƌoďaďlǇ just ƌuŶ high ŵost of the tiŵe ;…Ϳ it's pƌoďaďlǇ ŵoƌe the faĐt 
that I'll just run high just to stop that risk of being low, which yeah, isn't good, so, yeah (P1) 
͚I just, Ǉou kŶoǁ, it's the ǁhole, uŵ. If I ƌuŶ at ϲ I hǇpo ŵoƌe fƌeƋueŶtlǇ, if I ƌuŶ at ϭϬ I doŶ't 
feel any different and I don't hypo as frequently so why not run at ϭϬ?͛ (P6) 
͚I used to, aŶd I still do to a ĐeƌtaiŶ eǆteŶt ƌuŶ ŵǇ ďlood sugaƌs ďefoƌe ďed, Ƌuite high. IŶ the 
teeŶs. That ǁas a seĐuƌitǇ ŵeasuƌe foƌ ŵe.͛ (P5) 
Experiences of managing blood glucose 
͚I'ǀe alǁaǇs goŶe up aŶd doǁŶ. EǀeŶ ǁheŶ I eat the saŵe thing, on the same day. My sugars 
go up aŶd doǁŶ.͛ (P7) 
͚I ǁas alǁaǇs up aŶd doǁŶ, up aŶd doǁŶ all the tiŵe.͛ (P6) 
͚AŶd theŶ I ǁas haǀiŶg like seǀeƌe dƌops aŶd highs͛ (P3) 
͚“o theƌe's just the faĐt that theƌe ǁas all of these otheƌ faĐtoƌs, that Ǉou ĐaŶ't ƌeally control 
for and you can't, you can't sort of pre-emptively manage, you know, you have to reactively 
ŵaŶage theŵ so, that's ƌeallǇ fƌustƌatiŶg I fouŶd.͛ (P1) 
͚I ǁasŶ't sĐhooled iŶ aŶǇthiŶg aďout, aŶǇthiŶg aŶǇǁheƌe Ŷeaƌ like ĐaƌďohǇdƌate ĐouŶtiŶg. 
There's Ŷo logiĐ, it ǁas all just like, hit aŶd ŵiss.͛ (P4) 
͚GeŶeƌallǇ I go oŶ hoǁ I feel oƌ hoǁ the sugaƌs aƌe daǇ to daǇ.  Rather than see the pattern 
ǁhiĐh isŶ't ƌeallǇ ǀeƌǇ helpful, I should look aŶd see the patteƌŶ ŵoƌe ofteŶ.͛ (P2) 
 ͚AŶd doiŶg a feǁ ŵoƌe blood sugars that, then, you start realising what's going on. And, 
aĐtuallǇ, ;…Ϳ it ǁasŶ't uŶtil I theŶ staƌtiŶg tǁiggiŶg, I ǁas like it's all aďout the data aŶalǇsis 
really, it's what it comes down to, is knowing where to see those spikes and what the 
commonality is between all those spikes. And eliminating that. Or, making allowances for 
that. ;…Ϳ  It's tǁo eŶds of the speĐtƌuŵ. OŶe, iŶ that it's a ŵuĐh, a ŵuĐh ďiggeƌ paiŶ iŶ the 
arse. But, it gives you better long term results. Um, and short term results͛ (P6) 
͚You haǀe to giǀe it a lot of Ǉouƌ tiŵe aŶd thought. You haǀe to ǁƌite doǁŶ sugaƌs iŶ a diaƌǇ 
oƌ look at theŵ oŶ Ǉouƌ Đoŵputeƌ gƌaphs oƌ ǁhateǀeƌ.͛ (P4) 
͚AŶd theŶ I leaƌŶ to Đaƌď ĐouŶt. “o it Đould ďe, aŶǇthiŶg ǁith ĐaƌďohǇdƌate that I eat, I kŶoǁ 
to haǀe iŶsuliŶ ǁith it. “o I ĐaŶ eat, aŶǇthiŶg I ǁaŶt. As loŶg as I ĐouŶteƌaĐt it ǁith iŶsuliŶ.͛ 
(P7) 
͚“o it doesŶ't ŵatteƌ if Ǉou haǀe a ďig ŵeal, ďiggeƌ ŵeal thaŶ Ŷoƌŵal Ǉou just iŶjeĐt the ƌight 
amount of insulin for it and vice-versa really, but if you want some food, there's nothing to 
stop you to have that food, as long as you know, and you give it your best shot the amount 
of iŶsuliŶ͛ (P8)  
͚I'ǀe goŶe fƌoŵ like ϵ.ϳ doǁŶ to ϳ.ϯ iŶ the last Ϯ ŵoŶths is, Ǉeah. 
On the HbA1c? 
Yeah 
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And what's that like, to have brought the HbA1c down? 
I'm so proud of it [laughs] it's almost like, getting your degree results all over again just like 
oooooh, Ǉou did good, Ǉou got a ϭst tǇpe thiŶg.͛ (P3) 
͚AŶd, Ǉou kŶoǁ, stuff like that ǁill giǀe ŵe like a, a soƌt of a, like a happiness kick because. 
Yeah, and mainly like, the, the satisfaction of, if I've had like 3 straight days of like having 
like ϲ, ϳ, ϴ's, I'ŵ like ͞Ǉessss, ŶailiŶg it͟. AŶd theŶ like I feel good͛ ;Pϰ) 
Experiences of hypoglaecemia 
͚BeĐause I'ǀe ďeeŶ hǇpo I theŶ feel ƌough foƌ the ƌest of the daǇ͛ (P2) 
'Um, yeah, had fits in the night and she used to get the paramedics out and I'd get blue 
lighted thƌough to hospital. AŶd ďe ǀeƌǇ ǀeƌǇ pooƌlǇ.͛ (P5) 
͚I lost ŵǇ fiƌst ǁaƌŶiŶg state foƌ ŵǇ hǇpos.  So, I'd go from like fine, to really not fine really 
ƋuiĐklǇ͛ (P1) 
͚I ǁas ǁalkiŶg hoŵe fƌoŵ sĐhool, ;…Ϳ I got to the ŵiddle of the ƌoad, ŵǇ fƌieŶd ǁeŶt off aŶd 
my mum phoned her up half an hour later and said where was I?  They both came out and 
found me in the middle of the ƌoad ďeĐause I'd Đollapsed hǇpo, ;…Ϳ I doŶ't ƌeŵeŵďeƌ it, I 
just remember being told about it, was scary, yeah. (P2) 
͚I used to, uŵ, ďe so sĐaƌed of haǀiŶg a fit duƌiŶg the Ŷight͛ (P5) 
͚OďǀiouslǇ like ǁheŶ, ǁheŶ I'ŵ loǁ I'll ŵake ǀeƌǇ ďad deĐisioŶs aŶd I'll be slow and 
annoying, you know, to be around. Uh, cos you haven't got the glucose in your brain so it's 
Ŷot ǁoƌkiŶg pƌopeƌlǇ͛ (P4) 
͚It's affeĐted eǆaŵs aŶd stuff, I'ǀe had hǇpos iŶ eǆaŵs, eƌŵ, aŶd uŶtil I got 
special dispeŶsatioŶ,͛ (P1) 
͚It does get annoying if you're low and then you can't go somewhere or do something 
ďeĐause it's loǁ aŶd Ǉou haǀe to ǁait foƌ it to Đoŵe ďaĐk up uŵ, it ĐaŶ get fƌustƌatiŶg͛ (P2) 
Feeling frustrated and restricted by treatment regimes 
͚Not haǀiŶg a lie-in, for, at least 10 years where I split my basal between 8am and 8pm and 
that was it, you couldn't do it at 7 or 9, you had to set your alarm for 8 o'clock and wake up 
aŶd iŶjeĐt aŶd theŶ go ďaĐk to sleep, aŶd thiŶgs like that͛ (P3) 
͚OK if I get up iŶ the ŵoƌŶiŶg I haǀe to have breakfast and I have to have lunch and, um, 
there was always that worry that if there wasn't a meal coming then I'd get really anxious 
aďout it͛ (P1) 
͚I ǁas haǀiŶg to get up aŶ houƌ eaƌlieƌ, Đos Ǉou had, oƌigiŶallǇ Ǉou had to haǀe it aŶ houƌ iŶ 
advance of, eating. And you were only allowed certain things. So I had to have breakfast, 
then a mid-morning snack, then lunch, then a mid-afternoon snack, then dinner and then an 
eǀeŶiŶg sŶaĐk.͛ (P7)  
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͚I ǁas doiŶg tǁo iŶjeĐtioŶs a daǇ at set tiŵes, so I had to eat at set times and have snacks at 
set times. And set amount of carbohydrates so everything had to be weighed out. My 
potatoes, ŵǇ ƌiĐe, that soƌt of thiŶg.͛ (P5) 
͚I do haǀe to ďe Ƌuite Đaƌeful aďout ǁhat I'ŵ eatiŶg oƌ hoǁ I'ŵ feeliŶg͛ (P1) 
͚If diaďetes was to stop, today, um, I would probably still be looking at stuff for the next 10 
Ǉeaƌs aŶd tƌǇiŶg to figuƌe out the aŵouŶt of ĐaƌďohǇdƌates.͛ (P6) 
͚I'ŵ a hell of a lot ŵoƌe aǁaƌe of ǁhat I'ŵ eatiŶg. ;…Ϳ that's a positiǀe thiŶg. EŶĐouƌagiŶg us 
to eat betteƌ. It has eŶĐouƌaged, it's eŶĐouƌaged ŵe to eat ďetteƌ Ǉou kŶoǁ,͛ (P4) 
͚No, Ǉou go out foƌ aŶǇ kiŶd of leŶgth of tiŵe it's Ǉou kŶoǁ, Ǉou'ǀe got Ǉouƌ iŶjeĐtioŶ ǁith 
you, you've got your blood test kit with you, and um, you know bit of Lucozade or dextrose 
tablets or something with you, yeah you just [sighs], you got to be prepared 
[laughs].  Because sometimes you could, you known even the best laid plans, you know, 
you've just gotta not be without those things really, well you shouldn't be without those 
thiŶgs.͛ (P8) 
͚AŶd that adǀaŶĐe plaŶŶiŶg of, I ĐaŶ go aǁaǇ foƌ a Ŷight heƌe, ďeĐause I kŶoǁ hoŵe's Ŷeaƌ. 
But if I'm going away from home, I have to make sure I'm organised with the medication. 
And make sure I've got more than enough. And food, and hypo food. Cos people that I go to 
ŵaǇ Ŷot haǀe food that I like, oƌ the food that, is, is like suitaďle.͛ (P7) 
͚It's ŵoƌe of a hassle ;…Ϳ ǁheŶ, the puŵp Ŷeeds to ďe ĐhaŶged eǀeƌǇ ϯ daǇs.͛ (P6) 
͚I kŶoǁ that like, as good as ŵǇ, all ŵǇ circadian rhythms and my carbohydrate ratios are, if 
I'm having, you know, a little portion of couscous and some lovely fried vegetables. That's 
going to work perfectly. But if I have a Dominos or a curry, even if I've got spot on ratios, it's 
goiŶg to ďe ďuggeƌed.͛ (P4) 
Additional health complications  
͚I do get uŵ soŵe pƌoďleŵs ǁith ŵǇ leg, aŶd theǇ did saǇ it ǁas Ŷeƌǀe daŵage͛ ;PϮͿ 
͚I had a ŵassiǀe ďleed iŶ oŶe of ŵǇ eǇes. Uŵ. AŶd I ĐouldŶ't see out of that eǇe ;…Ϳ sigŶed 
off work, 5 months later I had surgery to remove the clot. And then, a year later, the same 
thing happened in the other eye. So, for those 5 months, I completely lost my 
iŶdepeŶdeŶĐe͛ (P5) 
͚Wheƌe I aŵ todaǇ is, I'ǀe got ĐhƌoŶiĐ kidŶeǇ disease, uŵ, so it just ƌesults iŶ a lot of 
tiredness.  Um, I have diabetic neuropathy um so the legs, bottom half of my legs are just 
quite painful quite a lot of the time, and a lot of numbness when it comes to my feet.  I've 
had some laser surgery done in both eyes [pause] and all this kind of happened, fairly kind 
of ƌapidlǇ ;…Ϳ “o, all that happened and I, was put on to ill-health retirement from 
work.  This time last year, so, yeah.  I was basically assessed that I wouldn't be going back to 
ǁoƌk aŶd that ǁas that theŶ.͛ (P8) 
͚It's sĐaƌǇ losiŶg Ǉouƌ sight, losiŶg oŶe of Ǉouƌ seŶses. You miss so much, you just, I got 
depƌessed. Uŵ, just fouŶd life ƌeallǇ diffiĐult.͛  ;Pϱ) 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  142 
 
 
 
͚Yeah, so I thiŶk the ďaĐkgƌouŶd ƌetiŶopathǇ, uŵ, kiĐked it off just ďeĐause I kŶeǁ it ǁas a 
sign of a long term effect. Um, and up until that point I'd not seen any of the long term 
effects. Um, that, you know, the long term side effects of actually having it. And at that 
poiŶt it ǁas kiŶd of a tƌiggeƌ poiŶt͛ (P6) 
͚I eŶded up haǀiŶg appeŶdiĐitis, got ƌushed iŶ ǁith full DKA iŶ iŶteŶsiǀe Đaƌe foƌ ϯ ǁeeks, 
and had about 2 months off college [pause] and I think that was my first like, holy crap 
there's no actually control over my body, appendicitis can cause this, and I think that scared 
ŵe a lot.͛ (P3)  
 ͚Has developing the complications changed the way you feel about living with it? 
[pause] Yeah, I mean it's all consuming.  Diaďetes is all ĐoŶsuŵiŶg to ŵe Ŷoǁ.͛ (P8) 
͚I thiŶk it ǁas pƌoďaďlǇ aƌouŶd the tiŵe of the eǇe agaiŶ. That ǁas a ŵassiǀe shake up foƌ 
ŵe. Massiǀe.͛ (P5) 
 
Psychological impact of T1D 
Psychological and emotional distress 
͚BeĐause of eǀeƌǇthiŶg that ǁas goiŶg oŶ it ƌeallǇ affeĐted ŵǇ ŵood ƌeallǇ ŶegatiǀelǇ͛ (P1) 
͚The haƌdest thiŶg I thiŶk has just ďeeŶ, the, Ǉeah, that kiŶd of psǇĐhologiĐal pƌessuƌe that 
it's had oŶ ŵe.͛ (P4) 
͚I kŶoǁ diaďetiĐs aƌe ŵoƌe pƌoŶe to gettiŶg depƌessioŶ aŶd I do go thƌough phases of it.͛ 
(P5) 
͚I thiŶk it ĐaŶ ďe, I thiŶk it ĐaŶ ďe depƌessiŶg ǁheŶ Ǉou thiŶk aďout all the stuff that's piliŶg 
up agaiŶst Ǉou.͛ (P6) 
͚I ŵeaŶ [pause] I, It's kiŶd of theƌe's a ŵood thiŶg as ǁell, I ĐaŶ get into some real downers 
about my situation because it can just really take you to really dark places sometimes I 
thiŶk.͛ (P8) 
͚WheŶ I ǁas a teeŶageƌ it ƌeallǇ aŶŶoǇed ŵe at oŶe poiŶt aŶd got ŵe doǁŶ͛ (P2) 
͚It just fƌustƌates ŵe Ƌuite a lot͛ (P3) 
͚It͛s defiŶitelǇ giǀeŶ ŵe a lot of like feaƌ͛ (P4) 
͚I thought aďout the psǇĐhologiĐal effeĐt haǀiŶg diaďetes has had oŶ ŵe aŶd I thiŶk the 
biggest impact has been the 'threat' that is always at the back of my mind. Sometimes it's 
very real and in the short-term (i.e., hǇposͿ aŶd soŵetiŵes it͛s the ŵoƌe distaŶt ǁoƌƌǇ ;i.e., 
"how's my high blood sugar today going to affect my eyesight or limbs in 20 years time"(...) 
It's something that, for me, comes in ebbs and waves - it's always there, but sometimes it 
can induce real paŶiĐ aŶd feaƌ͛ ;Pϭ post iŶteƌǀieǁ ǀia eŵailͿ 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  143 
 
 
 
͚You kŶoǁ, it's uŵ, it's, it's, it's Ŷot aŶ easǇ thiŶg to liǀe ǁith. ;...Ϳ aŶd ďeiŶg aďle to get that 
message across to people who don't live with it, that it isn't an easy thing to live with. Um. 
You know. Is iŵpoƌtaŶt, I thiŶk.͛ ;Pϲ) 
͚It ǁas diffiĐult to ǀeƌďalise ŵǇ thoughts aŶd feeliŶgs ;…Ϳ I kŶoǁ fƌoŵ past eǆpeƌieŶĐe 
talkiŶg aďout ŵǇ diaďetes iŶ aŶǇ depth ǁould ďƌiŶg ŵe to teaƌs oƌ ŵake ŵe ƌeallǇ upset͛ 
(P1) 
͚“o thƌough thiŶgs like that, that, the uh, uh, yeah the sort of negative stuff from the 
diaďetes has got ďetteƌ. Uŵ. Yeah, it's Ŷot like, it's Ŷot fiǆed͛ ;Pϰ) 
Constant awareness and worry 
͚I thiŶk it's soŵethiŶg Ǉou haǀe to eǆpeƌieŶĐe, I thiŶk Ǉou, Ǉou ƌeallǇ Ŷeed to kiŶd of Ϯϰ/ϳ ϳ 
daǇs a ǁeek, ;…Ϳ I just think you have to, whether it's the very fact that you have to inject or 
that you have to be aware of [pause] you can't switch off from being a diabetic, you can't 
foƌget aďout it͛ (P8) 
͚The Ŷuƌses doǁŶ the hospital, uŵ, pitĐhed it, eƌƌ, ǀisualised it, like an iceberg. You know, 
you got the tip of the iceberg which is your normal day to day stuff that you have to deal 
with, that everyone has to deal with. Um, you know, family issues, work issues, stresses, car 
problems, all that stuff. And then underneath the water you've got the rest of it, which is 
Ǉouƌ diaďetes. ;…Ϳ kŶoǁiŶg that theƌe's so ŵuĐh uŶdeƌŶeath the, that leǀel of the ǁateƌ, 
um, that can effect everything else that everybody else has to deal with anyway. I think it 
ĐaŶ ďe Ƌuite dauŶtiŶg.͛ (P6) 
͚BeĐause that's always a constant thing that's running in the back of your mind, is oh what 
have I eaten today?  What have I done today?  What ǁill I Ŷeed to do?͛ (P1) 
͚It͛s this thiŶg of it just ǁeaƌiŶg Ǉou doǁŶ oǀeƌ tiŵe like a, Ǉeah. All these tiŶǇ little 
ŵoŵeŶts ǁheƌe Ǉou haǀe all these, uh, like pƌoďleŵs ďeĐause of the diaďetes͛ (P4) 
͚But theƌe is just so ŵaŶǇ little thiŶgs, that just Đhip aǁaǇ at Ǉou oǀeƌ the Ǉeaƌs, Ǉou'ƌe just 
like, diaďetes is a paiŶ iŶ the ďuŵ.͛ (P3) 
͚I suppose it ǁas the feeling of always having to pay attention to how I felt and if I was going 
to ďe hǇpo͛ (P2) 
͚BeĐause all Ǉou Ŷeed to do is ĐoŶĐeŶtƌate oŶ ǁoƌk aŶd Ǉou'ǀe got this otheƌ thiŶg just kiŶd 
of sitting there going right, is the blood sugar ok? Is it getting back down to where it should 
be?' (P6) 
͚MaiŶlǇ to do ǁith ǁoƌƌǇiŶg aďout goiŶg loǁ. HǇpos. Uh, I'ǀe alǁaǇs felt, ĐoŶstaŶtlǇ just, iŶ 
feaƌ of uh. I guess it's a, a ǁeiƌd feaƌ of eŵďaƌƌassiŶg ŵǇself.͛ (P4) 
͚You͛ǀe alǁaǇs got the thought of thiŶgs Đould go ǁƌoŶg oƌ the complications that could 
happeŶ.͛ (P2) 
͚The loŶg teƌŵ ƌisks of diaďetes, that's alǁaǇs theƌe as a thought͛ (P3) 
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͚Quite a lot of feaƌ aďout, health pƌoďleŵs iŶ the futuƌe. Uŵ [pause], ǁoƌƌǇiŶg aďout ǁheŶ 
I'm gonna, you know, kick the bucket because of it.͛ (P4) 
͚I'ŵ sĐaƌed of ǁhat͛s aƌouŶd the ĐoƌŶeƌ ƌeallǇ.͛ (P8) 
͚Kids.  AlǁaǇs oŶ the foƌefƌoŶt of ŵǇ ŵiŶd, ďeĐause, ;…Ϳ it's ĐoŵiŶg to that poiŶt iŶ life, aŶd 
then I just keep thinking if my diabetes isn't controlled, that can cause miscarriages, it can 
cause children to have disaďilities, Ǉou kŶoǁ heaƌt defeĐts, eǀeƌǇthiŶg ;…Ϳ aŶd theŶ like, 
passing down the auto immune deficiency you know, you could have a diabetic child down 
the liŶe aŶd, that's a sĐaƌǇ thought͛ (P3) 
͚Well, ǁe had ouƌ fiƌst Đhild ;…Ϳ last year. Erm, [pause] and it's things like seeing him, grow. 
“eeiŶg hiŵ gƌoǁ up aŶd thiŶkiŶg to ŵǇself, ͞I doŶ't ǁaŶt hiŵ to ďe diaďetiĐ, ďut I kŶoǁ 
theƌe's a ĐhaŶĐe of it.͟ Eƌŵ, Ǉeah I kŶoǁ theƌe's a higheƌ possiďilitǇ that he Đould ďeĐoŵe 
diabetic because of ŵe.͛ (P6) 
͚Foƌ the futuƌe. I'ŵ ǁoƌƌied a lot aďout haǀiŶg kids. BeĐause I do ǁaŶt to haǀe kids, ďut I 
don't really wanna have a kid and have it be diabetic. It's in my family. Err, I do kind of worry 
aďout that,͛ (P4) 
͚I got to a poiŶt, pƌoďaďlǇ a Đouple of months later where I was like, it doesn't matter how 
hard I try, it's always going to be wrong, or there's always going to be something there that's 
goiŶg to get iŶ the ǁaǇ ;…Ϳ psǇĐhologiĐallǇ it's like, I'ŵ tƌǇiŶg ƌeallǇ haƌd to do soŵethiŶg ďut 
I caŶ't do it so, uŵ Ǉeah it has Ƌuite a ďig Ŷegatiǀe iŵpaĐt iŶ that ƌespeĐt. ͛ (P1) 
͚MaǇďe it eŵphasises the feeliŶgs of, ĐaŶ't ĐoŶtƌol it, Ŷot worthlessness but that sort of 
thiŶg, aŶd just I'ŵ Ŷot good eŶough tǇpe of thiŶg, ďut it ǀaƌies͛ (P2) 
͚Befoƌe I ǁas managing it well, it was just like this constant little, sort of like reminder of, 
you're a failure. It's like, bad blood sugar, high blood sugar, low blood sugars, every day, like 
ϱ tiŵes a daǇ. It's like ͞Ǉou'ƌe aŶ idiot, Ǉou'ƌe aŶ idiot, Ǉou'ƌe aŶ idiot, you're doing it wrong, 
Ǉou'ƌe aŶ idiot, Ǉou'ƌe a failuƌe͟, Ǉou kŶoǁ.͛ (P4) 
͚I ŵeaŶ theƌe's ďeeŶ soŵe ǀeƌǇ suĐĐessful diaďetiĐs, ďut, I'ŵ Ŷot oŶe of theŵ͛ (P8) 
Behavioural impact of T1D 
͚But, uŵ, ďut I do kŶoǁ that it affeĐts ŵǇ ŵood Ŷoǁ. Whetheƌ that's, whether that's 
phǇsiĐal, ǁhetheƌ that's just a psǇĐhologiĐal thiŶg I doŶ't kŶoǁ͛ (P6) 
͚Like the aŵouŶt of tiŵes that I'll just sŶap at ŵǇ husďaŶd foƌ Ŷo ƌeasoŶ, aŶd I'll Đoŵe ďaĐk 
like, I'll go off and I'll check my bloods and I'll come back and, I know it's no excuse but my 
ďloods aƌe high, soƌƌǇ.͛ (P3) 
͚Loǁ oƌ high ďlood sugaƌ ŵake ŵe iƌƌitated aŶd iƌƌitaďle aŶd, Ǉou kŶoǁ, ďeiŶg ŵaǇďe a ďit 
of a Ŷightŵaƌe to ďe aƌouŶd.͛ (P4) 
͚I just get ŵoodǇ, I get iƌƌitaďle, uŵ gƌuŵpǇ I thiŶk. ;…Ϳ aŶd I do put that doǁn to, just how 
Ǉou feel ǁith Ǉouƌ diaďetes, if Ǉou doŶ't feel gƌeat theŶ Ǉou feel gƌuŵpǇ,͛ (P8) 
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͚A fƌieŶd of ŵiŶe ǁho ǁas oŶ his stag do aŶd he ǁas hoŵe ďǇ ŵidŶight. Cos he ĐouldŶ't 
stand, or walk, or speak. Um, and I was the one taking him home because I was the sensible 
one out of everyone because I was the one that had to, you know, had other things to, to 
kiŶd of thiŶk aďout. “o. I thiŶk it ŵakes Ǉou ŵoƌe seŶsiďle as ǁell.͛ (P6) 
͚I ǁas Ŷeǀeƌ a kid to ďuŶk sĐhool oƌ go off oŶ ƌaŶdoŵ ƌoad tƌips oŶ aŶǇ hour of the night 
with friends with drink in the back of the car, in my mind like where are we going and what 
time because I need to make sure my insulin is going to be kept quite cool and I need to 
know where can get snacks from and are we going to eat today? [laughs]͛ (P3) 
͚IŶ a ǁaǇ I guess it's like, uh, it kiŶd of keeps ŵe, ŵoƌe iŶĐliŶed to ďe like ƌegulaƌ, Ŷot 
ďooziŶg aŶd stuff, like that.͛ (P4) 
͚I thiŶk the, it ĐaŶ ďe a Ŷoƌŵal kiŶd of fƌustƌatioŶ aďout, Ǉou kŶoǁ otheƌ people ĐaŶ just get 
up and go and just do whatever they like, but no I've got to think about injections and food, 
and no I've got to plan and I can't be so kind of "spontaneous" um, like the rest of the 
populatioŶ ĐaŶ,͛ (P8) 
͚But theǇ ŵake it ŵoƌe diffiĐult, ďeĐause I ĐaŶ't just, go, let's go away to my friends for a 
weekend, if I don't have enough medication. Things like that. Sort of. I have to make sure 
I've got food on me, wherever I go. And spare insulin. And insulin pumps. And needles. And 
ďlood testiŶg stƌips.͚ ;Pϳ 
͚I suppose Ǉou Đould go ǁith the floǁ ŵoƌe iŶstead of haǀiŶg to alǁaǇs ďe pƌepaƌed.͛ (P2) 
Impact on development and sense of self 
͚I suppose the ŵaiŶ thiŶg ǁas ďeiŶg diffeƌeŶt, aŶd Ŷot ǁaŶtiŶg to ďe diffeƌeŶt ǁaŶtiŶg to ďe 
the same as everybody else.  Um, the why me? scenario͚ (P2) 
͚“o Ǉeah, just felt diffeƌeŶt, didŶ't ǁaŶt to feel diffeƌeŶt. WaŶted to just fit iŶ aŶd ďe the 
saŵe as eǀeƌǇďodǇ else.͛ (P5) 
͚You just ǁaŶt to ďe kiŶd of, like eǀeƌǇoŶe else, aŶd Ǉou ĐaŶ't ďe like eǀeƌǇoŶe else, Ǉou'ƌe 
not like everyone else, you are [pause] you are a diabetic and you have to do the bloody 
iŶjeĐtioŶs oƌ puŵps as the Đase ŵaǇ ďe, uŵ, aŶd Ǉou ĐaŶ't foƌget aďout it͛ (P8) 
͚I felt that as a lot of ŵǇ fƌieŶds ǁeƌe goiŶg thƌough this, oƌ just, oƌ a, aŶǆious aǁkǁaƌd 
phase, and kind of coming out the other end of it sort of better for it. I felt like, with me, it 
kind of almost, was the other, the opposite. I felt like I was becoming less confident about 
life as like a young person. Because of, noticing more and more, the diabetes, inhibiting my 
life. HoldiŶg ŵe ďaĐk, giǀiŶg ŵe aŶǆietǇ aŶd stƌess͛ (P4) 
͚I had a ƌeďellious tiŵe soƌt of as a teeŶageƌ at oŶe poiŶt, aŶd ǁas ǀeƌǇ ŵuĐh, I ĐaŶ do 
anything anybody else can do.  I used to go out with my friends at the weekends and eat 
sweets and my Mum could never understand why my sugars where high and I never told 
heƌ uŶtil a feǁ Ǉeaƌs ago͛ (P2) 
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͚I just ďeĐaŵe ƌeallǇ ďlasé ǁith it.  I was just like, aah yeah I can have a handful of chocolate 
it ǁill ďe fiŶe ďǇ diŶŶeƌ tiŵe, ;…Ϳ I thiŶk iŶ ďeiŶg ďlasé theƌe ǁas a ďit of ƌeďellioŶ goiŶg oŶ͛ 
(P3) 
͚As I ǁeŶt thƌough ŵǇ teeŶage Ǉeaƌs, I ƌeďelled. I ǁas like, it's Ŷot happeŶiŶg to ŵe. I'd ďuǇ 
sweets on the way home, and eat them, without my mum knowing. Not do insulin for them. 
Um. Didn't test my blood sugars. Just ƌeallǇ ƌeďelled.͛ (P5) 
͚I'd just got togetheƌ ǁith ŵǇ ǁife. We ǁeƌe eŶgaged to ďe ŵaƌƌied. AŶd I just, Ǉou kŶoǁ, 
the whole turning point in your life, you're kind of, um, you're kind of thinking, there's other 
priorities now and I want to be around foƌ as loŶg as possiďlǇ ĐaŶ.͛ (P6) 
͚Yes, I thiŶk pƌoďaďlǇ ǁith the ŵatuƌitǇ Đaŵe the ƌealisatioŶ that I had to ǁoƌk ǁith it, 
rather than against it.͛ (P2) 
͚I thiŶk, just gƌoǁiŶg up's helped. Hŵŵ, aŶd pƌioƌities ĐhaŶgiŶg. ;…Ϳ I thiŶk diaďetes has 
made me grow up a lot faster, and I don't know if that's a negative or a positive, I like to 
thiŶk it's a positiǀe, ďut, Ǉeah.  I thiŶk, I thiŶk that does help͛ (P3) 
͚Well it's haƌd to sepaƌate the diaďetes fƌoŵ ŵe as a peƌsoŶ.͛ (P1) 
͚I doŶ't see ŵǇself as the giƌl ǁith diaďetes. I'ŵ just ŵe.͛ (P7) 
͚I'ŵ Ŷot fƌighteŶed of it Ŷoǁ. I aĐĐept that I'ǀe got it. Uŵ, it's paƌt of ŵe.͛ (P5) 
͚I suppose ŶoǁadaǇs I just aĐĐept it's paƌt of ŵe͛ (P2) 
͚it's alǁaǇs ďeeŶ a paƌt of ŵe͛ (P6) 
͚Diaďetes is a paƌt of ǁho Ǉou aƌe, it's, that's it, that is one of my biggest personality things, 
it's now become part of my life.  It's paƌt of ŵe Ŷoǁ͛ (P3) 
 
Social impact of T1D 
Perceived impact of diabetes on others 
͚It does affeĐt ƌelatioŶships͛ (P6) 
͚If, Ǉou'ƌe talkiŶg aďout paƌtŶeƌs, ŵǇ giƌlfƌiend, will have to put up with me kind of being a 
ďit of a hoƌƌoƌ,͛ (P4) 
͚Cos, as a ǇouŶgest, ǁheŶ Ǉou ŵoǀe out, Ǉouƌ ŵuŵ ǁoƌƌies aŶǇǁaǇ. AŶd theŶ oďǀiouslǇ 
with the diabetes it's that, more of an added worry for mum. I think she worries when I go 
out clubďiŶg, ďeĐause of the diaďetes, aŶd ďeiŶg feŵale [laughs]͛ (P7) 
͚But Ǉeah I kŶoǁ people aƌe ǁoƌƌied aďout hoǁ, if I'ŵ goiŶg to ďe hǇpo aŶd I keep gettiŶg 
told by my partner all of the time now, check your sugar levels see what they are, um and 
other people as ǁell at tiŵes.͛ (P2) 
͚Yeah, diffiĐult foƌ ŵǇ ŵuŵ. Eƌŵ, I'ǀe got aŶ oldeƌ ďƌotheƌ so she ǁas ǁoƌkiŶg, lookiŶg afteƌ 
my brother and coming to hospital. Um, I felt a bit of a burden, to my parents. (P5) 
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͚I thiŶk aďout it aŶd I feel like 'oh I ǁas suĐh a Ŷightmare, I feel so guilty' (P4) 
͚Theƌe's stuff that I'ǀe hiddeŶ fƌoŵ otheƌ people that, uŵ, espeĐiallǇ paƌeŶts. ;…Ϳ I'ǀe hiddeŶ 
stuff from parents because I didn't want them to feel that they put that many years into 
looking after me and then I went and [pause] sĐƌeǁed it up.͛ (P6) 
͚But Ǉeah, it's a lot to do ǁith Ŷot puttiŶg otheƌ people out aŶd thiŶkiŶg it's ŵǇ ĐoŶditioŶ 
and not anybody else's to deal with but, I know it does have a knock-on effect on other 
people.͛ ;PϮ 
Help and support from others 
͚With my Mum. Um, obviously she had been there since, she was there when I was 
diagnosed. Um, and she's always supported me in everything. Really has, she's the only one 
that uŶdeƌstaŶds ǁhat I'ǀe ďeeŶ thƌough.͛ ;Pϱ) 
͚MǇ husďaŶd's ƌeallǇ good ǁith it.  When we first got together, he printed off a 200 page, in 
a ring binder all about diabetes and side effects and help sheets and he had a little draw by 
the side of the bed where he kept sweets and my spare blood meter in and, um, I think that, 
feels as though, in some ways you know that people are accepting it more and are there to 
suppoƌt Ǉou.͛ (P3) 
͚MǇ giƌlfƌieŶd has helped ŵe a lot. BeĐause she's like, this ƌeallǇ good ǀoiĐe of ƌeasoŶ that I 
doŶ't haǀe iŶ ŵǇ ŵiŶd.͛ (P4) 
͚I had a ǀeƌǇ good gƌoup of fƌieŶds that all learnt how to do my blood sugars. All learnt what 
needed to be done. All learnt like, all had my mums number just in case. Things like that. So 
I had them as a group. Kind of, it wasn't so daunting. I think if I'd been on my own, it might 
haǀe ďeeŶ.͛ ;Pϳ 
͚EǀeƌǇoŶe kŶoǁs I'ŵ diaďetiĐ at ǁoƌk. Uŵ. You kŶoǁ, it's Ŷot like I keep that soƌt of thiŶg 
hidden. It's pointless hiding it. You know, um. Everyone's pretty, pretty ok if I turn round and 
say I need to go get something to eat. They're fine about that. Um. [pause] And, and, they 
kŶoǁ I'ŵ aƌguŵeŶtatiǀe soŵetiŵes [laughs]͛ (P6) 
͚But, the seĐƌetaƌǇ theƌe heƌ husďaŶd's diaďetiĐ so, uŵ, she uŶdeƌstaŶds aŶd is Ƌuite ǁilliŶg 
to help if Ŷeeds ďe͛ (P2) 
͚WheŶ I ǁas ǁoƌkiŶg I ŵade suƌe, I thiŶk pƌettǇ ŵuĐh eǀeƌǇoŶe knew that I was a diabetic, 
and, you know I, there was kind of no issues, everyone knew I was diabetic and I'd do blood 
tests in front of people and, yeah, I did at my desk I didn't go to the toilet for instance and 
do it.͛ (P8) 
͚I thiŶk uh people's peƌĐeptioŶs aŶd people's uŶdeƌstaŶdiŶg of it is ďetteƌ Ŷoǁ͛ (P5) 
͚I thiŶk people's kŶoǁledge has got a lot ŵoƌe.͛ (P3) 
͚I thiŶk, it's ďeĐoŵiŶg ŵoƌe, ĐoŵŵoŶ. People aƌe seeiŶg it ŵoƌe, so theǇ'll understanding it 
ŵoƌe.͛ (P7) 
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͚Like, eǀeƌǇoŶe kiŶd of kŶoǁs, is aǁaƌe of it and it sort of just, present, and vocalised.  That 
has ŵade ŵe, ďe ŵoƌe, I guess ŵoƌe aĐtiǀe ǁith it. ;…Ϳ it's just ďeĐause it's, giǀes it like a 
soƌt of, Ŷoƌŵal, eƌƌ, like feel to it͛ (P4) 
͚“o, Ǉeah aŶd askiŶg foƌ help aŶd aĐĐeptiŶg help is ƌeallǇ difficult.  But at the same time I 
really want it, and now I'm really aware, I still want them to go, you know, are you alright? 
so, Ǉeah, ďalaŶĐiŶg those tǁo is, diffiĐult.͛ (P1)  
͚I thiŶk Ŷoǁ it's the faĐt like Ǉou kŶoǁ, I'ŵ ŵaƌƌied haǀe a house, I Ŷo longer have people, 
anyone to fall back on, this is now me standing on my own, you know, don't have the family 
suppoƌt oƌ the, Ǉou kŶoǁ, that's it ƌeallǇ, I'ǀe got to, pull ŵǇ fiŶgeƌ out͛ (P3) 
͚I thiŶk oŶe of the haƌdest thiŶgs ǁas haǀiŶg to deal ǁith it Ǉourself [laughs]. Um, you know 
when somebody else was taking care of it, it's nice and easy. When you're having to take 
Đaƌe of it Ǉouƌself, it's a ǀeƌǇ diffeƌeŶt kettle of fish. Yeah.͛ (P6) 
Stigma and lack of understanding from others 
͚You alǁaǇs feel like Ǉou'ƌe oŶ Ǉouƌ oǁŶ aŶd ŶoďodǇ else Ƌuite uŶdeƌstaŶds͛ (P2) 
͚I'ǀe ofteŶ said that people ǁho aƌeŶ't diaďetiĐ should ďe diaďetiĐ foƌ a Ǉeaƌ, aŶd just so that 
theǇ, theǇ get it ;…Ϳ No oŶe ƌeallǇ gets it. Uŵ, Ǉou kŶoǁ. It's Ŷot theŵ that's haǀiŶg to faĐe 
this for the next 50 years. 40 years maybe, who knows. But, you know, it's not them that's 
haǀiŶg to look at that.͛ (P6) 
͚OďǀiouslǇ Ǉou'ǀe got the ǁhole diaďetes teaŵ of like ƌidiĐulous aŵouŶts of people aƌouŶd 
Ǉou, ďut ŶoŶe of theŵ aƌe diaďetiĐ. ;…Ϳ I doŶ't think anyone apart from a diabetic will ever 
uŶdeƌstaŶd,͛ (P3) 
͚I, eǀeŶ Ŷoǁ, I fiŶd the, loǀelǇ as theǇ aƌe, the diaďetiĐ doĐtoƌs aŶd Ŷuƌses, gƌeat. But. 
They're not diabetic themselves. They don't live with it day in day out. They don't have the 
frustrations of why's my blood sugar high when I have done the right amount of insulin? Or, 
you know. (P5) 
͚healthĐaƌe pƌofessioŶals ĐaŶ saǇ, ah Ǉou ĐaŶ do this, Ǉou ĐaŶ do that, ǁell Ǉouƌ ďlood 
sugars too high, your too low or, but I'm not being funny, you need to be a diabetic to truly 
uŶdeƌstaŶd diaďetes.͛ (P8) 
͚If Ǉou'ƌe hǇpo it's diffiĐult foƌ otheƌ people to soƌt of uŶdeƌstaŶd aŶd soŵe people I thiŶk 
aƌe ǀeƌǇ sĐaƌed of Ǉou goiŶg hǇpo all the tiŵe, ŵoƌe so thaŶ I thiŶk ǁe aƌe ouƌselǀes͛ (P2) 
͚A lot of people doŶ't understand the actual sensation feelings that you're going through, a 
lot of people now, they have the knowledge, they know what diabetes is, but I still to this 
day can't describe to a non-diabetic, the feeling of going hypo. (P3) 
͚People doŶ't uŶdeƌstand how, you know. You understand how sweaty you get when your 
blood sugar drops quickly and, you know. How irritable you can get, and, and, for no reason. 
AŶd, oƌ, theƌe's, foƌ the tiŶiest little thiŶg ĐaŶ just set Ǉou off͛ (P6) 
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͚People alǁaǇs kiŶd of talk about type 2 diabetes which is, yeah, lifestyle, so you know it's 
thought of you kind of brought it upon yourself, so it's not a worthy cause to, it's not 
thought of as a ǁoƌthǇ Đause.  I thiŶk tǇpe ϭ gets Đaught up iŶ that ƌeallǇ.͛ (P8) 
͚MǇ ďiggest ďug ďear, is the generic "Oh did you eat too much sugar as a kid?" or "Ohh, is it 
because you were overweight?" and I'm like Noo, stop just, you have no idea, because 
eǀeƌǇthiŶg is aďout tǇpe Ϯ, people doŶ't kŶoǁ it͛ (P3) 
͚Oƌ I'ǀe had ͞oh, ďut Ǉou'ƌe Ŷot fat͟. Yeah I know! [Laughs] Cos I'm not type 2. There's no, 
understanding from, I think, members of the public and the hospital between the two 
diffeƌeŶĐes.͚ (P7) 
͚OŶe of the aŶŶoǇiŶg thiŶgs is the ŵisĐoŶĐeptioŶs aďout, uŵ, oƌ the ŵisuŶdeƌstaŶdiŶg 
about the differences between diabetics. You kinda get bundled under type 2 and you, you 
kinda just get bundled under a diabetes umbrella. You know. And people don't realise that 
90% of diabetics are actually type 2, and that, type 1 is, you know, you can't do anything 
aďout it, it happeŶs. It's oŶe of those thiŶgs͛ (P6) 
͚But it's theŶ ǁheŶ Ǉou'ǀe got like jokeƌs at ǁoƌk aŶd thiŶgs that aƌe just like, "ooooh Ǉou'ƌe 
one of those diabetics" and I'm like, that's just not settling well with me because actually 
this is part of ǁho I aŵ,͛ (P3) 
͚“eĐoŶdaƌǇ sĐhool, uŵ, theǇ ǁaŶted ŵe to go to the fiƌst aid ƌooŵ to iŶjeĐt. AŶd I ƌefused. I 
said ͞I'ŵ Ŷot doiŶg it͟. I'ŵ Ŷot, I'ŵ Ŷot giǀiŶg up ŵǇ luŶĐh ďƌeak to Đoŵe aŶd iŶjeĐt, foƌ Ǉou 
to supervise me, to check what I'm doing with the needles. I'm not leaving them around. 
And so I kind of felt like I was a drug addict, like they would, that's how they were treating 
ŵe.͛ (P7) 
͚Uŵ, I ƌeŵeŵďeƌ haǀiŶg hǇpos iŶ Đlasses ďefoƌe, aŶd people, theƌe ǁas oŶe ďoǇ iŶ 
particular, still remember his name, taking the micky out of me and being really nasty to 
ŵe.͛ (P5) 
͚Me aŶd ŵǇ ďƌotheƌ aŶd a feǁ fƌieŶds, ;…Ϳ ǁeŶt to a puď of aŶ eǀeŶiŶg.  And, I think I was 
going to do my night time injection and a member of staff came over and said, can you do 
that in the toilets, don't do it where everybody can see.  Isn't that encouraging bad drug 
users to use the toilets rather than actually having people ask and then obviously I'd answer 
ďut she didŶ't ďelieǀe that I ǁas diaďetiĐ aŶd that ǁas ;…Ϳ Ƌuite upsettiŶg as well because 
it's like I didŶ't like the ǁaǇ it ǁas doŶe at all͛ (P2) 
͚I doŶ't thiŶk people ƌealise it ĐaŶ ďe as, daŶgeƌous, as it ĐaŶ ďe. If that ŵakes seŶse? Yeah, 
it, it can turn quite quickly and it can be dangerous. People don't realise that. They see it as 
'oh you just eat sugar'. Or 'you shouldn't have sugar'. (P7) 
͚“o I do still thiŶk a lot of people thiŶk diaďetes is less thaŶ it is.͛ (P3) 
͚It's oŶe of those, uŵ, ǁhat do theǇ Đall theŵ? ;…Ϳ UŶseeŶ ĐoŶditioŶs, Ǉeah. It's oŶe of those 
things, where people just go 'oh, you look fine'. Yeah, I really don't feel fine [laughs]. Um, 
Ǉou kŶoǁ, aŶd people doŶ't uŶdeƌstaŶd͛ (P6) 
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͚I ƌeŵeŵďeƌ thiŶkiŶg I had to staǇ iŶ, ďeĐause, if aŶǇoŶe fƌoŵ ǁoƌk sees ŵe, theǇ'ƌe goŶŶa 
think that I look fine, because, looking at me you couldn't see that there was anything 
ǁƌoŶg ǁith ŵǇ eǇe Đos all the ďlood ǁas oŶ the iŶside.͛ (P5) 
͚People Ŷeed to kŶoǁ, to kŶoǁ I Ŷeed help. “o, I had the otheƌ daǇ, 'ďut Ǉou doŶ't look 
diabetic, you look very well for being diabetic'. I'm like, 'yeah, cos I've worked hard at this. 
You normally don't look ill unless it's the beginning of the diabetes or you've got problems' 
[laughs].͛ (P7) 
 
Influence of healthcare teams 
Support from the diabetes team 
͚LoŶg stoƌǇ shoƌt. TheǇ'ƌe eǆĐelleŶt.͛ (P6) 
͚‘eallǇ ƌeĐeŶtlǇ theǇ'ǀe ďeeŶ a gƌeat teaŵ foƌ ŵe,͛ (P3) 
 ͚But I kŶoǁ that if I phoŶed theŵ up theŶ theǇ'd saǇ Đoŵe iŶ aŶd talk to us. Uŵ. Yeah, I 
kŶoǁ the suppoƌt is theƌe if I ǁaŶt it.͛ (P5) 
͚The diaďetiĐ Ŷuƌse aŶd as I saǇ I see heƌ thƌee oƌ fouƌ tiŵes a Ǉeaƌ uŵ she's ǀeƌǇ good͛ (P2) 
͚MǇ diaďetes Ŷuƌse is ŵǇ ƌoĐk͛ (P3) 
͚“he ǁas kiŶd of aǁesoŵe. Like, Ǉeah she, ǁas like, just, theƌe ǁas so ŵuĐh ŵoƌe 
communication. And I felt like we were, I felt like, I felt like she was really looking to 
understand, me, and hoǁ she Đould help ŵe ŵaŶage the diaďetes ďetteƌ͛ (P4) 
 ͚Uŵ, MǇ Ŷuƌse, iŶ paƌtiĐulaƌ ǁill ŵake ŵe look at the sugaƌ leǀels, a lot of the tiŵe she'll 
ask me what I think, I should do, and, er probably 50/50, I know what I need to do but I'm 
not quite sure how to do it, or well no, most of the time I know what I need to do or I'll tell 
heƌ aŶd she'll just agƌee.  “o I suppose it's ƌeassuƌaŶĐe, is a keǇ thiŶg foƌ ŵe͛ (P2) 
͚ThiŶgs like theǇ'ƌe Ŷot just haŶdiŶg it to Ǉou oŶ a plate, theǇ'ƌe ŵakiŶg ŵe kiŶd of think and 
theǇ'ƌe suppoƌtiŶg ŵe doiŶg it͛ ;Pϯ) 
͚AďsolutelǇ faŶtastiĐ duƌiŶg pƌegŶaŶĐǇ. Uŵ, it, I had to go theƌe eǀeƌǇ tǁo ǁeeks, ǁhiĐh ǁas 
a paiŶ. But suppoƌt fƌoŵ theŵ ǁas aŵaziŶg.͛ (P5) 
͚TheǇ ǁeƌe good, the, the, the Ŷuƌses ǁeƌe good ǁheŶ I ŵoǀed oŶto the pump, they were 
ǀeƌǇ helpful͛ (P4) 
͚AŶd I thiŶk, theǇ oďǀiouslǇ ǁaŶt ŵe to Đall up at the ŵoŵeŶt ďeĐause I'ǀe oŶlǇ just 
switched over to a pump, or, just, being within the past year, but. They're like, you know, 
'just give us a call if you need anything'. Uŵ, so, theǇ'ƌe ƌeallǇ good.͛ ;Pϲ) 
͚I haǀe ŵoƌe, health Đaƌe ĐheĐk ups. WhiĐh I guess, is a positiǀe. BeĐause thiŶgs ĐaŶ ďe seeŶ, 
earlier, if there are any other complications. Like, if I, hadn't have had all my check ups, they 
wouldn't have found that I had high cholesterol. Because it's not from the diabetes. It's 
heƌeditaƌǇ.͛ (P7) 
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͚AŶd the diaďetiĐ teaŵ I suppose the ƌeassuƌaŶĐe of the otheƌ tests that theǇ do like the 
Đholesteƌol,͛ (P2) 
͚WheŶ Ǉou'ǀe ǁoƌked haƌd aŶd ǁheŶ Ǉou haǀe put out a lot of effoƌt to try and get your 
bloods down and to control them, and it's just the reassurance of them saying "you're 
controls better" and "well done, we noticed this" and it's just the little pat on the back 
soŵetiŵes that theǇ giǀe Ǉou,͛ (P3) 
͚Uŵ, ǁheƌeas, agaiŶ, down here um, they're very, they were very kind of 'we know. We 
know that people didn't look after and don't look after themselves at points in their life, we 
kŶoǁ that it's haƌd ǁoƌk'.͛ (P6) 
Difficulties with the diabetes team 
͚What ƌole does the diaďetes team have in your life at the moment? 
Err, right now.  Not a lot.  I see the ĐoŶsultaŶt oŶĐe a Ǉeaƌ ;…Ϳ ďut it͛s Ŷeǀeƌ ƌegulaƌ ĐoŶtaĐt 
;…Ϳ theƌe͛s Ŷot a lot of suppoƌt theƌe I guess ;…Ϳ I'ŵ suƌe theǇ do lots of stuff ďut I just doŶ't, 
I'm not in contact so I doŶ't kŶoǁ it, oƌ kŶoǁ theŵ at all.͛ (P1)   
͚Yeaƌs ago, I didŶ't, didŶ't ƌeallǇ haǀe aŶǇ diaďetes teaŵs iŶǀolǀed. TheǇ ǁeƌeŶ't ƌeallǇ, 
oǀeƌlǇ helpful.͛ (P6) 
͚Foƌ ŵe, I ĐaŶ't thiŶk of aŶǇthiŶg to ďe hoŶest, ďeĐause I [pause] I doŶ't kŶoǁ ǁhat theǇ ĐaŶ 
do foƌ ŵe to ďe hoŶest.͛ (P8) 
͚MaǇďe it's just ďeĐause I doŶ't, ƌeallǇ ƌelate, I doŶ't feel like ǁe ƌeallǇ ĐoŵŵuŶiĐate 
pƌopeƌlǇ.͛ (P4) 
͚I had a ďit of a, dodgǇ, kiŶd of, diaďetiĐ Ŷuƌse. Who I didŶ't ƌeallǇ, get oŶ ǁith. I used to hide 
from her, when she came to the house. Um [pause], I just, she was very harsh. There was no 
kiŶd of, ĐoŵpassioŶate, Đaƌe of, let a Đhild get heƌ head ƌouŶd eǀeƌǇthiŶg. It ǁas ͞this is 
ǁhat Ǉou aƌe doiŶg, this is hoǁ Ǉou should ďe doiŶg it͟. It's like, 'ok I get that, ďut, let ŵe 
get ŵǇ head ƌouŶd it fiƌst'.͛ (P7) 
͚IŶ kiŶd of ŵǇ, ŵǇ teeŶage Ǉeaƌs theƌe used to ďe a district nurse or diabetes nurse who 
used to come round our house and would kind of harangue me for, not being as well 
ĐoŶtƌolled as I should, ;…Ϳ she'd just Đoŵe ƌouŶd and come and check me out, and find out I 
ǁasŶ't doiŶg as I ǁas told so she ǁould tell ŵe off.͛ (P8) 
͚EǀeƌǇ tiŵe I ǁeŶt to the hospital foƌ ĐheĐk-ups I got told off for the high blood sugars, and I, 
come teenage years I was just like I don't need this hassle, go away, and, um, I'm doing my 
oǁŶ thiŶg.͛ (P5) 
͚WheŶ I ǁeŶt ƌouŶd to see, ǁeŶt doǁŶ to see hiŵ. Uŵ, so, ďut he ŵade Ǉou feel like, he 
made you feel like, you know, 'well you haven't done this therefore you're a bad diabetic' 
soƌt of thiŶg.͛ (P6) 
͚I'ǀe always gone up and down, but made to feel like it's my fault, from the diabetes team. 
EǀeŶ ǁheŶ Ǉou pƌoǀe, like, it's like, ͞ǁell, ǁhat aƌe Ǉou doiŶg?͟. It's like, Ǉou ĐaŶ see ǁhat 
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I'm doing, I've given you a food diary. I'm not hiding anything, cos I'm pretty honest, I will 
tell you if I've done something wrong. (P7) 
͚OK, if Ǉou, eǀeŶ if Ǉou haǀeŶ't doŶe as ǁell as Ǉou should haǀe, if theǇ ĐaŶ talk to Ǉou aďout 
it in a kind of nice kind of adult manner, instead of maybe treating like a school boy or 
something, then you know, they may get more out of you and persuade you to improve 
thiŶgs.͛ (P8) 
͚You go theƌe aŶd Ǉou ǁait at outpatieŶts aŶd Ǉou Ƌueue up aŶd Ǉou ƌe-book your 
appointment for a day you know you can make it, and then 2 weeks later you get a letter 
thƌough the post saǇiŶg ǁe had to ŵoǀe Ǉouƌ appoiŶtŵeŶt,͛ ;Pϯ) 
͚AŶd fƌustƌated at the hospital ďeĐause, last tiŵe I foƌgot oŶe ǁas ďeĐause theǇ'd aĐtuallǇ 
cancelled the one before because my consultant had retired and they didn't tell, well they 
did tell ŵe theǇ'd ďooked a Ŷeǁ oŶe ďut I didŶ't get the letteƌ,͛ (P6) 
͚TheǇ eitheƌ get ĐaŶĐelled oƌ, Ǉou'ƌe ǁaitiŶg foƌ houƌs aŶd houƌs aŶd houƌs aŶd houƌs͛ ;Pϱ) 
͚Theƌe's alǁaǇs a ǁait. You go foƌ Ǉouƌ appoiŶtŵeŶt aŶd Ǉou'ƌe theƌe like aŶ houƌ lateƌ still 
waiting for him. But they expect you to wait. They expect you to do that, even though, like, 
Ǉou ŵight take tiŵe out of ǁoƌk͛ ;Pϳ 
͚HospitalisatioŶ ǁith DKA.  That ǁas tough ;…Ϳ that ǁas Ƌuite a diffiĐult tiŵe.  Just the 
whole, getting my head around that, and Ǉou kŶoǁ afteƌǁaƌds theǇ seŶd Ǉou to a shƌiŶk ;…Ϳ 
they just said, we think it would be beneficial for you to go to this shrink, here's an 
appoiŶtŵeŶt. ;…Ϳ I ǁeŶt to shƌiŶk aŶd afteƌ the like ϮŶd, the ϭst ǁeek it ǁas just like a get to 
know me type thing, and the 2nd week I went, I was in floods of tears, for like 20 minutes, 
aŶd he didŶ't ŵeŶtioŶ ŵǇ diaďetes oŶĐe ;…Ϳ aŶd I thiŶk at the tiŵe I asked hiŵ a ƋuestioŶ 
oŶ diaďetes aŶd he didŶ't kŶoǁ, he didŶ't haǀe a Đlue ǁhat diaďetes ǁas ;…Ϳ “o I stopped 
going, because I was like I'm not going to talk to you about unrelated matters which to me 
don't mean anything when actually, you don't have a clue about diabetes, which is why I'm 
heƌe iŶ the fiƌst plaĐe.͛ (P3) 
Attending carbohydrate counting courses 
͚AŶd theŶ I did the DAFNE equivalent course, which was great. That was, to be honest, I 
thiŶk that ǁas the ďest thiŶg I'ǀe eǀeƌ doŶe, positiǀelǇ, foƌ tuƌŶiŶg the diaďetes aƌouŶd.͛ 
(P4) 
͚I thiŶk oŶe of the ďest thiŶgs that's happeŶed iŶ the last feǁ Ǉeaƌs, uŵ is theƌe's a course 
that the hospital ;…Ϳ WhiĐh ǁas a faŶtastiĐ eƌ, uŵ Đouƌse ƌeallǇ.͛ (P8) 
͚Well theǇ did the DAFNE Đouƌse, aŶd that ǁas ƌeallǇ helpful. ;…Ϳ it just gaǀe ŵe iŶfoƌŵatioŶ 
that, I didn't have, really basic stuff that should be compulsory. Umm, and I think that the 
GPs and consultants just assumed that I knew, that, they might have told us but I don't 
remember.  “o Ǉeah, ƌeallǇ good to haǀe all that iŶfoƌŵatioŶ ƌeallǇ.͛ (P1) 
͚AŶd I got all these skills aďout ĐaƌďohǇdƌate ĐouŶtiŶg aŶd theŶ I staƌtiŶg getting, like feeling 
ďetteƌ aďout it I thiŶk͛ (P4) 
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͚OŶĐe ǁe ǁeƌe giǀeŶ a ƌatio of uŶits aŶd ĐaƌďohǇdƌates, uŵ, I stopped feeliŶg huŶgƌǇ all the 
time, and that was, quite a big shock, anyway, because I just thought it was normal to be 
hungry all the time, so that ǁas ƌeallǇ good.͛ ;Pϭ 
͚I'd saǇ, oŶe of the ďiggest thiŶgs, aŶd aĐtuallǇ eǀeŶ though I didŶ't ƌealise it at the tiŵe, uŵ, 
afteƌ joiŶ, afteƌ doiŶg the ;…Ϳ Đouƌse ǁas that theƌe is aĐtuallǇ otheƌ people out theƌe ǁho 
go through the same crap. Um, who deal with the same thing day in day out. Um, who, have 
ďeeŶ thƌough the saŵe thiŶg Ǉou'ǀe ďeeŶ thƌough͛ (P6) 
͚OŶe of the ƌeallǇ good thiŶgs, theƌe ǁas a gƌoup of eight of us, ;…Ϳ uŵ aŶd, Ǉeah hoǁ ǁe, 
how people would talk about well my blood sugar was like 6 and its gone up to 15 there and 
I don't know why, and then you sometimes do an injection and, you know to counteract that 
and, the next minute I'm getting a hypo, and, you know people, what I'd call sane sensible 
people would struggle and, and I thought I'm not alone here, I felt it was with other people 
that tƌulǇ uŶdeƌstood͛ (P8) 
Simplistic view of diabetes 
͚“o, it's alŵost like the teaŵs haǀe alǁaǇs felt that, diaďetes is ďlaĐk aŶd ǁhite. But it's Ŷot. 
And like, obviously you get the text books about diabetes. And they seem to follow that. 
And they don't seem to look at you as an individual as to why you might, be up and down, or 
thiŶgs like that͛ (P7) 
͚I kiŶd of soŵetiŵes ǁoŶdeƌ that, the aŵouŶt of people theǇ ĐhuƌŶ thƌough, ǁoƌƌies ŵe a 
ďit ;…Ϳ theƌe's oŶlǇ so ŵaŶǇ people that theǇ ĐaŶ aĐtuallǇ kŶoǁ thƌough aŶd thƌough͛ ;Pϯ) 
͚“oŵetiŵes I feel like the ŶuƌsiŶg, the ƋualitǇ of the ŶuƌsiŶg is ŵaǇďe slightlǇ just soƌt of, uh, 
follow the training and just, do the stuff that you've kind of been taught, rather than, talk to 
ŵe aŶd ƌeallǇ kiŶd of fiŶd out ǁhat, ǁhat, ǁhat ǁe Đould do to iŵpƌoǀe thiŶgs.͛ (P4) 
͚AŶd I just thiŶk, to a ĐeƌtaiŶ eǆteŶt, Ǉou'ƌe a doĐtoƌ/Ŷuƌse telliŶg ŵe Ǉou Ŷeed to this, Ǉou 
need to do that, you need to do the other. Actually, don't patronise me, because you don't 
live with the condition. You don't know, one day, you can eat the same thing, do the same 
amount of insulin, perfect control. Next day, you eat exactly the same, do exactly the same 
aŶd it's up theƌe oƌ doǁŶ theƌe͛ (P5) 
͚Most of the time I'm, between 12 and 17 and if my HbA1c is still coming back good that's 
Ŷot, theƌe's soŵethiŶg Ŷot ŵatĐhiŶg up theƌe aŶd that is ǁhat theǇ look at,͛ (P1) 
͚EspeĐiallǇ ǁheŶ I feel soŵetiŵes ŵostlǇ ŵǇ sugaƌs aƌe high oƌ Ŷot ĐoŶtƌolled ǀeƌǇ ǁell and 
then the diabetic team say they are fine, it's like, it's not fine, I'm not happy with them but, 
theǇ geŶeƌallǇ aƌe,͛ (P2) 
͚I ĐaŶ't help ďut thiŶk that diaďetes is suĐh aŶ iŵŵeŶselǇ ĐoŵpliĐated disease to ŵediĐate. 
You've really got to like look at why a blood, you can't just look at like a few days of blood 
sugaƌs aŶd ďe like 'let's ŵake these ĐhaŶges',͛ (P4) 
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͚You just see a doĐtoƌ that's a, Ǉep, Ǉep, Ǉep, Ǉep, ok Ǉou'ƌe fiŶe. It's ŵoƌe of a pƌoĐess I 
think. I find the help from the diabetes team, the diabetic centre, much more valuable than 
ŵǇ aŶŶual ƌeǀieǁs.͚ (P5) 
͚I feel like, I'ǀe Ŷeǀeƌ had aŶǇ, ƌeal help ǁith the sǇsteŵ, the soƌt of, the, the health sǇsteŵ 
around diabetes at least for um, the emotional side of this disease. Which I think is like, you 
kŶoǁ, eƋual the gettiŶg the ďlood sugaƌs soƌted out, it's just as iŵpoƌtaŶt.͛ (P4) 
͚The psǇĐhologiĐal effeĐt haǀiŶg diaďetes has had oŶ ŵe aŶd I thiŶk the ďiggest iŵpaĐt has 
ďeeŶ the 'thƌeat' that is alǁaǇs at the ďaĐk of ŵǇ ŵiŶd ;…Ϳ I feel it's soŵethiŶg that is 
definitely missed and trivialised by not only the people surrounding diabetics but even the 
ŵediĐal staff aŶd teaŵ tƌaiŶed to ǁoƌk ǁith Ǉou͛ (P1) 
͚But theǇ just seeŵ to haǀe like a, nonchalant attitude in A&E as far as I'm concerned, and as 
far as I've witnessed. So, I think, a, a better understanding. Not, as extensive as the diabetes 
team, or as in depth. But a greater understanding and not just what they read in a text book. 
Because I've had paramedics, I've had a paramedic come out and goes 'I don't know 
aŶǇthiŶg aďout diaďetes'.͛ (P7) 
 
Ways of coping 
Discussing diabetes 
͚I do alǁaǇs like talkiŶg aďout it. Cos it's like a ŶiĐe soƌt of, offload͛ (P4) 
͚I thiŶk aĐtuallǇ talkiŶg to otheƌ diaďetiĐs is Ƌuite a good thiŶg, ďeĐause Ǉou alǁaǇs feel like 
Ǉou'ƌe oŶ Ǉouƌ oǁŶ aŶd ŶoďodǇ else Ƌuite uŶdeƌstaŶds ďut, theƌe is a lot of people that do͛ 
(P2) 
͚KŶoǁiŶg otheƌ people out theƌe haǀe kiŶd of goŶe thƌough it aŶd theƌe aƌe people out 
there who feel the same. And all the rest of it. That's, that, that helps. Helps ŵassiǀelǇ͛ (P6) 
͚I set up a suppoƌt gƌoup ;…Ϳ We'ǀe all fouŶd it ƌeassuƌiŶg that theƌe's otheƌ people out that 
go through the same feelings and frustrations and thoughts and worries, and you're not on 
Ǉouƌ oǁŶ͛ (P5) 
͚MǇ oǁŶ theƌapǇ has alloǁed ŵe to leaƌŶ ĐopiŶg ŵeĐhaŶisŵs͛ (P1) 
͚“o I'ǀe had CBT aŶd that's helped ŵe ĐoŶtƌol ŵǇ aŶǆietǇ iŶ ƌelatioŶ to that, ďut also iŶ 
relation to everything else because I can now recognise the signs of anxiety and I can, I can 
ŵaŶage theŵ͛ (P5) 
Technology 
͚ThiŶgs like Facebook make that easier. Join groups. That helps. Um, because there's always 
soŵeoŶe lookiŶg aƌouŶd foƌ aƌtiĐles aŶd latest aŶd gƌeatest stuff. Uŵ.͛ (P6) 
͚Moƌe stuff's out theƌe, that ŵakes ŵe thiŶk aĐtuallǇ, I'ŵ Ŷot the oŶlǇ oŶe ;…Ϳ like if Ǉou'ǀe 
got any question you can type it into Google and within 20 seconds, you can see like 100s of 
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other diabetics around the world who are asking the same question, and I think that at least 
foƌ the fiƌst ϭϬ Ǉeaƌs of ŵǇ, haǀiŶg diaďetes that ǁasŶ't aǀailaďle,͛ (P3) 
͚The Ŷeǁ eƋuipŵeŶt, the teĐhŶologǇ has got so ŵuĐh ďetteƌ oǀeƌ the Ǉeaƌs,͛ (P2) 
͚Just the adǀaŶĐe iŶ teĐhŶologǇ. Uŵ, eǀeŶ fƌoŵ ǁheŶ I ǁas fiƌst diagŶosed, it ǁas sǇƌiŶge 
and insulin vials. Then I went onto pens which made it a lot easier, um, and now as I say I'm 
on a pump which, I got, control, I can do point, point one of a unit, now. Um, which was 
gƌeat͛ (P5) 
͚“o I'd pƌoďaďlǇ saǇ the thiŶgs that haǀe ŵade it ďetteƌ haǀe ďeeŶ teĐhŶologǇ ŵoƌe thaŶ 
aŶǇthiŶg else,͛ (P6) 
͚“iŶĐe I'ǀe goŶe oŶ the puŵp, ŵǇ diaďetes has iŵpƌoǀed. I'ŵ ŵoƌe kiŶd of, steadǇ.͛ (P7) 
Not thinking about or engaging with diabetes 
͚I guess a lot of ŵǇ life I haǀeŶ't ƌeallǇ thought too ŵuĐh aďout the diaďetes.  I just tƌied to 
live [pause] as, I tried to live as everybody else has lived, and, did what I wanted to do rather 
thaŶ ǁhat I should haǀe doŶe.͛ (P8) 
͚The ŵaiŶ thiŶg has ďeeŶ Ŷot ŵakiŶg a ďig deal out of it, I thiŶk foƌ ŵe so that I still feel 
Ŷoƌŵal, I thiŶk. ;…Ϳ aŶd oŶ the flipside of ŵe tƌǇiŶg to ďe Ŷoƌŵal is that soŵetiŵes, I Đould 
potentially be in a dangerous situation because people didn't realise the gravity of a hypo, 
or even know that I was diabetic, or know what to do if I needed help so, from a safety point 
of ǀieǁ, it pƌoďaďlǇ ǁasŶ't that good͛ (P1) 
͚I ǁas just like, Ǉou kŶoǁ. “lightlǇ, iŶdiffeƌeŶt toǁaƌds it, I didŶ't, I thiŶk.͛ (P4) 
͚I hadŶ't ƌeallǇ looked afteƌ ŵǇ diaďetes pƌopeƌlǇ ǁhile I ǁas gƌoǁiŶg aŶd ;…Ϳ just ǁaŶted to 
just igŶoƌe it aŶd ďuƌǇ Ǉouƌ head iŶ the saŶd.͛ (P6) 
 ͚I haƌdlǇ tested, I haƌdlǇ did, I just did the set amount of insulin that I had erm and I didn't 
really think about it.  I didŶ't, [pause] I doŶ't ƌeŵeŵďeƌ ƌeallǇ thiŶkiŶg aďout it,͛ (P1) 
͚I ǁasŶ't goiŶg to the hospital appoiŶtŵeŶts ŵuĐh.͛ (P4) 
͚Uŵ, theƌe ǁeƌe Ŷights I didŶ't ďotheƌ doiŶg loŶg aĐting insulin because it was either painful 
or, um [pause] or because I just, just didn't want to. I don't like, I wouldn't be able to tell you 
ǁhat ǁas ƌuŶŶiŶg thƌough ŵǇ head ϮϬ Ǉeaƌs ago Ŷoǁ, ǁheŶ I ǁas thiŶkiŶg ͞I'ŵ Ŷot goiŶg to 
do it toŶight'.͟ (P6) 
Accepting and engaging with diabetes 
͚NoǁadaǇs I just aĐĐept it's paƌt of ŵe aŶd I haǀe to ǁoƌk ǁith it ŵoƌe thaŶ agaiŶst it, aŶd 
that's Ǉeah that's a ďig thiŶg͛ (P2) 
͚“o I kiŶd of saǇ to ŵǇself 'I'll Ŷeǀeƌ, ǁhat's the poiŶt of igŶoƌiŶg the diaďetes ǁheŶ it's there 
for the rest of my life'. I might as well work with it, to kind of, get the most out of my life 
aŶd, ǁhat I ǁaŶt.͛ (P7) 
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͚AĐtuallǇ I'ǀe just got to eŵďƌaĐe it ďeĐause otheƌǁise I'ŵ sĐƌeǁed, I'ŵ stuĐk ǁith it 
aŶǇǁaǇ.͛ (P3) 
͚I'ŵ Ŷot fƌighteŶed of it Ŷoǁ. I aĐĐept that I'ǀe got it͛ (P5) 
͚I just soƌt of deĐided I'll haǀe to take it daǇ ďǇ daǇ ďeĐause I ǁas testiŶg ŵǇ ďloods all the 
tiŵe, aŶd it ďeĐaŵe, like Ǉeah just too ŵuĐh,͛ (P1) 
͚You kŶoǁ, I ŵight eŶd up iŶ a ǁheel Đhaiƌ. Oƌ I ŵight eŶd up haǀiŶg a heart attack, pfff, 
doŶ't kŶoǁ, doŶ't thiŶk aďout it. Uŵ, I just take eaĐh daǇ as it Đoŵes ƌeallǇ.͛ (P8) 
Hope and positivity 
͚I'ǀe Ŷeǀeƌ eǀeƌ let it stop ŵe doiŶg aŶǇthiŶg.͛ (P7) 
͚I tƌǇ Ŷot to uŵ, full stop, let aŶǇ ŵoƌe, use, use the diaďetes foƌ aŶ eǆĐuse, foƌ aŶǇthiŶg.͛ 
(P4) 
͚A lot of thiŶgs haǀe ĐhaŶged oǀeƌ the Ǉeaƌs alƌeadǇ theƌe's still time to make a lot of 
iŵpƌoǀeŵeŶts.͛ (P2) 
͚“oŵetiŵes, if ŵǇ sugaƌs aƌe a ďit loǁ I get to haǀe a ĐhoĐolate ďisĐuit ǁhiĐh I Ƌuite like 
[laughs]. You've gotta have those little ŵiĐƌo ƌeǁaƌds to keep Ǉou saŶe I guess͛ ϵPϰ, 
͚I doŶ't kŶoǁ if theƌe is aŶǇthiŶg aĐtuallǇ positiǀe fƌoŵ ďeiŶg diaďetiĐ, ďut I thiŶk theƌe's a 
lot of positives you can make, whilst being diabetic if that makes sense?  So, making yourself 
positive situatioŶs, ďeĐause, it's ǁho Ǉou aƌe͛ (P3) 
͚I'ŵ Ƌuite a positiǀe peƌsoŶ ǁith diaďetes. [Laughs] Cos I kiŶda haǀe to ďe. I'ŵ a positiǀe 
peƌsoŶ aŶǇǁaǇ.͛ (P7) 
͚AŶd the ƌeseaƌĐh that's ďeiŶg doŶe. I kŶoǁ theǇ'ǀe ďeeŶ talkiŶg aďout islet tƌaŶsplaŶts aŶd 
all sorts of thiŶgs. I thiŶk that's faŶtastiĐ if theǇ ĐaŶ do it͛ (P5) 
͚Ǉou kŶoǁ Ǉou'ƌe alǁaǇs heaƌ, theƌe ǁas, theƌe ǁas a soƌt of, ďƌeak thƌough, Ŷeǁs stoƌǇ 
about the, the, the stem cells, err, work that, it's maybe leading to a cure for the diabetes 
and they'd done it in mice and stuff. And you, and you hear things about cures all the time. 
Obviously that would be great, I do sometimes think about that. Err. So there is a bit of like, 
hope, foƌ the futuƌe.͛ (P4) 
 ͚I thiŶk that ǁas a tough ŵoŵeŶt, ďut Ǉou kŶoǁ I think I turned that around and made it 
out stƌoŶgeƌ.͛ (P3) 
͚I thiŶk I'ǀe ďeeŶ thƌough a lot ǁith the diaďetes ǁhiĐh I thiŶk has ŵade ŵe stƌoŶgeƌ as a 
person. I think I've learnt from it and I think I want to help others. I think that's a positive. 
And I think that I'ǀe Đoped ǁith a lot.͛ ;PϱͿ 
 
 
 
EXPERIENCES OF LIVING WITH TYPE 1 DIABETES  157 
 
 
 
Appendix O: End of study report for NRES committee and R&D departments 
 
Salomons Centre for Applied Psychology  
Canterbury Christ Church University, Runcie Court  
Broomhill Road, Tunbridge Wells  
TN3 0TF  
  
 
Dear Research Ethics Committee, 
Study Title: Exploring the experiences of people living with type 1 diabetes and their 
implications for psychological support. 
REC reference: 14/LO/1236 
I am writing to inform you that the above study has now been completed. Please find 
attached a brief summary of the research findings. Please do not hesitate to contact me if 
you require any further information. 
Yours sincerely, 
Michael Wilding 
Trainee clinical psychologist 
CC:                NHS Trust R&D 
        NHS Trust R&D 
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Summary of Research 
Study Title 
Exploring the experiences of people living with type 1 diabetes and their implications for 
psychological support. 
Research Context 
Living with diabetes can present a number challenges for individuals concerned.  Managing diabetes 
day to day involves a complex medication and behavioural regime which interrelates with various 
important psychosocial factors.  Previous research suggests that people living with diabetes are as 
much as two-three times more likely to experience mental health difficulties compared with the 
general population.  However evidence is emerging that many of these difficulties may in fact be a 
direct result of feeling distressed about living with a complicated and stressful chronic health 
condition, and not necessarily resultant from co-morbid psychiatric illness.  These experiences are 
known by the term diabetes related distress.  To date psychosocial factors related to living with 
diabetes have mainly been explored quantitatively.  However, qualitative approaches have increased 
in popularity in diabetes research in recent years and can add valuable and rich information to 
existing data from quantitative research.  Extant qualitative research in diabetes has mainly focused 
on people living with type 2 diabetes or children with type 1 diabetes, leaving adults living with type 
1 diabetes as a relatively under researched group 
Research Aims 
The study aimed to answer the following research questions: 
Primary: What are the lived experiences of adults with type 1 diabetes?  
Secondary: What aspects of living with type 1 diabetes are experienced as distressing? 
What are the potential implications for health services? 
Method 
Eight adults living with type 1 diabetes were interviewed about their experiences.  Interviews were 
transcribed and analysed using interpretative phenomenological analysis. 
Results 
Many themes emerged from participants interviews.  Some example themes are; Feeling frustrated 
and restricted by treatment regimes, psychological and emotional distress, constant awareness and 
worry, impact on development and sense of self, stigma and lack of understanding from others, 
support from diabetes team and experiences of a simplistic view of diabetes. 
Implications and Conclusions 
Participants reported a wide variety of experiences related to the biological psychological and social 
components of type 1 diabetes.  Some of these were experienced as highly distressing whilst others 
were more easily managed.  This was often dependent on individual differences and was not 
necessarily static over time.  Further awareness of this in practice and a focus on diabetes and its 
treatment within the context of people͛s unique psychosocial circumstances is highly important in 
supporting people to reduce diabetes related distress, which can improve glycaemic control, health 
related quality of life and wellbeing 
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Appendix P: Author guidelines from journal chosen for publication - Diabetic Medicine 
Retreived from: http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291464-
5491/homepage/ForAuthors.html 
1. ABOUT DIABETIC MEDICINE 
Aims & Scope 
Diabetic Medicine, the official journal of Diabetes UK, is published monthly in simultaneous 
print and online editions.  
The journal publishes a range of key information on all aspects of diabetes mellitus and 
issues regularly include original articles, reviews, reports, editorials, comment, news and 
correspondence. All material is peer-reviewed. The journal seeks to provide a forum for the 
exchange of information between clinicians and researchers worldwide and all health 
professionals responsible for the care of patients with diabetes.  
Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to care for, 
connect with and campaign on behalf of all people affected by and at risk of diabetes.  
2. MANUSCRIPT CATEGORIES 
Diabetic Medicine invites the following types of submission: 
Research articles 
Original research articles relevant to diabetes mellitus science and practice aƌe the jouƌŶal͛s 
primary mode of communication. Clinical science and clinically-relevant basic science papers 
will be considered. Original articles must include a structured abstract (maximum 250 
words), should not exceed 3,000 words of text and should be limited to 30 references. 
Inclusion of supplementary materials in the form of underlying datasets, multimedia files or 
accompanying slidesets is encouraged.  
Authors of qualitative research articles are advised to contact the Editorial Office for 
guidance on manuscript length prior to submission.  
Manuscripts should adhere to reporting standards. Randomised controlled trials should 
adhere to the CONSORT Checklist. Observational studies should adhere to the relevant 
STROBE Checklist. Systematic reviews and meta-analyses should adhere to the PRISMA 
Checklist. Checklists must be completed and submitted electronically with the manuscript 
usiŶg file desigŶatioŶ ͚“uppoƌtiŶg DoĐuŵeŶt NOT foƌ PuďliĐatioŶ͛.  
For purposes of presentation only, accepted research articles are divided into the following 
sections:  
Care Delivery 
Complications 
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Educational and Psychological Aspects 
Epidemiology 
Genetics 
Health Economics 
Metabolism 
Pathophysiology 
Treatment 
Reviews 
The journal aims to publish concise, high-quality review articles of recent advances in 
laboratory or clinical research. Review articles are usually solicited by the Editor-in-Chief but 
unsolicited reviews are welcome. All will undergo peer-review. Review articles must include 
an unstructured abstract (maximum 250 words), should not exceed 5,000 words of text and 
should be limited to 50 references. Use of illustrations and figures is encouraged.  
Trial protocols 
Diabetic Medicine now welcomes submission of trial protocols. Manuscripts must include a 
structured abstract (maximum 250 words), should not exceed 3,000 words of text and 
should be limited to 30 references. Inclusion of supplementary materials in the form of 
underlying datasets, multimedia files or accompanying slidesets is encouraged. For trial 
protocols of health care interventions, the last section of the abstract should be Trial 
Registration: listing the trial registry and the unique identifying number, e.g. Trial 
Registration: Current Controlled Trials ISRCTN73824458. Please note there should be no 
space between the letters and numbers of the trial registration number. The trial registers 
that currently meet all of the ICMJE guidelines can be found at 
http://www.icmje.org/faq_clinical.html . Publishing your trial protocol in Diabetic Medicine 
does not commit you to submitting subsequent reports of the study to us, although we do, 
of course, welcome such submissions.  
Short reports 
Concise reports of original or important observations, short reports should not exceed 1,500 
words and are limited to one figure, one table and 20 references. A structured abstract is 
required.  
Case reports 
Case reports submitted after 1 May 2012 will be published online-only in Diabetic 
Medicine. The abstracts of case reports will continue to be published in the relevant print 
issue. Case reports remain fully citable and will continue to be indexed by PubMed. 
Case reports should describe unusual clinical cases and must carry a new or important 
message. Cases that present a diagnostic, ethical or management challenge, or that 
highlight aspects of mechanisms of injury, pharmacology or histopathology are deemed of 
particular educational value. Descriptions of a series of cases stand a greater chance of 
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being accepted. The Editors reserve the right to ask authors to revise a single case report 
into a Letter to the Editor.  
Case reports should not exceed 1,500 words and are limited to 3 tables and/or 3 figures and 
20 references. A structured abstract (maximum 250 words) must be provided using the 
following sub-headings: Background, Case Report, Discussion. The submission of 
supplementary materials (additional figures, tables, datasets, multimedia files, etc.) which 
add value to cases is encouraged.  
Letters 
Items of correspondence may be in response to issues arising from recently published 
articles, or short, free-standing pieces expressing an opinion. Letters should be formatted in 
one continuous section and should not exceed 800 words, 1 figure/table and 10 references. 
No abstract is required. Please give the name(s) and affiliation(s) of authors at the end of 
the letter. All letters are subject to peer-review.  
Editorials/Commentaries 
Editorials and commentaries provide expert opinion to hot topics. Whilst typically 
commissioned by the Editors, unsolicited submissions are welcome. Editorials and 
commentaries should not exceed 1,000 words and 10 references. No abstracts are required.  
3. SUBMISSION OF MANUSCRIPTS 
All submissions must be made online at the Diabetic Medicine ScholarOne Manuscripts 
site. New users should first create an account. Once a user is logged onto the site, 
submissions should be made via the Author Centre.  
A Submission Checklist is available to help authors comply with the journal style and the 
submission requirements.  
4. PREPARATION OF MANUSCRIPTS 
Manuscripts must be written in English. 
Manuscript text must be saved in Word (.doc or .docx) or Rich text Format (.rtf). Please do 
not submit text in PDF format (.pdf).  
Figures must be saved as separate figure files. 
Abbreviations must be defined when first used in the abstract and in the main text, as well 
as when first used in table and figure captions.  
Manuscripts must be as succinct as possible. Repetition of information or data in different 
sections of the manuscript must be carefully avoided. Text must comply with the word limits 
defined in Section 2, and, where appropriate, include:  
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Title page 
The first page of all manuscripts should contain the following information:  
1) the title of the paper (maximum 50 words) 
2) a running head not exceeding 75 characters 
3) names of authors as initial(s) followed by surnames 
4) names of the institutions at which the research was conducted, clearly linked to 
respective authors 
5) name and email address of corresponding author 
6) manuscript word count 
7) a statement of all funding sources 
8) any conflicts of interest disclosures (see Section 5) 
9) a bulleted novelty statement (maximum 100 words) which describes the novelty of the 
data presented and their impact on the field (Research Articles, Short Reports and Case 
Reports only).  
Abstracts 
Authors submitting research articles and short reports should note that structured abstracts 
(maximum 250 words) are required. The structured abstract should adopt the format: Aims, 
Methods, Results, Conclusions.  
Structured abstracts for case reports should adopt the format: Background, Case Report, 
Discussion.  
Abstracts should contain no citations to previously published work.  
Review articles require abstracts but they need not be structured. Letters do not require 
abstracts.  
Text 
This should in general, but not necessarily, be divided into sections with the headings: 
Introduction, Patients and Methods, Results, Discussion, Funding, Conflicts of Interest, 
Acknowledgements, References, Tables, Figure Legends.  
Tables & figures 
Tables and figures should not be inserted in the appropriate place in the text but should be 
included at the end of the manuscript, each on a separate page.  
Tables and figures should be referred to in text as follows: Fig. 1, Figs. 2–4; Table 1, Table 2. 
Each table and/or figure must have a legend that explains its purpose without reference to 
the text; legends should include include keys to symbols and indicate the statistical 
significance of differences. Where a figure has more than one panel, each panel should be 
labelled in the top left-hand corner using lower case letters in parentheses, i.e., (a), (b), etc., 
and a brief description of each panel given in the figure legend.  
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Colour illustrations are welcomed and all colour is published free of charge to the author.  
Authors are themselves responsible for obtaining permission to reproduce previously 
published figures or tables. When an individual is identifiable in a photograph written 
permission must be obtained (see Section 5 below).  
Figure requirements 
Figure files should be provided in high resolution .eps format, minimum 800dpi (for graphs 
and charts) or .tiff format, minimum 300dpi (for photographs or a combination of images 
and text). Figures with multiple parts (A, B, C) or images should be provided as separate 
files. Do not copy and paste figure files into the manuscript word document.  
If you no longer have the original data to improve/recreate graphs, charts or combination 
figures to high resolution, please crop the graph area in Microsoft PowerPoint and re-type 
all text and numbers in the figure. Text should be Arial or Times New Roman in minimum 
14pts. Any lines in the figures must be at least 1.5 or 2pts thick. We accept .ppt files.  
For more information on file requirements, please refer to 
http://authorservices.wiley.com/prep_illust.asp.  
References 
References should be in Vancouver format and appear in the text as consecutive numbers in 
sƋuaƌe ďƌaĐkets, e.g., ͚iŶ ouƌ pƌeǀious ƌepoƌts [ϭ,Ϯ] aŶd those of Smith et al. [3–ϲ]͛ aŶd 
should be listed numerically in the reference list at the end of the article.  
Format references as below, using standard (Medline) abbreviations for journal titles. If 
multi-authored, include the first six authors followed by et al.  
1. Department of Health. The New NHS: Modern, Dependable. London: The Stationery 
Office, 1997.  
2. Fogari R, Mugellini A, Destro M, Corradi L, Lazzari P, Zoppi A et al. Losartan and 
amlodipine on myocardial structure and function: a prospective, randomized, clinical trial. 
Diabet Med 2012; 29: 24–31.  
3. Eye Care Wales. Screening for Diabetic Retinopathy. March 2009. Available at 
http://www.wales.nhs.uk/sites3/page.cfm?orgid=562&pid=12776 Last accessed 1 January 
2012.  
Reporting standards 
Manuscripts should adhere to reporting standards. Randomised controlled trials should 
adhere to the CONSORT Checklist. Observational studies should adhere to the relevant 
STROBE Checklist. Systematic reviews and meta-analyses should adhere to the PRISMA 
Checklist. Checklists must be completed and submitted electronically with the manuscript 
usiŶg file desigŶatioŶ ͚“uppoƌtiŶg DoĐuŵeŶt NOT foƌ PuďliĐatioŶ͛.  
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Style guide 
Diabetic Medicine does not recognise the term 'diabetic' as a noun. Preferred style is 
͚people ;oƌ peƌsoŶͿ ǁith diaďetes͛ oƌ ͚iŶ the gƌoup ǁithout diaďetes͛, ƌatheƌ thaŶ ͚diaďetiĐ 
people ;oƌ peƌsoŶͿ͛, 'diaďetiĐ patieŶt' oƌ ͚ŶoŶ-diaďetiĐ gƌoup͛. The teƌŵs 'TǇpe ϭ' aŶd 'TǇpe Ϯ 
diabetes mellitus' (abbreviated to Type 1 and Type 2 DM) are preferable to IDDM and 
NIDDM. 'Men' and 'women' should be used in preference to 'males' and 'females'. 
͚PaƌtiĐipaŶt;sͿ͛ oƌ ͚peƌsoŶ͛/͛people is pƌefeƌƌed to ͚patieŶt;sͿ͛ oƌ ͚suďjeĐt;sͿ͛.  
Abbreviations & units 
Except for units of measurement, abbreviations are strongly discouraged. Avoid 
abbreviations in the title of the manuscript and in the Abstract. The spelled-out abbreviation 
followed by the abbreviation in parentheses should be used on first mention unless the 
abbreviation is a standard unit of measurement.  
SI units must be used throughout except for blood pressure (mmHg) and haemoglobin (g/l). 
Gas or pressure values should be given as mmHg with kPa in parentheses or vice versa. 
Where molecular weight is known, the amount of a substance should be expressed in mol or 
appropriate subunit (mmol). Energy should be expressed in kcal or joules (J). The solidus 
may be used in a unit as long as it does not have to be employed more than once (e.g. 
mmol/l is acceptable), but ml/min/kg is not acceptable and should be replaced with ml min-
1 kg-1.  
HbA1c Measurement 
Diabetic Medicine has adopted dual reporting of glycated haemoglobin (HbA1c) 
measurement. HbA1c measurements must be reported in IFCC units (mmol/mol - no 
decimal point) in addition to derived NGSP units (% - one decimal). IFCC units should be 
listed first followed by NGSP units in parentheses. A HbA1c conversion table is available 
here. NG“P “D͛s ĐaŶ ďe ĐoŶǀeƌted diƌeĐtlǇ to IFCC “D͛s. To do so the slope of the Masteƌ 
Equation to convert NGSP results to IFCC units must be used. For example: 0.3% SD NGSP = 
0.3 X 10.93 = 3.3 mmol/mol SD IFCC (then round to the nearest integer).  
5. DECLARATIONS & PUBLICATION ETHICS 
Original publication 
Submission of a manuscript will be held to imply that it contains original unpublished work 
and is not being submitted for publication elsewhere at the same time. The author must 
supply a full statement to the Editor about all submissions and previous reports that might 
be regarded as redundant or duplicate publication of the same or very similar work. Data 
that have been published as an abstract of no more than 300 words in a scientific meeting 
are acceptable; the abstract reference should be quoted under the abstract.  
Conflicts of interest 
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Authors are responsible for disclosing all financial and personal relationships between 
themselves and others that might be perceived by others as biasing their work. To prevent 
ambiguity, authors must state explicitly whether potential conflicts do or do not exist.  
Ethics 
When reporting experiments on human subjects, indicate whether the procedures followed 
were in accordance with the ethical standards of the responsible committee on human 
experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as 
revised in 1983. Do not use patients' names, initials or hospital numbers, especially in 
illustrative material. When reporting experiments on animals, indicate whether the 
institution's or a national research council's guide for, or any national law on, the care and 
use of laboratory animals was followed. A statement describing explicitly the ethical 
background to the studies being reported should be included in all manuscripts in the 
Materials and Methods section. Ethics committee or institutional review board approval 
should be stated.  
Patients have a right to privacy that should not be infringed without informed consent. 
Identifying information should not be published in written descriptions, photographs and 
pedigrees unless the information is essential for scientific purposes and the patient (or 
parent or guardian) gives written informed consent for publication. Identifying details 
should be omitted if they are not essential but patient data should never be altered or 
falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and 
informed consent should be obtained if there is any doubt. For example, masking the eye 
region in photographs of patients is inadequate protection of anonymity.  
Authorship 
All persons designated as authors should qualify for authorship and all those who qualify 
should be listed. Each author should have participated sufficiently in the work to take public 
responsibility for appropriate portions of the content. One or more authors should take 
responsibility for the integrity of the work as a whole, from inception to published article. 
Authorship credit should be based only on 1) substantial contributions to conception and 
design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or 
revising it critically for important intellectual content; 3) final approval of the version to be 
published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of 
data or general supervision of the research group, by themselves, do not justify authorship. 
All others who contributed to the work who are not authors should be named in the 
Acknowledgements section.  
Committee on Publication Ethics (COPE) 
As a member of the Committee on Publication Ethics (COPE), adherence to these submission 
criteria is considered essential for publication in Diabetic Medicine; mandatory fields are 
included in the online submission process to ensure this. If, at a later stage in the submission 
process or even after publication, a manuscript or authors are found to have disregarded 
these criteria, it is the duty of the Editor to report this to COPE. COPE may recommend that 
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action be taken, including but not exclusive to, informing the authors' professional 
regulatory body and/or institution of such a dereliction.  
The website for COPE may be accessed at: http://publicationethics.org/ 
6. ADDITIONAL INFORMATION ON ACCEPTANCE 
Copyright 
If your paper is accepted, the author identified as the formal corresponding author for the 
paper will receive an email prompting them to login into Author Services; where via the 
Wiley Author Licensing Service (WALS) they will be able to complete the license agreement 
on behalf of all authors on the paper.  
For authors signing the copyright transfer agreement 
If the OnlineOpen option is not selected the corresponding author will be presented with 
the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be 
previewed in the samples associated with the Copyright FAQs below:  
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp 
For authors choosing OnlineOpen 
If the OnlineOpen option is selected the corresponding author will have a choice of the 
following Creative Commons License Open Access Agreements (OAA):  
 Creative Commons Attribution Non-Commercial License OAA   Creative Commons Attribution Non-Commercial -NoDerivs License OAA  
To preview the terms and conditions of these open access agreements please visit the 
Copyright FAQs hosted on Wiley Author Services 
http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit 
http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.  
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and 
members of the Research Councils UK (RCUK) you will be given the opportunity to publish 
your article under a CC-BY license supporting you in complying with Wellcome Trust and 
‘eseaƌĐh CouŶĐils UK ƌeƋuiƌeŵeŶts. Foƌ ŵoƌe iŶfoƌŵatioŶ oŶ this poliĐǇ aŶd the JouƌŶal͛s 
compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.  
For RCUK and Wellcome Trust authors click on the links below to preview the terms and 
conditions of this license:  
 Creative Commons Attribution License OAA 
To preview the terms and conditions of these open access agreements please visit the 
Copyright FAQs hosted on Wiley Author Services 
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http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit 
http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.  
OnlineOpen 
OnlineOpen is available to authors of primary research articles who wish to make their 
article available to non-subscribers on publication, or whose funding agency requires 
grantees to archive the final version of their article. With OnlineOpen, the author, the 
author's funding agency, or the author's institution pays a fee to ensure that the article is 
made available to non-subscribers upon publication via Wiley Online Library, as well as 
deposited in the funding agency's preferred archive.  
To preview the terms and conditions of these open access agreements please visit the 
Copyright FAQs hosted on Wiley Author Services 
http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit 
http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html. 
All OnlineOpen articles are treated in the same way as any other article. They go through 
the journal's standard peer-review process and will be accepted or rejected based on their 
own merit.  
Note to NIH Grantees 
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions 
authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version 
will be made publicly available 12 months after publication. For further information, click 
here.  
Proofs 
The corresponding author will receive an email alert containing a link to a web site where 
the proofs can be downloaded as an Acrobat PDF. A working e-mail address must therefore 
be provided for the corresponding author. In the absence of the corresponding author, 
please arrange for a colleague to access the e-mail to retrieve the proofs.  
Acrobat reader can be downloaded (free of charge) from the following website: 
http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be 
opened, read and corrected on screen. Further instructions will be sent with the proof.  
Please note that you have final responsibility for what is stated in the proofs of your 
manuscript. Significant textual alterations are unacceptable at proof stage without the 
written approval of the Editor-in-Chief, and they are likely to result in the delay of 
publication.  
Author Services 
Author Services enables authors to track their article—once it has been accepted—through 
the production process to publication online and in print. Authors can check the status of 
their articles online and choose to receive automated e-mails at key stages of production. 
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The author will receive an e-mail with a unique link that enables them to register and have 
their article automatically added to the system. Please ensure that a complete e-mail 
address is provided when submitting the manuscript. Visit Author Services for more details 
on online production tracking and for a wealth of resources including FAQs and tips on 
article preparation, submission and more.  
Accepted Articles 
Further to acceptance in Diabetic Medicine, manuscripts are immediately made publicly 
available online. 'Accepted Articles' have been peer-reviewed and accepted for formal 
publication, but have not been subject to copyediting, composition or proof correction. The 
service provides for the earliest possible dissemination of research data following article 
acceptance. Accepted Articles appear in PDF format only and are given a Digital Object 
Identifier (DOI), which allows them to be cited and tracked. The DOI remains unique to a 
given article in perpetuity and can continue to be used to cite and access the article further 
to print publication. More information about DOIs can be found online at 
http://www.doi.org/faq.html. Accepted Articles will be indexed in PubMed.  
Neither Diabetes UK nor Wiley can be held responsible for errors or consequences arising 
from the use of information contained in Accepted Articles; nor do the views and opinions 
expressed necessarily reflect those of Diabetes UK or Wiley.  
Early View 
Research Articles (Research: Subcategory and Short Report: Subcategory) accepted by 
Diabetic Medicine are covered by Wiley-BlaĐkǁell PuďlishiŶg͛s EaƌlǇ Vieǁ seƌǀiĐe. Early View 
articles are complete full-text articles published online in advance of their publication in a 
printed issue. Articles are therefore available as soon as they are ready, rather than having 
to wait for the next scheduled print issue. Early View articles are complete and final. They 
haǀe ďeeŶ fullǇ ƌeǀieǁed, ƌeǀised aŶd edited foƌ puďliĐatioŶ, aŶd the authoƌs͛ fiŶal 
corrections have been incorporated. Because they are in final form, no changes can be 
made after online publication. The nature of Early View articles means that they do not yet 
have volume, issue or page numbers, so Early View articles cannot be cited in the traditional 
way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be 
cited and tracked before it is allocated to an issue. After print publication, the DOI remains 
valid and can continue to be used to cite and access the article.  
Offprints 
A PDF offprint of the online published article will be provided free of charge to the 
corresponding author via Author Services. Paper offprints of the printed published article 
may be ordered online. Please click on the following link, fill in the necessary details and 
ensure that you type information in all of the required fields: 
http://offprint.cosprinters.com. If you have queries about offprints please e-mail 
offprint@cosprinters.com. 
